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BTAC benzyltrimethylammonium chloride 
BTMSA bis-trimethisilylacetylene 
BuLi n-butyl lithium 
'Bu tert-butyl 
Bz benzoyl 
CAN ceric ammonium nitrate 
Cbz carbobenzyloxy 
CEVE chloroethyl vinyl ether 
Cp* C5Me5 
CSA camphor sulfonic acid 
DBU 1 ,8-diazabicyclo[5,4,O]undec-7-ene 
DCM dichioromethane 
d.e. diastereomeric excess 
DEAD diethyl azodicarboxylate 
DEKM diethylketomalonate 
DHAP dihydroxyacetone phosphate 




DPPA diphenylphosphoryl azide 
DS dodecyl sulfate 
E.I. electron impact 




EVE ethyl vinyl ether 
FAB fast atom bombardment 
FucT fucosyltransferase 
GDP guanosine diphosphate 
IEDDA inverse electron demand Diels-Alder 
J coupling constant 
LDA lithium diisopropylamide 
MeLi methyl lithium 
mp melting point 
m/z mass/charge ratio 
NMO N-methyl-morpholine-N-oxide 
NMR nuclear magnetic resonance 
Nuc nucleophile 
P generic protecting group 
Ph phenyl 
R generic substituent 
RF retention factor 
sat. aq . saturated aqueous 
sLe' sialyl Lewis-X 
TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TBVE tert-butyl vinyl ether 
TEMPO 2,2 ,6,6-tetramethyl- 1 -piperidinyloxy 
Tf trifluoromethylsulfonyl (triflyl) 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TIPS tri-iso-propylsilyl 
tic thin layer chromatography 
TMS trimethylsilyl 









This thesis describes the design and testing of various strategies for the synthesis of 
the polyhydroxylated bis-hydroxymethyl piperidine i, a component of a potential 







The first chapter reviews the current methods by which complex piperidines are 
synthesised and outlines the aims of this project. The second chapter describes the 
attempted construction of an appropriate linear precursor for a nucleophilic 
cyclisation of an amine onto an epoxide. This chapter also describes an approach 
which attempted the electrophilic cyclisation of an alkene onto an imine, however an 
aza-Cope [3,3]-sigmatropic shift took precedence. The third chapter describes 
attempts to construct the target via a catalytic aza-Diels-Alder reaction of an 
oxazinone. The fourth chapter describes an approach in which an inverse electron 
demand Diels-Alder reaction was used to establish the core stereochemistry. The 
piperidine ring was set up via a ring cleavage/reclosure method incorporating a 
Hofmann rearrangement and oxidative cleavage of an alkene. This method was used 
to synthesise the piperidine ii, however time constraints did not allow the extension 
of the approach beyond this test-case to the target i. 
ZH2Ae 	
. AcO'' 
6H 	 6R 	 6H 
ii iii 
It is proposed that a simple, efficient and adaptable methodology for the synthesis of 
this motif has been established. 
x 
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Chapter 1: Introduction 
Part I: The biological significance of L-fucose 
The role of carbohydrates in biology 
The biological importance of carbohydrates in the storage and transport of energy for 
living cells has long been known. Recently, carbohydrates have also been identified 
as essential mediators of cell-cell and cell-protein interactions, and hence they play a 
key role in signalling and recognition processes within the body. Research into this 
new area has already provided some promising results, leading to the development 
and testing of carbohydrate-based therapeutics.' 
Most carbohydrates of biological importance are covalently linked monosaccharide 
polymers known as oligosaccharides or glycans. These oligosaccharides can be 
expressed on cell membranes or attached to external residues of proteins 
(glycoproteins) allowing interaction with the chemical environment surrounding the 
host. Processes such as the immune response, the interaction of bacteria, viruses or 
cancer cells with their surroundings and the mechanisms of tissue growth and repair 
are all believed to rely on this type of molecular recognition. Hence, the ability to 
regulate the biosynthesis of these oligosaccharides could be beneficial. 
The biological response to foreign bodies 
One area in which oligosaccharide induced cell-cell adhesion has been highlighted is 
the recruitment of white blood cells (leukocytes) to the site of an injury (figure l).' 
This process occurs via a complex series of events, triggered by the release of 
signalling molecules called cytokines from the affected area (a). The cytokines cause 
the endothelial cells lining the capillaries to change shape and express glycoproteins 
called E-selectins on their surface (b). The glycoprotein interacts with a 
tetrasaccharide called sialyl Lewis x (sLex)  anchored to the cell membrane of 
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leukocytes, causing the latter to adhere to the endothelium and pass though to the site 
of injury (c). 
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(a) Release of cytokines; (b) activation of endothelial cells; (c) recruitment of leukocytes. 
Figure 1 
In general this process is favourable. However the recruitment of too many 
leukocytes can be detrimental, as is the case in septic shock, chronic inflammatory 
diseases such as psoriasis and rheumatoid arthritis, and the reperfusion tissue injury 
that occurs following a heart attack, stroke or organ transplant. 2 It has also been 
reported that high levels of sLe' are expressed on the surface of certain tumor and 
cancer cells, suggesting that they exploit the adhesion process during metastasis. 4 
Consequently, an inhibitor of the association between sLex  and E-selectin could be 
useful as an anti-inflammatory or anti-cancer agent. 
2 
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Inhibition of the cell-protein interaction 
An attempt to effect this inhibition might follow one of two different approaches. 
The first is centred on the design of sLe' analogues which could compete with the 
intracellular sugar moiety for the E-selectin binding site and hence decrease the 
efficiency of leukocyte (or cancer cell) adhesion. Although the synthesis and testing 
of various analogues has been reported in the literature, 5-7  the chemical synthesis of 
such oligosaccharides tends to be lengthy and impractical for large scale production. 
Some enzymatic syntheses have been developed but this approach can also have 
drawbacks, namely expensive and unstable reagents, enzymatic inhibition by the 
products and poor availability of the required glycosyltransferase enzymes. 
A more subtle approach would be to inhibit one or more glycosyltransferase enzymes 
involved in the biosynthetic pathway of sLe'. Inhibition of a key enzyme would 
decrease the amount of the oligosaccharide on the membranes of the target cells, 
reducing their affinity for the endothelium, and hence repress the recruitment of 
leukocytes. As there are very few cases described in the literature in which this 
approach has been attempted, 81° such an inhibitor would be an interesting synthetic 
target. 
Glycosidase and glycosyltransferase inhibition 
Although relatively little is known in detail about the mechanism of glycosyl transfer 
employed by glycosyltransferases, they are thought to operate in a manner similar to 
glycosidases" (the reverse process of glycosyl transfer). Glycosidases have been the 
focus of much research, and hence an examination of glycosidase inhibition should 
provide an insight into the complementary process. 
Early glycosidase inhibitors identified include 6-aldonolactones (such as 1) or 
glycosylamines (such as 2). Whilst these analogues of monosaccharides displayed 
competitive inhibition of glycosidases they lacked long term stability in aqueous 
solution. 
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Figure 2 
In recent years, however, some natural glycosidase inhibitors with polyhydroxylated 
piperidine and pyrrolidine motifs have been isolated from plants and microorganisms 
(e.g. 3, 4 and 5). Apart from the basic structural similarities between these azasugars 
and their equivalent glycosides, it is thought that protonation of the ring-nitrogen, 
which occurs at physiological pH, results in an cation which is stereoelectronically 
and geometrically similar to the oxonium transition state in the natural process, thus 
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Figure 3 
The synthesis of unnatural azasugars has attracted much interest in recent years, and 
has been useful in probing the mechanisms and specificity of various glycosidases. 
One recent example has been the synthesis from L-gulonolactone 6 of amine 7, a 
bicyclic mimic of a-L-fucose, in 36% overall yield (scheme l). 
El 
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a) MeS0 20, DCM, pyridine, -20°C; then NaN 3 , DMF; b) MeLi, THF, -70°C; c) Amberlite 
IR-120, H form, H 20; d) H2 , Pd/C, H 20; 36% overall yield. 
Scheme 1 
The bicyclic amine 7 proved to be a powerful inhibitor of fucosidases (e.g. Ki = 6 
.iM against human liver (x-fucosidase), but exhibited only weak inhibition of human 
ct-( 1 ,3)-fucosyl transferase. N-acetylated and N-alkylated analogues had no effect on 
any of the enzymes studied indicating that a basic site may be helpful in increasing 
binding between the bicyclic fucose mimics and the target enzymes. 
The failure of glycosidase inhibitors to show the same activity towards their 
complementary glycosyltransferases might be explained by examining the transition 
state for the transfer process. It has been proposed that the mechanism for glycosyl 
transfer from a GDP-glycoside to an OH group of another glycoside proceeds via an 
ion-pair mechanism involving a flattened half-chair glycosyl cation transition state 8, 
thus implying that the GDP-glycoside and the acceptor sugar are interacting with the 
enzyme simultaneously (figure 4, using fucosyl transfer as an example). 12  It is 
believed that the pyrophosphate fuctionality chelates to a divalent metal cation 
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Figure 4 
This proposal has recently been supported by research on ct( 1 ,3)-fucosyltransferase-
V, a human FucT, implying an ordered, sequential mechanism with GDP-fucose 
binding first and GDP released last.' 3 The results also suggest that significant 
cleavage of the GDP-fucose bond occurs prior to nuclophilic attack by the acceptor 
hydroxyl group, in keeping with an intermediate mechanism between SN 1 and SN2. 
Whilst an azasugar alone might be sufficient to inhibit glycosidases, it is clear that a 
glycosyltransferase inhibitor would require all three sections (the azasugar, the 
pyrophosphate group and the acceptor glycoside) in order to mimic the transition 
state 8 accurately. 
This proposal is supported by results implying synergistic inhibition of an a(1,3)-  
fucosyltransferase. 6, 10 When two potent a-L-fucosidase inhibitors were tested 
against an a( 1 ,3)-FucT in the presence of an acceptor (LacNAc) they showed only 
moderate inhibition, but the effect was increased on addition of GDP. It is believed 
that the azasugar, acceptor sugar and GDP interact in the active site thus providing 















Further development of this idea has led to the synthesis of the trisubstrate (e.g. 9) 
and bisubstrate (e.g. 10) analogues (figure 6), in which two or three components of 













The trisubstrate analogue 9 has shown potency as an inhibitor of several UDP- 
glucuronosyltranferases,' 4 however the bisubstrate analogue 10 showed 
disappointing inhibition: only a slight increase compared with free GDP. 12  This 
suggests that the enzyme is strongly dependant upon recognition of the phosphate 
moiety via chelation to the divalent cation metal cofactor. 
The importance of this chelation has encouraged the search for effective, non-
charged pyrophosphate mimics which might permit easier transport across the cell 
membrane. Malonate (11), tartrate (12) and monosaccharide (13) linkages have been 
tested, but were, in general, poor substitutes.' 5 
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Figure 7 
Inhibitor design 
The biosynthetic pathway to sLe' must be understood in order to plan an effective 
approach to hinder its formation. It has been shown that the final step is the addition 
of the fucose moiety by an a-1,3-fucosyltransferase enzyme and that the hydroxyl 
groups of fucose are necessary for biological activity ; 2 therefore it is proposed that 
inhibition of this enzyme would result in the desired reduction in sLe' biosynthesis. 
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The trisubstrate analogue 14, which possesses each of the three components believed 
to interact simultaneously with the enzyme, might be an effective transition state 
mimic and hence show inhibitory properties toward the a( 1 ,3)-FucT enzyme 
involved in sLex  biosynthesis. 
0 
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By analogy with known glycosidase inhibitors, the protonated azasugar moiety 
should mimic the oxonium transition state whilst maintaining the substitution pattern 
of the fucose ring. In addition, it is hoped that the use of a bis-hydroxymethyl 
functionality to connect the three components will mimic the elongated C-O bonds in 
the transition state and also make the molecule more stable, the quaternary 
"anomeric" carbon being less susceptible towards hydrolysis or metabolism. 
The key part of this proposed inhibitor is the polyhydroxylated piperidine core, and it 
is this that represents the major synthetic challenge of this project. 
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Part II: Piperidine synthesis 
The piperidine motif is one of the most common building blocks of both natural and 
unnatural products with interesting biological properties.' 6 For this reason a lot of 
work has been carried out to investigate the possible methods of constructing this 
moiety and, more recently, doing so in a stereoselective fashion. 17  The key synthetic 
steps that have been developed range from traditional methods, such as SN2-
displacements, to transition metal catalysis and enzymatic processes. 
This section will present and discuss some of these methods, however, as the area of 
piperidine synthesis is vast, this report will only provide a brief overview with 
particular attention being given to the most recent procedures and to those which 
employ more original methodologies. 
SN2 displacement reactions 
Possibly the simplest and most common procedure for the synthesis of piperidines is 
the intramolecular nucleophilic displacement of a good leaving group by an amine. 
Halides and activated alcohols such as sulfonates and phosphates have all been used 
effectively in this approach.' 7  Often, the majority of the synthesis is dedicated to the 
formation of the linear precursor, either via stereoselective bond formation or 
manipulation of chiral pool molecules, with the ring formed in the latter stages. 
Recently, Kazmaier and co-workers have reported the synthesis of highly substituted 
piperidines using this method. ' 82 ' The acyclic precursor 15 was synthesised in 99% 
d.e. via an asymmetric aldol reaction using tin catalysis. Removal of the benzyl 
protection afforded the primary alcohol 16 which was cyclised to the piperidine 17 in 
an excellent 92% yield using Mitsunobu conditions (scheme 11). The authors state 
that the approach affords a "straightforward and highly stereoselective synthesis of 
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Conditions: 
(a) i) 2.5 equiv. LDA ii) 2.5 equiv SnC1 2, 90%; iii) isomer separation; (b) H 2, Pd-C, MeOH, 
94%; (c) PPh 3 , DEAD, THF, ii, 30 mm, 92%. 
Scheme 11 
Recently, Liu et al. reported a convenient method for the construction of chiral 
piperidines and piperidinones involving the desymmetrisation of prochiral 
anhydrides using an amine nucleophile. 22 The anhydride 18 was prepared using 
conventional methods and treated with (5)-a-methylbenzylamine and triethylamine 
at low temperature to afford the chiral amide 19 in greater than 94% d.e. and Ca. 70 
% yields after purification (scheme 3). Reduction of the carboxylic acid followed by 
bromination and cyclisation via a simple SN2  displacement afforded the piperidinone 
21, which was alkylated stereoselectively using standard procedures. The N-
protected piperidine 23 was generated by reduction and, following side chain 
manipulations, simple hydrogenation afforded the free amine 25. 
11 
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Ph 	 Ph 	 Ph 
25 	 24 	 23 	 22 
R = 4-fluorophenyl-; R' = (1,3-benzodioxol-5-yloxy)methyl- 
Conditions: 
(a) (S)-methylbenzylamine, NEt 3 , toluene, -78°C -+ ii, 20h, 70%, >94% d.e.; (b) i) NEt 3 , 
isobutyl chioroformate, THF, -78 - 0°C, 20h then NaBH4, water, 0°C --> rt, 20h, 86%; ii) 
PBr3 , cone. hydrobromic acid, 0°C —* ii, 4 days, 70%; (c) NaH, THF, reflux, 20h, 85%; (d) 
LDA, CICO2Me, THF, -78°C, 4h, 78%, 99% d.e.; (e) LiA1H 4 THF, reflux, 72h, 65%; (f) H2 , 
Pd-C, MeOH, 68%. 
Scheme 3 
In a recent paper, Kobayashi et al. generated a complex cyclisation precursor 27 via 
a Mannich type reaction of aldehyde 26 employing a Lewis acid-surfactant-
combined catalyst (LASC) in water. 23 Spontaneous cyclisation occurred upon 
bromination at the appropriate position to afford the protected piperidine 28. 
Treatment with cerium ammonium nitrate removed the o-methoxybenzyl protection 
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Conditions: 
(a) Yb(DS) 3 , H20, 0°C, 95%, syn:anti = 40:60; (b) i) HF, quant.; ii) Ph 3P, CBr4 , 89%; iii) 
isomer separation; (c) CAN, 78%. 
Scheme 4 
Nucleophilic epoxide opening 
It has been reported that alkynyl epoxides can be opened by N-tosyl amines if the 
alkyne is precoordinated to CO2(CO)8. 24 In this way, the epoxide 30 was converted to 
the piperidine 31 and 32 in 85% yield with a 9:1 ratio of diastereomers. The alkyne 
functionality could be recovered using cerium ammonium nitrate (scheme 5). This 
result is interesting as it was also reported that the pyrrolidine 33 was the major 
product if the precoordination of CO 2(CO)8 was not carried out. This process 
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OAc 	 OAc 
Tosyl 	 Tosyl 
33 34 
Conditions: 
(a) i) CO 2(CO) 8 ; ii) BF 3 .OEt2 ; iii) CAN, 85%, 31:32 = 9:1; (b) 8F 3 .OEt2 ; ii) Ac20. 33:34 = 
91:9. 
Scheme 5 
Reduction of ö -Iactams 
Another common procedure for the synthesis of piperidines is the reduction of ö-
lactams formed by simple condensation procedures. Altenbach and Himmeldirk have 
reported an elegant synthesis of (5)-deoxy-allo-nojirimicin by lactamisation and 
reduction (scheme 6).25  The amine 35 underwent a spontaneous intramolecular 
cyclisation onto the a,3-unsaturated ester upon nitrogen deprotection to afford the 
lactam 36. Formation of the oxazolidine blocked the top face (as drawn) of the 
molecule, preventing osmium tetroxide dihydroxylation on the undesired face. After 
some protecting group manipulations, the lactam functionality was reduced with 
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Conditions: 
(a) i) Et20/H20/TFA 1:1:3, rt, lh; ii) EtOAc, sat. aq . NaHCO 3 , rt, 15h; (b) i) PhH, 2,2-DMP, 
TsOH, 78°C; ii) acetone/H 20, 1:1,4% 0s0 4 , NMO, rt, 55h; MeOH, NEt 3 , (9:1) rt, 18h; (c) i) 2N 
HCI, 50°C, 5h; ii) TDSCI, py, rt, 40h; iii) BH 3 .SMe2, THF, 24h - Dowex® 50X8-400 H 
Scheme 6 
Some elegant syntheses of polyhydroxylated piperidines have been reported by Fleet 
and co-workers which take advantage of the complex substitution patterns naturally 
found in sugars . 263 ' A recent example is the synthesis of 5-epi-deoxyrhamnojirimicin 
42 from L-rhamnose. 26 The nitrogen was introduced via displacement of a triflate 
with sodium azide to afford the lactone 40. Upon hydrogenation, the amine 
intermediate underwent a spontaneous cyclisation to the lactam 41, which was 
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Conditions: 
(a) i) Tf20, pyridine, DCM, -40°C; ii) NaN 3 , DMF; (b) H 2 , 10% Pd-C, MeOH; (c) BH 3 .SMe2 , 
THF then cone. HC1, EtOH. 
Scheme 7 
Amat et al. utilised the conjugate addition of organocuprates to chiral bicyclic 
lactams such as 43 as the key asymmetric step in the synthesis of 3,4,5-trisubstituted 
piperidines.32 Reduction of the lactone 44 using lithium aluminium hydride and 
aluminium chloride, followed by deprotection of the piperidine 45 afforded the 
trisubstituted product 46 (scheme 8). The authors attribute the selectivity to a 
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R = CO2Bn 
Conditions: 
(a) PhCu(CN)Li, THF, -78°C, 80%; (b) Aid 3 , LiAIH4 , THF, 25°C, 80%; (c) i) H 2 , Boc 20, 
Pd(OH) 2 , EtOAc, 25°C, 75%; ii) TFA, DCM, 55%. 
Scheme 8 
Earlier this year, Freville et al. reported an interesting reaction of a chiral lactim 
ether 48 with acetylacetone in the presence of a nickel catalyst. 33  Stereoselective 
reduction of the product enamine 49 with lithium aluminium hydride or 
hydrogen/Raney nickel afforded the ketone 50 or alcohol 51 respectively (scheme 9). 
17 
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Conditions: 
(a) (CH 3)2SO 4 ; (b) acetylacetone, Ni(acac) 2 , heat; (c) LiAIH 4 ; (d) H2 , Raney Ni, MeOH. 
Scheme 9 
Metathesis 
Transition metal catalysed metathesis reactions have been developed during the last 
decade and have proven to be extremely useful for the preparation of large ring 
systems in good yields. 34,35  It is only recently that this versatile reaction has been 
applied to the synthesis of smaller ring systems, and to piperidines in particular. Most 
of the recent results can be summarised as the construction of an appropriate 
allyl/homoallyl substituted amine precursor 52, which is subjected to ring closing 
metathesis (RCM) conditions to give the piperidine 53 as demonstrated in 
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Scheme 10 
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Hassner and co-workers reported the synthesis of the piperidine 57 by RCM of the 
amine 55 using Grubbs catalyst 56 at room temperature (scheme 11).36  The 
secondary amine 55 was generated by simple allylation of compound 54 with allyl 
bromide and potassium carbonate. 
LSO2Ph 







cI cy3 	 o 
54 	 55 PCy3 Ph 	 57 
56 
Conditions: 
(a) allyl bromide, K2CO3,  DMF, 0°C —* rt; ii) CH 3 COCI, NEt3 , PhH, 0°C —* rt; (b) 56, DCM, 
Ft. 
Scheme 11 
Similarly, Agami et al. report the use of Grubbs catalyst 56 to effect the RCM of 
simple N-Boc amines such as 58 to synthesise 2-substituted-N-Boc-A-4,5-piperidines 
37 59 in excellent yields (scheme 12). A more recent paper reports the extension of 
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Sabat and Johnson used RCM of carbamate 60 as the key step in their synthesis of 
4-hydroxypipecolic acid derivatives from vinyiglycinol in good yields (scheme 13).39  
These unnatural amino acids are useful chiral building blocks for biologically active 
molecules as is demonstrated by the conversion of the RCM product 61 into the 
naturally occurring biologically active compound 62. 
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(a) Grubbs catalyst 56, DCM, 88%; (b) i) Dess-Martin, DCM; ii) CH 3CH=CHCH=PPh 3 , 
THF; iii) 12,  benzene, h v, 30 mm; (c) AcCI, MeOH. 
Scheme 13 
Banba et al. employed RCM as the key step in the synthesis of fagomine 67 (and 
some of its congeners) which is a natural product and glucosidase inhibitor . 40 The 
authors used the D-serine derived Garner aldehyde 63 as the chiral starting point in 
the synthesis of the precursor 64 which was subjected to a typical RCM procedure 
using Grubbs catalyst 56 in order to establish the ring system. Further manipulation 
using standard chemical procedures afforded the polyhydroxylated products such as 
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(a) Grubbs Catalyst 56, DCM, 97%; (b) Oxone ®, CF3 COCH3 , NaHCO3 , aq. Na2 .EDTA, 
MeCN, 30% (anti-isomer: 60%); (c) H2SO4, dioxane, water, 44%. 
Scheme 14 
In 2000, Voigtmann and Blechert reported a more unusual approach in which a 
ruthenium catalyst 56 is used to synthesise a disubstituted piperidine via a domino 
ring-opening/ring-closing metathesis (ROM/RCM) procedure (scheme 1 5).4 1 
OAc 
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The precursor 70 was synthesised via a palladium catalysed allylation of the allyl 
acetate 68 with retention of stereochemistry. Submission of the cyclopentene 70 to 
the metathesis conditions afforded the pipecolic acid derivative 71 in an excellent 
95% yield. Subsequent reactions converted this piperidine to the novel bicyclic 
indolizidine 72 in 7% overall yield. This example highlights the versatility of this 
reaction for the facile synthesis of highly substituted derivatives as both alkenes of 
ROM/RCM product 71 are used as "handles" to introduce other functional groups 
by, for example, dihydroxylation or oxidative cleavage. 
Intramolecular hydroamination 
Molander et al. recently reported the synthesis of pinidinol 76, a 2,6-di substituted 
piperidine via an intramolecular hydroamination reaction using a neodymium 
catalyst (scheme 16). 42  
NH 2 OTBDPS a 	 OTBDMS 	b 	 OH 
N 	 ".. 
74 	 75 	 76 
Pinidinol 
Proposed Transition state 
Conditions: 
(a) 9% Cp*2NdCH(TMS)2, CA, rt, 90%; (b) i) KOH, MeOH then HCI; ii) KOH, 66%. 
Scheme 16 
Treatment of the amino alkene 74 with the catalyst in deuterobenzene at room 
temperature afforded the cyclised product 75 in excellent 90% yield and greater than 
100:1 diastereoselectivity in favour of the cis-disubstituted piperidine 75. The 
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proposed transition state 77 is used to account for the high selectivity. Simple 
deprotection of the alcohol afforded the natural product 76. 
Rearrangements 
In 1986 Ciufolini reported the rearrangement of N-(furfurylmethyl)sulfonamides to 
piperidines. 43 Recently, Koulocheri and Haroutounian applied this methodology to 
the synthesis of the piperidine 	D-Glucal 78 was converted to the chiral, 
nonracemic N-furfurylsulfonamide 79 which underwent the rearrangement after 
treatment with inCPBA to give the aminal 80 (scheme 17). The (2S)-hydroxymethyl-
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(a) i) H9SO4 , H2SO4,  MeOH; ii) TBDPSCI, imid., DMAP, DMF, 92%; iii) DPPA, DBU, toluene, 
0°C, 84%; iv) H 2 , Pd-C, MeOH, then TsCI, Et3N, DCM, 87%; (b) mCPBA, DCM, 91%; (c) i) 
HC(OE03 , BF3 .OEt2 , 4A mol. sieves, THF, 0°C, 81%; ii) NaBH 4, CeC13 .71120, MeOH -30°C; iii) 





Piperidines can also be synthesised using an aza-Diels-Alder reaction of a diene with 
an imino dienophile. The most common procedure uses Danishefsky's diene 457 and 
an appropriate imine which is attached to a chiral auxiliary in order to control the 
stereoselectivity. 17 Recently, however, Kobayashi reported the first catalytic 
enantioselective aza-Diels-Alder reaction between the diene 84 and the imine 85 for 
the synthesis of the piperidinone 86 in 93% yield and 93% e.e. using a chiral 
Zr/BINOL catalyst 87 (scheme 18).48 
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(a) [Zr] 87, 1-methylimidazole, toluene, -45°C, 93%, 95%e.e. 
Scheme 18 
Yu et al. describe the use of lanthanide triflates to catalyse the aqueous aza-Diels-
Alder reaction of an imine with cyclopentadiene.49' 50  The imine is generated in situ 
from the condensation of benzylamine hydrochloride with a carbohydrate-derived 
aldehyde 88. A number of lanthanide catalysts were tested and the best proved to be 
neodymium triflate, which afforded a 44% yield of the bicyclic amine 89. It was 
reported that this yield increased to 72% when 40mol% of the catalyst was used. 
Further manipulation of this product completed the synthesis of the complex bicyclic 
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(a) cyclopentadiene, benzylamine hydrochloride, Nd(OT0 3 , water, 48h, 44%. 
Scheme 19 
1,3-Dipolar cycloaddition 
Herdeis and Schiffer have recently reported the use of a tandem Wittig - [2+3] 
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(a) Ph 3P=CHCO2Et, toluene, 20°C, 4 days; (b) NEt 3 (cat.); (c) toluene, 100°C, 14h; (d) i) 




The azide precursor 91 was treated with ethoxycarbonyl 
methylene(triphenyl)phosphorane to yield the alkene 92 which spontaneously 
cyclised to afford a 2:1 mixture of triazolines 93 and diazomines 94. Addition of base 
and subsequent heating afforded the single product enamine 95, which was 
stereoselectively reduced from the less hindered face by catalytic hydrogenation to 
give the piperidine 96. 
Claisen rearrangement 
Angle and Henry recently reported the total synthesis of (-)-methyl palustramate 102 
in which the key step was a conformationally restricted Claisen rearrangement 












LCLAISEN IPSO 	 0 	OTIPS MeO2C 	 X H 	 TIPS OH 	 ) 	 Ph Ph 
102 	 101 100 
Conditions: 
(a) i) DIBAL; H 2C=CHMgBr, 71%; ii) LiA1H 4, 89%; (b) BrCH 2CO2Ph, EtN('Pr)2, 71%; 
(c) ('Pr) 3 SiOTf, NEt3 , 96%. 
Scheme 21 
The precursor 99 was prepared as a 32:1 mixture of diastereomers in three steps from 
the lactone 97. Treatment of alkene 99 with base and TIPSOTf generated the silyl 
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enol ether 100 which spontaneously underwent a Claisen [3,3]-sigmatropic shift to 
give the pipecolic ester 101 in excellent 96% yield. Side chain modifications and 
deprotection of the nitrogen afforded the target 102. 
Enzymatic procedures 
Monterde et al. reported the cyclisation of an imine with displacement of a primary 
alkyl bromide as the ring forming step (scheme 22). Interestingly, the cyclisation 
precursor was formed using an enantioselective (R)-oxynitrilase-catalysed trans 
cyanation of aldehyde 103 followed by silylation to give the protected cyanohydrin 
104 in good yield and enantiomeric excess. Addition of a Grignard reagent afforded 
the metallated imine 105 which cyclised spontaneously under the basic reaction 
conditions to afford the cyclic imine 106. Stereospecific reduction to the carbamate 


























(a) i) (R)-Oxynitrilase, 2-pentanone/2-hexane cyanohydrin; ii) TBDMSC1, imid., DMAP 
(cat.), DCM, 90%; (b) PhMgBr, THF; (c) i) MeOH; ii) NaBH 4 ; iii) CbzCl, H20,92%; (d) 




Wong and co-workers have developed an elegant chemoenzymatic strategy for the 
synthesis of azasugar analogues. 5'8' 56-58  The synthesis of the complex piperidine 114 
is reported in a recent paper .56  The key steps are the construction of the imido-sugar 
110 via an enzymatic aldol reaction followed by hydrogenation to afford the amine 
111 which cyclises spontaneously to afford cyclic imine 112. The imine 112 is a 
versatile intermediate which can be simply converted to a family of complex 
piperidines including the novel amino iminocyclitol 114 (scheme 23). 
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109 110 111 
1k 
CN 
OH 	d 	 H' 	OH 	C 	 _jSI OH 
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HO 	 HO 	 HO 
HO HO HO 
114 	 113 	 112 
Conditions: 
(a) i) DHAP, rabbit muscle aldolase, pH 6.7, 25°C; ii) acid phosphatase, pH 5.0, 37°C, 78% 
(2 steps); (b) H 2 (1 atm), Pd-C, aq. HCl, quant; (c) KCN, dioxane, H 20, 77%; (d) H 2, Pt02 , 
conc. HCl, EtOH, 99%. 
Scheme 23 
Summary 
In summary, the biological importance of piperidines has driven the search for new 
methods for the construction of this motif. Recent advances in the field have 
provided the synthetic chemist with a comprehensive array of stereoselective 
approaches towards this goal, thereby enabling the synthesis of complex natural 
products as well as novel compounds. 
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Part Ill: Retrosynthetic analysis of the target 
molecule 14 
It is proposed that the initial disconnections of the target molecule 14 result in the 
separation of the three sections: the azasugar 115, acceptor glycoside 116 and GDP 
117 moieties (scheme 24) 
0 	 OH 
_Glycoside 	 X, Glycoside 116 
H I 
GDP 	 N 	
OH 0 	 D 
H' 
HO 	 OH 	 HO"'OH 
- 	 X\ 
OH OH GDP 
14 	 115 	117 
Scheme 24 
The formation of the glycoside-azasugar bond might be achieved simply by SN2 
displacement of a suitable leaving group (X) by the primary hydroxyl of the azasugar 
115 ' 59 and similarly the incorporation of the GDP unit might be possible by 
displacement of a leaving group from the terminal phosphate. The construction of the 
GDP-X reagent 117 is well established in the literature, 60-62  and therefore the major 
synthetic challenge of this project became the synthesis of the azasugar 15. 
There was no established method for the construction of the a,a'-disubstituted 
piperidine ring and therefore an original approach was needed. When the target 
molecule 15 was subjected to retrosynthetic analysis, it was envisaged that it might 
be built up via cyclisation of nitrogen onto an electrophilic carbon centre (scheme 
25). 
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Scheme 25 
Preliminary investigations on model substrates carried out within the group looked at 
a variety of methods to achieve this cyclisation (scheme 26).63 
P 
I 	 P 
Cy 6-exo-trig 
118 	 119 
P 
I 	 P 
NH 6-exo-tet 	
Ct_OH 
120 	 121 
X = HgOAc, HgOCOCF 3 , SePh; P = CO 2Et, CO2 Bu, CO2Bn, COMe, COCF 3 , S0 2Bn, Ts. 
Scheme 26 
The results showed that an intramolecular 6-exo-tet cyclisation of an N-tosyl 
protected amine 120 on to a gem-disubstituted epoxide with Lewis acid catalysis 
would be the most promising method, affording the hydroxymethyl piperidine 121 in 
56% yield; no products were formed when other nitrogen protecting groups were 
employed. The 6-exo-trig cyclisations of alkene 118 were discounted as it proved 
difficult to convert the initial metallated products 119 to alcohols. This series of test 
reactions identified the epoxide 122 as a key intermediate. Retrosynthetic analysis of 
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The carbon chain could be conveniently disconnected to give a fragment derived 
from L-alanine 123 and an acetylene 124. It was envisaged that the epoxide 
functionality could be introduced via the ketone 125 which could be further 
disconnected to give acetylene and an appropriate a-hydroxy carbonyl compound 
126. 
The planned route to the target 115 is shown in scheme 28. The initial steps (a-d) had 
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Conditions:  64 
(a) i) BnBr, A920, ether, reflux, 82%; ii) DIBAL (1M in toluene), DCM, -78°C, 60%; iii) 
BTMSA, MeLi:LiBr, THF, 0°C, 75%; (b) i) TEMPO, NaOC1, BTAC, NaBr, sat. aq.NaHCO 3 , 
sat. aq . NaCl, DCM, 0°C, 97%; ii) HOCH 2CH20H, TMSC1, DCM, 88%; iii)K 2CO3 , MeOH, 
93%; (c) i) EtMgBr, N-Boc-L-alaninal, -78°C, 59%; (d) i) BzC1, Et 3N, DCM, 90%; ii) TFA 
then TsCI, Et3N, DCM, 40%; Montmorillonite Kb, DCM, reflux, 40%. 
Scheme 28 
Further manipulation of the various protecting groups in order to yield the desired N-
tosyl derivative 128 proved to be problematic. Attempts to remove the N-Boc 
protection in acid were unpredictable, resulting in baseline material or complex 
mixtures. Both benzyl and methoxymethyl ether protection of the hydroxyl 
functionality were attempted but were unsuccessful. Finally, benzoyl protection of 
the alcohol 127 proved to be compatible with the subsequent nitrogen 
deprotectionitosylation which proceeded in 40% yield. Deprotection of the carbonyl 
group to generate the ketone 128 was not straightforward but was achieved in a 
moderate 40% yield using montmorilonite K 1 in DCM. In order to complete the 
synthesis of the piperidine target 115, the reduction, epoxide formation and the key 
cyclisation step still needed to be achieved. 
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Despite progressing a long way towards completing the synthesis of the target 115, 
the final steps had proved problematic. Many different routes, reagents and 
protecting groups had been employed in an attempt to complete the synthesis, but 
none had proved successful. With this in mind, the initial aim of the current project 
was to address some of the problems encountered during the synthesis of the 
intermediate 128 and attempt to complete the synthesis of the azasugar 115. 
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Chapter 2: Results and Discussion Part I 
Nucleophilic cyclisation approach 
The first reaction that was attempted was the formation of benzyloxy acetaldehyde 
130 by reduction of benzyloxy acetic acid ethyl ester 129 using DIBAL in DCM at 
-78°C (scheme 29). 
a 
EtO 
)t. OBn 	 H )LOBfl 
129 	 130 
Conditions: 
(a) DIBAL (1M in toluene), DCM, -78°C, 63-95% 
Scheme 29 
This reaction did not proceed as expected, giving inconsistent yields despite all 
attempts to use pure reagents and exclude water. Interestingly, the starting material 
was found to have decomposed slightly to give the aldehyde 131, but even removal 
of this material by careful column chromatography failed to improve the results of 
the reduction. This surprising rearrangement of the ester might be explained by acid 
catalysed migration of the benzyl group to the oxygen of the enol tautomer (scheme 
30). 
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129 	 131 
Scheme 30 
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Incorporation of the timethylsilyl acetylene unit was achieved by reaction of the 
aldehyde 130 with the lithium reagent derived from bis-trimethylsilyl acetylene 











Previous work 64  had suggested that the use of 1.6-1.8 equivalents of the lithium 
reagent afforded good yields (70-80%) of the racemic alcohol 132 whereas 1.2-1.5 
equivalents gave lower yields (11-57%). Hence, slight decomposition of the 
organolithium reagent prior to the addition might explain the disappointing 39% 
yield of this reaction. 
With the reduction of the ester 129 and acetylide addition proving inconsistent, an 
attempt was made to eliminate them from the synthesis by cutting out the 
reduction/oxidation sequence in the proposed route (see scheme 28) by direct 
addition of the trimethylsilylacetylide reagent to the ester 129 or an equivalent 
carboxylic acid moiety. 
Addition of lithium acetylide directly to the ester 129 afforded none of the desired 
ketone. However repetition of the reaction in the presence of borontrifluoride 
etherate afforded the desired acetylenic ketone 133 in 42% yield (scheme 32). 
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Me3Si 	 H 
129 	 140 	 141 
Conditions: 
(a) TMSCECLi, BF 3 .OEt2 , THF, -78°C, 42%; (b) sat. aq . NH4CI, 30 mm. 
Scheme 32 
The terminal silyl group appeared to be easily removed: partial desilylation occurred 
on silica, and when the quenched reaction was stirred for thirty minutes at room 
temperature, only the desilylated acetylenic ketone 134 was recovered. Despite the 
poor yield, this result suggested that the proposed shortening of the pathway might 
be successful once this procedure had been optimised. 
In 1981, Nahm and Weinreb reported that the addition of organolithium reagents to 
N-methoxy-N-methyl amides 135 allowed the formation of the respective ketones 
137 in good yields. 66  It was proposed that chelation of the lithium cation between the 
methoxyl group and the developing oxyanion stabilises the tetrahedral transition state 
136, thus preventing its decomposition to the more reactive ketone 137 and 
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Scheme 33 
We considered that the use of a Weinreb amide derivative of the glycolate moiety 
might improve the efficiency of the direct addition of the acetylene subunit, 
overcoming the problems associated with the use of the ester 129. In a similar 
procedure to that reported by Williams et al. the amide intermediate 139 was 
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synthesised by simple addition of NO-dimethyl hydroxylamine hydrochloride to 
benzyloxyacetyl chloride 138 in the presence of pyridine. 67  Incorporation of the 
acetylene group was achieved in 78% yield by addition of the lithium acetylide to the 















(a) MeONHMe.HC1, pyridine, 0°C, 95%; (b) TMSCCLi, THF, -78°C, 78% 140 and 141 
combined yield. 
Scheme 34 
Partial desilylation occurred on silica affording a mixture of the two ketones 140 and 
141. This made purification difficult, but was not anticipated to be a problem as 
subsequent desilylation was required for further manipulation of the molecule. This 
result indicated that direct addition of the acetylene subunit was a viable alternative 
to the previous approach which had suffered from inconsistent results. It also 
shortened the synthetic pathway by two steps. 
The next steps of the planned synthesis were the protection of the ketone 141, 
addition to an appropriate aldehyde and subsequent manipulation of the protecting 
groups. However, it had proved difficult to exchange the Boc protecting group for a 
tosyl group (which had been shown to be necessary in order to effect the ring-closing 
step) and, despite the use of many different reagents, hydrolysis of the ketal had only 
been achieved in 40% yield (see scheme 28). In light of these results, it was decided 
to test a slightly different strategy which might overcome these problems. 
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The acyclic target can be considered to be made up of three sections: the subunit 
derived from L-alanine (LHS) joined via the acetylene to the glycolate moiety (RHS) 
as shown in scheme 35. 
0 Glycolate (RHS) 
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Scheme 35 
Previous syntheses had joined the RHS and acetylene first, then coupled this 
fragment 143 to the LHS 142. It was noted that there might be no need for the ketone 
protection that had proved to be so problematic if the LHS and acetylene bridge were 
brought together to give the acetylene 144 prior to addition to the RHS via the amide 
139 as above. With this modification in mind, the aldehyde 148 was synthesised as 
shown in scheme 36. 
JYMe 
a 	 b 	
fl BocHN 	
OH j( 	 B0cHN 	 OMe 	 BocHN 
	
0 	 0 	 0 
146 147 148 
Conditions: 
i) CICO 2Me, N-methylpyrrolidine, DCM, THF, -14°C; ii) MeONHMe, RT, 75%. 
LiAIH4 , THF, -20°C, 89%. 
Scheme 36 
Results and Discussion Part I 
Activation of iV-Boc-alanine 146 with methyl chioroformate followed by addition of 
N,O-dimethylhydroxylamine afforded the Weinreb amide 147 in 75% yield. 
Reduction to the aldehyde 148 was achieved in 89% yield by reaction with lithium 
aluminium hydride in THF according to the procedure developed by Kosynkina et 
al. 68 
The addition of an organometallic reagent to the aldehyde 148 can give two possible 
products resulting from attack from different sides of the carbonyl. With the presence 
of the a-methyl substituent adjacent to the carbonyl, it was hoped that metal ion 
chelation (as described by the Cram chelation model) might favour formation of the 
desired S,S-amino alcohol 150 (figure 9), although only a small excess could be 
expected because the methyl group is too small to exert a strong directing influence 
and the N-Boc group is not generally considered to chelate efficiently to Lewis acids. 
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Figure 9 
The addition of a range of organometallic reagents of alkynes 151 and 152 (figure 
10) to the L-alaninal 148 had been investigated previously within the group. 64 
Additions involving the more substituted compound 151 had resulted in 11-77% 
yields (depending upon which method was used) and diastereomeric ratios of 3:1 to 
9:1 in favour of the desired SS-aminoalcohol. The less hindered acetylene 152 had 
been reported to add to L-alaninal 148 in a poor 45% yield and with a d.r. of 2:1 in 
the best case (M = MgBr; figure 10). The poor diastereomeric ratios highlight the 
low steric demands of both the reagent and the substrate. 








M = Li, MgBr, Cu, ZnBr; M' = Li, MgBr. 64  
Figure 10 
In 1984, Brown et al. reported the use of lithium alkyltrifluoroborate reagents 
(RBF3 Li) for additions of acetylenes to anhydrides, affording acetylenic ketones 
such as 154 in 70-80% yields (scheme 37). 
a 
0 
153 	 154 
Conditions: 
(a) i) n-BuLi, -78°C, THF; ii) BF 3 .OEt2 , -78°C; iii) Ac 20, 80% 
Scheme 37 
As this method had not previously been attempted it was decided to apply it to the 
addition of the silylacetylene subunit to the aldehyde 148 in order to increase the 
selectivity of the addition. The trifluoroborate salt was made in situ by addition of 
borontrifluoride etherate to a solution of the lithium acetylide made by desilylation of 
BTMSA with methyl lithium in THF at -78°C (scheme 38). Addition of the aldehyde 
148 to a four-fold excess of this reagent afforded the diastereomeric alcohols in 74% 
combined yield and with Ca. 5:1 ratio (indicated by 'H NMR) in favour of the desired 
S,S-isomer 155. 
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(a) TMSCCLi (4 equiv.), BF 30Et2 , THF, -78°C, 74% (combined yield), 155:156 Ca. 5:1 by 
NMR. 
Scheme 38 
Neither the mechanism nor the reacting species of this transformation is known. The 
unexpectedly high d.r. (considering the low steric bulk of the reagent) might be a 
result of efficient complexation with the substrate, or, as organolithium reagents are 
known to exist as dimers or tetramers in solution, it might be the case that the 
addition of the lewis acid increases this aggregation, thus increasing the steric 
demands of the nucleophile. The reaction could never be driven to completion, and 
interestingly, when the mode of addition was reversed (the acetylide reagent was 
added to a solution of the aldehyde) no reaction occurred. It is possible that a 
deprotonation reaction competes with the desired nucleophilic addition, effectively 
protecting the aldehyde as the enolate, and preventing the addition. Alternatively the 
products 155/156, a,f3-aminoalcohols, might form a complex with the reagent 
rendering it unreactive. 
The diastereomers 155/156 could not be separated by flash column chromatography 
and hence were carried through to the next step. Desilylation of the aminoalcohols 
was achieved in methanolic K2CO3 (scheme 39). The crude reaction afforded a 
quantitative yield of the diastereomeric mixture of alcohols. Fortunately, it was 
discovered that the major isomer 157 was crystalline and this allowed resolution by 
recrystallisation, albeit in no more than a 47% yield. 
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(a) i) K2CO3,  MeOH, RI; ii) Recrystallisation (slow evaporation of ether from hexane), 47% 
Scheme 39 
The crystal structure of the major diastereomer was determined using X-ray 




Reaction of the acetylene 157 with TBDMSC1 and imidazole in DCM afforded the 
silyl protected alcohol 159 in quantitative yield. The next key step in which the 
carbon backbone of the target was assembled was attempted via deprotonation of the 
acetylene 159 using n-BuLi and subsequent addition of the acetylide reagent to the 
amide 139 (scheme 40). 
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(a) TBDMSC1, imidazole, DCM, 40°C, quantitative; (b) i) n-BuLi (2.2 equiv.), THF, -78°C, 
2h; ii) Weinreb amide 139, THF, 14%. 
Scheme 40 
Analysis of the products identified recovered substrates, the ketone resulting from 
addition of n-BuLi to the amide 139 and a small amount of an unknown compound 
which appeared to rapidly decompose at room temperature. The instability of this 
product made characterisation extremely difficult. Inspection of the 'H NMR 
spectrum revealed that resonances attributable to both substrate fragments could be 
seen: for example the TBDMS methyl groups at 0. 13, 0.15 and 0.90 ppm (acetylene 
fragment), and the benzyl group resonances at 4.65 and Ca. 7.30 ppm (glycolate 
fragment). In addition, the C=—CH resonance at 2.36 ppm was no longer present. The 
JR spectrum indicated the presence of an acetylene group at 2209 cm -1 (far removed 
from the acetylene resonance of the substrate at 2113 cm -1 ) and a broad C=O 
resonance at 1699 cm -1 which could incorporate both carbonyl groups. The APCI 
mass spectrum indicated a very weak peak at 406 Da which could be attributable to 
the loss of the t-butyl group, but no MH peak or other fragments could be identified. 
Attempts to characterise this product further proved fruitless as the product had 
decomposed and no clear results were obtained. However it was believed that these 
results were sufficient to support the conclusion that the desired acetylenic ketone 
160 had indeed been formed in 14% yield. 
The presence of unreacted substrates and the 1 -benzyloxyhexanone amongst the 
products suggested that deprotonation of the acetylene 159 (presumably to make the 
dianion) occurred very slowly (i.e. longer than two hours), and that the acetylide 
anion formed did not add efficiently to the amide 139. The addition of bulky 
nucleophiles to these substrates has been reported to be problematic as deprotonation 
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of the methoxy group and concomitant elimination of formaldehyde competes with 
addition to the carbonyl (figure 	970 
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Figure 12 
The fact that the acetylenic ketone 160 was formed at all proved that the planned 
synthetic pathway could work, however the instability of the product and low yield 
indicated that some alterations were necessary. 
It was thought that the yield of the coupling reaction and stability of the acetylenic 
ketone 160 might be increased by conversion of the aminoalcohol precursor 157 to 
an oxazolidine, which is a much smaller protecting group than the TBDMS group 
and has the added bonus of completely protecting the nitrogen. As the separation of 
the diastereomeric aminoalcohols 157/158 was low yielding it was decided to 
attempt the coupling on the diastereomeric mixture. Reaction of the alcohols 155/156 
with 2,2-DMP under standard conditions afforded the diasteriomeric oxazolidines 
161/162 in 84% yield. It was hoped that these diastereomers might be separated by 
column chromatography but attempts to do this afforded only mixtures of the 
diastereomers and were complicated by partial desilylation, presumably catalysed by 
silica. The precursor acetylenes 163/164 were made in 95% yield using methanolic 
K2CO3 as before (scheme 41). 
44 














a) 2,2-DMP, TsOH (cat.), DCM, reflux, 85%; b) K2CO3,  MeOH, RI, 95%. 
Scheme 41 
With the precursor in hand, the coupling step was attempted using n-BuLi to effect 











163/164 	 165/166 
Conditions: 
i) n-BuLi, THF, -78°C; ii) Weinreb amide 139, THF, -78°C, 48%. 
Scheme 42 
Analysis of the product again proved difficult as a result of the product instability. 
Despite taking care to eliminate acidity from the CDC1 3 NMR solvent, rapid 
decomposition of the product occurred. The 'H NMR spectrum was recorded 
immediately after purification, and this supported the assignment of the acetylenic 
ketones 165/166: the C=—CH resonance of the substrate had disappeared and both the 
oxazolidine (1.56 and 1.68 ppm) and glycolate (4.22, 4.64 and 7.25-7.45 ppm) 
resonances could be seen in the product. Subsequent attempts to gather further 
evidence to support this assignment were unsuccessful owing to the decomposition 
of the product to a complex mixture of polar compounds. 
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It seems that the introduction of the oxazolidine ring had indeed improved the 
success of the coupling reaction, increasing the yield to 48% from 14% in the case of 
the TBDMS acetylene 160. It is thought that this is a result of two factors. Firstly, the 
double protection of the nitrogen meant that only one deprotonation could occur 
which allowed the reaction to be carried out more quickly, thus reducing the 
possibility for decomposition. Secondly, the steric hindrance of the nucleophile was 
reduced because the ring effectively tied the hydroxyl protecting group away from 
the reacting centre, thus enabling an easier approach to the carbonyl. Unfortunately 
the instability related to the acetylenic ketone functionality that had hindered 
characterisation of the silylated derivative 160 remained a problem for the 
oxazolidines 165/166. 
There are many possible changes that could alter the success of this route. For 
example the use of a benzylcarbamate instead of the t-butylcarbamate for protection 
of the nitrogen might increase the stereoselectivity of the acetylide addition to the 
aldehyde 148. It might also be the case that the use of different cationic metal species 
would increase the yield of the addition to the amide 139. 
However, it was decided that the nature of the molecules involved was such that 
purification, handling and stability problems would always be causing problems with 
the route. This inherent instability compounded the protecting group orthogonality 
difficulties that had been experienced throughout the pathway and hastened the 
decision to rethink the initial retrosynthesis. Despite the progress that had been made, 
no further work was carried out on this aspect of the project. 
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Electrophilic cyclisation approach 
An alternative approach was initiated involving a possible electrophilic cyclisation as 
the key step for the synthesis of the piperidine ring. Tietze et al. have reported the 
6-endo-trig cyclisation of alkenes such as 167 onto electron deficient imines using 
trimethylsilyl triflate as the catalyst (scheme 43)•71 
CO2Et 
NCO2Et 	a 5  
167 
EtO2C 	CO2 Et 
HN +HNJ 
EtO2C 	CO2Et 
168 	 169 
Conditions: 71 
TMSOTf, 'BuOMe, 168:169, 19:1, 96%. 
Scheme 43 
A comparison of the piperidine product 168 with the target 115 identifies the 
common motif (figure 13). It can be seen that these reaction products would be 
excellent precursors of the target 115: reduction of the ester groups of the molecule 
168 and oxidation of the alkene would introduce the majority of the functionality of 
the piperidine 115. 
Common 
Motif 











Results and Discussion Part I 
At first this approach looked encouraging, however a broader literature search 
suggested that an aza-Cope [3,3]-sigmatropic shift (path B) might occur in 
competition with the intended electrophilic cyclisation process (path A). In one 
example, in which a hydroxyl group was present in the 3-position, the pyrrolidine 






X 30 NH 	 N 
I I 	 I 
Pr 	 Pr Pr 







(a) HCHO, CSA, EtOH, reflux. 
Scheme 44 
It was hoped that protection of the hydroxyl functionality might hinder the undesired 
aza-Cope reaction (path B) and allow the cyclisation (path A) to take precedence. In 
addition, it was thought that the synthesis of the precursor could develop the 
chemistry already explored in the nucleophilic cyclisation approach detailed above. 
Consequently, an alternative retrosynthesis of the piperidine 115 was proposed which 
incorporates the electrophiliccyclisation as the key step (scheme 45). 
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PG = Protecting group; R = SiMe 3 or H 
Scheme 45 
At first, it was hoped that the vinylsilane 172 might be used in order to promote the 
cyclisation step through stabilisation of the cationic intermediate by the silicon 
(scheme 46). 
EtO2C CO2EI 









Unfortunately, attempts to synthesise the vinylsilane precursor by reduction of the 
diastereomeric acetylenes 155/156 proved inconsistent, affording varying mixtures of 
E and Z isomers 173 and 174. Reduction of the protected alcohol 175 also afforded a 
mixture of isomers 176 and 177 as well as unreacted alkyne 175 and the alkane 178 
resulting from over-reduction (scheme 47). This complex mixture could not be 
separated by chromatography, and consequently it was decided not to carry these 
further. 
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BocHN 	 + BOCHN S1Me3 
OH 	 OH 
173 174 
ISi 
BocHN 	 BOCHN SMe3 
OTBOMS 	 OTBDMS 
C 
30 	 176 177 
S1Me3 
BocHN 	 BOcHN 
OTBDMS 	 OTBDMS 
175 178 
Conditions: 
(a) PdIBaSO 4, H2 (1 atm), py, 69% (combined yield); (b) TBDMSC1, imid., DCM, 2h, 94%; 
(c) PdIBaSO 4 , H2 (1 atm), py, 68% (combined yield). 
Scheme 47 
As the vinylsilanes were proving difficult to isolate, it was decided to test cyclisation 
using the free alkene. Partial catalytic hydrogenation of the alkyne 157 was achieved 
using Lindlar's catalyst (scheme 48) affording the alkene 180 in 95% yield; over-
reduction to the alkane 179 occurred when palladium on carbon was used as the 
catalyst. Because the substrate and product possessed identical RF values, it was 
necessary to monitor the reaction by ESMS of samples taken at regular intervals. The 
reduction was stopped when the substrate had been consumed. 












(a) Pd/C, H 2 (1 atm), EtOAc, 1.5 h, 93%; (b) Lindlar's catalyst, H 2 (1 atm), EtOAc, 35 mm, 
95%. 
Scheme 48 
The choice of an alternative protecting group was not straightforward as it needed to 
withstand the strongly Lewis acidic conditions needed for Boc removal and 
subsequent cyclisation. Protection of the alcohol 157 as an ester was discounted 
because previous work carried out within the group had shown that the benzoyl ester 
of acetylene 181 was susceptible to acyl migration upon removal of the nitrogen 
protecting group; only the amide 182 was recovered (scheme 49)64 
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Conditions: 64 
(a) i) TFA; ii) sat. aq . NaHCO 3 . 
Scheme 49 
It was proposed that a carbonate protecting group might be more resistant to 
migration because the carbonyl group is less electron deficient than an ester 
r) 
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carbonyl. The fluorenylmethyloxycarbonyl (Fmoc) protecting group was chosen to 
test this hypothesis. 
Fmoc succinate did not prove to be sufficiently reactive to protect the hydroxyl 
functionality: only starting material was recovered when the alcohol 180 was stirred 
with the succinate in DCM and pyridine. However, the use of the more reactive 
Fmoc chloride in DCM and pyridine was successful, affording the carbonate 182 in 
99% yield. Finally, the Boc group was conveniently removed with TMSOTf in DCM 
at -78°C to give the cyclisation precursor 185 (scheme 50); no migration of the 
carbonate to the liberated nitrogen was seen. The use of this reagent allowed facile 
isolation of the amine as the triflate salt 185 which precipitated from solution when 
moisture was admitted to the reaction vessel. Presumably, the initial product of the 
reaction is the soluble N-silylated salt 184 which is hydrolysed by water to afford the 
insoluble product 185. 
X BocNH '  BocNH 
OH ÔFmoc 
180 183 
C rTfO+ 1 	d 
BocNH 







(a) Fmoc-succinate, DCM, py, rt, 20h; (b) FmocCl, DCM, py, 0°C, 3h, 99%; (c) TMSOTf, 
DCM, -78°C, lh; (d) vessel opened to atmosphere, -78°C - rt, 2h, 61%. 
Scheme 50 
The synthesis of the amine 185 meant that the key electrophilic cyclisation step could 
be tested. In a slight alteration to the procedure reported by Tietze et al. , 7 ' the amine 
was submitted to the reaction as the triflate salt 185. Not only was this easy to 
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handle, but deprotection of the base-labile Fmoc group was feared if the free amine 
was used. Consequently, a solution of the amine salt 185 and diethylketomalonate 
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H20 	EtO2C CO2Et 




E = CO2Et 
Conditions: 
(a) TMSOTf, DEKM, DCM, -78°C - rt, 4 days, 40%. 
Scheme 51 
Analysis of the reaction mixture indicated the amine 189b as the only identifiable 
product; all of the substrate had been consumed The 1 H NMR spectrum of the 
amine 189b clearly shows the two ethyl esters with resonances at 1.28 and 4.24 ppm 
and a characteristic Fmoc group of resonances in the aromatic region. Interestingly, 
the alkene geometry appears to be cis, as indicated by the coupling constant of 6.5 
Hz between the two vinyl protons. This implies that the carbonate group adopts an 
axial conformation in the chair transition state 186, despite being larger than the 
methyl group. The reason for this is not clearly understood, although it might be 
explained by considering the stereoelectronic effects of the C-O bond in the two 
different orientations (scheme 52). Orbital overlap between the C-O cy*orbital  and 
the C=C it-orbital can only occur if the C-O bond is in the axial position (path B). 
This stereoelectronic effect could destabilise the alkene, lowering the energy of the 
transition state B and thus resulting in preferential formation of the Z-isomer 189b. 
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This disappointing result confirmed our fears that the aza-Cope rearrangement would 
predominate over the desired cyclisation, even with hydroxyl protection. It is 
proposed that the product of this [3,3]-sigmatropic shift is then hydrolysed on work-
up to give the amine 189. The fact that none of the desired product was formed at all 
suggests that the alkene was not sufficiently nucleophilic to trap the iminium ion. 
The successful literature example 71  uses alkenes substituted at the 2-position (such as 
167, scheme 43) which stabilise the developing carbocation during the cyclisation 
step; unfortunately it seems that the loss of stability on going from a tertiary to a 
secondary carbocation is too great for the reaction to proceed. It was thought that the 
introduction of an alkoxy group to the 2-position might promote the reaction, but the 
resulting vinyl ether functionality proved too labile under the lewis acidic reaction 
conditions. 
Whilst interesting, this result supported the assertion made by Flann et al. that the 
aza-Cope "equilibration" occurs more rapidly than the cyclisation, 72 and also 
54 
Results and Discussion Part I 
destroyed both asymmetric centres of the precursor. Consequently, it was decided not 
to continue with this line of research. 
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Chapter 3: Results and Discussion Part II 
Appraisal of the approaches discussed in the previous chapter highlighted the key 
problems associated with the synthesis of the target 115. Firstly, the planned 
synthetic pathway was relatively long and linear: each unit of the chain was added 
and manipulated in turn. The sterochemical control of the synthesis was based on the 
a-carbon of L-alanine, a chiral centre which exerts a very weak steric influence. The 
quantity and density of functionalities of the molecules meant that they were difficult 
to handle and readily decomposed, even under mild conditions. Analysis of reaction 
products proved troublesome because of the high polarity, reactivity and instability 
of the compounds along the synthetic pathway. 
It was clear that each of these problems would need to be taken into consideration in 
the design of a new approach to the target piperidine 115. 
As the result of an extensive literature search, it was decided to use a Diels-Alder 
cyclisation as the key step in the synthesis of this complex piperidine ring. This 
established reaction is ideal for the synthesis of 6 membered rings with controlled 
stereochemistry. 73 In addition, the advent of hetero Diels-Alder reactions and the use 
of Lewis acid catalysis have greatly increased its scope and applicability. Most 
recently, the use of chiral ligands to control the facial selectivity of addition has 
brought this process to the forefront such that it is now an extremely useful method 
for the preparation of stereogenically enriched 6 membered rings. 
Two recent advances in Diels-Alder reactions were thought to be particularly 
relevant for the synthesis of the target. Firstly, the asymmetric inverse electron 
demand Diels-Alder (IEDDA) examples developed by the groups of Mark0 7480 and 
Posner 81-85  seemed to introduce a large proportion of desired stereochemistry and 
carbon skeleton in one step. Secondly, the development of enantioselective 
lanthanide metal catalysis in aza-Diels-Alder reactions by Kobayashi 48 suggested that 
the piperidine ring could indeed be made using this approach. 
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Aza-Diels-Alder reactions with imino 
dienophiles 
Retrosynthetic analysis of the piperidine 115 (scheme 53) indicated that it might be 
built up by reaction of a pyrone 190 with an imine equivalent 191. 









r 0 N . X 
190 191 
Scheme 53 
The pyrone 190 was commercially available and work was started on the synthesis of 
a range of C=N dienophiles by simple condensation of an appropriate amine, 
hydrazine or hydroxylamine with acetaldehyde as shown in scheme 54. 
0 N 
+ 	H 2N 	 r.4.JJI 'fl 
Entry R Conditions Outcome 
1 CH2Ph Et20, M9SO4 Complex polar mixture 
2 NHC6H4(NO2) 2 EtOAc Ca. 4:1 mixture of E- and Z-isomers 
3 OMe Na2CO3 , H20, MeOH, AcOH Volatile product lost on work-up 
4 O'Bu pyridine I Product isolated 
Scheme 54 
Unfortunately, these compounds proved very difficult to isolate. Whilst 'H NMR 
spectra of the crude products indicated only the desired products, they proved to be 
highly polar and unstable to hydrolysis. They could not be subjected to colunm 
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chromatography and could not be purified. All of the compounds synthesised existed 
as a mixture of E- and Z-isomers and the presence of a-protons meant that the imine 
could easily tautomerise to the enamine which could, in turn, initiate further 
undesired reactions. In most cases, the synthesis of the dienophile was followed by 
tic and, upon completion, the crude mixture concentrated, a sample taken and a 'H 
NMR spectrum recorded. 
Despite these problems, the crude dienophiles were immediately subjected to the 
IEDDA conditions described by Marko et al. 8° Unfortunately, no Diels-Alder 
products were ever isolated from the reaction; only recovered substrate 190 was ever 
identified. 
There are many possible reasons for the total failure of these reactions. Firstly, the 
imino dienophile might be too unstable under the reaction conditions. Secondly, the 
presence of the nitrogen substituent may have affected the catalytic complex so as to 
render it unreactive. Finally, it might be the case that the diene and dienophile are not 
compatible. 
To illustrate this last point, it should be noted that, in an IEDDA reaction, the diene is 
electron deficient. This lowers the energy of the ic-system (with respect to the 
unsubstituted case, i.e. butadiene) and consequently, in order for the reaction to 
procede, the dienophile needs to be electron rich so that the HOMO (dienophile) and 
the LUMO (diene) have the maximum orbital overlap. This coupling of electron poor 
diene with electron rich dienophile is demonstrated in the examples given by Marko 
et al. in which the pyrone reacts with vinyl ethers. 7480 
Using this as a qualitative guide, the results above might be rationalised as follows: 
As nitrogen is an electronegative atom, replacement of a carbon in an alkene with 
nitrogen could be considered to make the pi system more electron deficient as the 
electrons are held more strongly by the heteroatom. If this is the case, the HOMO-
LUMO overlap would be reduced thus preventing the reaction from occurring. 
Whilst this is a convenient representation, it should be highlighted that it is a very 
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basic rationalisation of the processes involved, and that the exact nature and energies 
of the pi orbitals of the dienophiles used are not known. 
Whatever the reason for the failure of all of these reactions, it was clear that an 
alternative approach was needed. 
Aza-Diels-Alder reactions of oxazinone dienes 
Returning to the retrosynthesis of the piperidine 115, it can be seen that a Diels-Alder 
reaction between an oxazinone 192 and a vinyl ether 193 could be used as the key 













115 	 192 	193 
Scheme 55 
In order to test this hypothesis, the oxazinone diene system needed to be synthesised. 
A literature search unveiled few syntheses of this type of ring system. Hoornaert and 
colleagues have made highly chlorinated derivatives of oxazinones such as 194 by 
reaction of cyanohydrins with oxalyl chloride (scheme 56).8692  In addition, they have 
reported that the heterocyclic products undergo hetero Diels-Alder reactions with 
simple alkenes at elevated pressures and temperatures. Despite these promising 
results, this approach was not very efficient for the unsubstituted derivative 194 that 
was needed for the target, and examination of the reaction conditions suggested that 
large scale reactions would be extremely hazardous. 
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(a) i) Phd, 0°C, 30 mm; ii) Me 3N.HCI, 90°C, 30%. 
Scheme 56 
Schulz and Steglich have published the synthesis of the oxazinone 199 in four 
relatively simple steps, 93  and hence it was decided to repeat this synthesis in order to 
test the Diels-Alder reaction. The reaction sequence is shown in scheme 57. 
b a Y OH 0 
	
ZHN( 	 ZHN 	 BrH 3N(° 
0 	 0 	 0 




N °°  
199 	 198 
Conditions: 
(a) Chioroacetone, NEt 3 , EtOAc, reflux, 5h, 77%; (b) 30% HBr/AcOH, 50°C, 10 mm, 93%; 
(c) NEt3 , 4A mol. sieves, CHC13 , 0°C, 15 mm, 85%; (d) i) NBS, AIBN (cat.) CC1 4, 65°C, 20 
mm; ii) py, rt —* 50°C, 15 mm, 46%. 
Scheme 57 
Conversion of the N-protected valine 195 to the acetonyl ester 196 was achieved in 
77% yield by reaction of the acid with chloroacetone. Deprotection of the nitrogen 
with HBr in glacial acetic acid afforded the amine as the hydrobromide salt 197, 
which was cyclised to make the imine 198 in 85% yield when basified with 
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triethylamine over molecular sieves. Finally, the ring was oxidised to the oxazinone 
199 via a radical brominationlelimination procedure. The final 
brominationlelimination proved troublesome, giving low and inconsistent yields, and 
often producing a large amount of a black tar. Even though the low yield of 46% was 
the best that was achieved for this last step, the synthesis of this oxazinone ring 
system in 28% from Z-valine 195 meant that the IEDDA reaction could be tried. 
The oxazinone 199 was submitted to the ytterbium catalysed JEDDA conditions 
developed by Marko et al.  80 as detailed in scheme 58. 
-0O 
 
199 	 200 
Conditions: 
(a) Yb(OTf) 3 , tBuOH, DIEA, DCM, EVE, 0°C -* rt, 3 days. No reaction. 
Scheme 58 
Isolation and purification of the products afforded only recovered starting material in 
51% yield. It is not clear what happened to the remainder of the oxazinone. Attempts 
to analyse the crude mixture of highly polar products by ESMS, tic, reverse phase tic 
and NMR all proved to be fruitless. No evidence could be found to indicate that the 
bicyclic product 200 had been formed at all. In addition to product instability, the 
possibility existed that the starting material did not survive the reaction conditions. 
With this in mind it was decided to test the stability of the oxazinone 199. When left 
in solution at room temperature for a 3 days, a blurring of the tic spot was noticed, 
and when stirred in refluxing toluene for 1 hour a complex polar mixture was formed 
Comparison of the tic plate of this test reaction with that of the attempted Diels-
Alder reaction suggested that the same decomposition products were being formed 
and thus supported the suggestion that the oxazinone 199 was unstable to the Diels 
Alder reaction conditions. It is reported that heterodiene systems such as these 
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undergo Diels-Alder reactions with both electron-rich and electron-deficient 
dienophiles, 8 ' and hence it might be the case that the substrate reacted with itself in a 
thermal [4+2] cycloaddition and this initiated the decomposition process, possibly 
including extrusion of CO2 in a retro-Diels-Alder fashion. 
It was also decided to test whether the presence of the oxazinone affected the 
efficiency of the catalytic system; hence the literature example (pyrone 190 with 
EVE) was carried out in the presence of the oxazinone (scheme 59). 
MeOO 
a 
ikro + NXIr0 
MeO2C 
190 	199 	 201 
Conditions: 
(a) Yb(OT03 , tBuOH, DIEA, DCM, EVE, 0°C —* rt, 19h, 81%. 
Scheme 59 
The success of this reaction indicated that the catalyst was unaffected by the 
oxazinone 199, and therefore implied simply that the heterodiene system was 
incompatible with the reaction in some way. 
One possible explanation for the failure of the aza-Diels-Alder reaction is that the 
substrate 199 does not have an ester group on the 3-position, thus denying the 
opportunity for bidentate coordination to the ytterbium (figure 14). Marko et al. have 
proposed that this interaction is essential for catalysis to occur. 80 
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Bidentate coordination 
not possible 
Me O 	0- 'L Yb 
to 
190 	 199 
Figure 14 
With this in mind, it was decided to attempt the synthesis of a bidentate oxazinone. 
Again there was little literature precedent for the synthesis of this class of molecule, 
however it was thought that oxidation of a cyclic imidate such as 206 might prove 
successful. Serine seemed to be the simplest starting point as it possesses an 
oxygenated side chain which could potentially bind to the ytterbium catalyst. The 
synthesis of the morpholine diones derived from amino acids is well precedented, 94 
although no serine analogues had been reported when this project was started 
(although a synthesis of the O-benzyl-serine derived analogue 206 has recently been 
reported), 95 and hence this was attempted using a slight adaptation of the literature 
procedure (scheme 6O). Acetylation of O-benzyi valine 202 was achieved in 
excellent yield by in situ protection of the acid as the silylester followed by addition 
of acetoxyacetyl chloride and base. A small sample of the amide 203 was 
recrystallised for analysis, however tic indicated that the crude product was 
essentially pure and this was carried through to the next step. The hydroxyl 
functionality was deprotected using sodium hydroxide and the intramolecular 
iactonisation achieved by heating the crude alcohol in refluxing toluene with acid 
catalysis to afford the morpholine dione 205 as a white crystalline solid. Finally, 
reaction with Meerwein's salt afforded the cyclic imidate 206 in 48% overall yield. 
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MeO MeO 0 
207 206 205 
Conditions: 
(a) i) TMSC1, DCM, MeCN, 60°C, 2h; ii) acetoxyacetyl chloride, NEt 3 , -30°C —> 0°C, 4h, 
99%; (b) NaOH, water, 11, 3h, 97%; (c) TsOH (cat.), toluene, reflux, 73%; (d) BF 40Me3 , 
DCM, rt, 20h, 68%; (e) i) NBS, AIBN (cat.), Cd 4 , 65°C, 20 mm; ii) py., 0°C, lh, no products 
identified. 
Scheme 60 
The crystal structure of the morpholine dione 205 (figure 15), determined by X-ray 
diffraction, confirmed the structure of this key intermediate. 
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02 
Figure 15 
The final step in this synthesis was the oxidation to the diene 207 needed for the 
IEDDA reaction. It was hoped that the brominationlelimination approach used 
previously could be extended to this system; hence the imidate 206 was reacted with 
NBS in the presence of AIBN (scheme 60). Unfortunately this reaction proved 
unsuccessful. Analysis by tic indicated that a distinct product was formed during the 
course of the reaction, however the work-up and concentration procedures destroyed 
this material and no products could be isolated and identified. 
Deprotonation of cyclic imidates such as 208 has literature precedent and is used to 
make unnatural amino acids by alkylation of the anion. 94  Asymmetric induction via 
transfer of chirality across the ring allows the stereochemistry of the alkylation to be 
controlled (scheme 61). 
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MeO 	 MeO 
208 
C 
o.c__ 	MeO ° 
OMe 
Conditions: 94 
(a) i) 'BuOK, THF, -75°C, 20 mm; ii) BnBr, THF, -75°C —* rt, 12h, 90-95%, d.e. > 95%. 
Scheme 61 
It was proposed that bromination of the anion of the imidate 206 with NBS and 
subsequent elimination of HBr could yield the desired oxazinone (scheme 62). 
	














(a) i) 'BuOK, THF, -75°C, 20 mm; ii) NBS, THF, -75°C —* ii, 18h, no products isolated. 
Scheme 62 
Unfortunately, when subjected to these conditions total decomposition of the 
substrate occurred and nothing could be identified from the complex product 
mixture. It is likely that the protected hydroxyl group alpha to the deprotonation site 
could be eliminated to give an alkene and this is why this approach was unsuccessful. 
A final attempt to oxidise the imidate 206 was made using DBU/BrCC13. This 
reagent has been very successful in the oxidation of heterocyclic ring systems such as 
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pyridinones, oxazolines and thiazolines and has been used in the oxidation of 3,4-
dihydrocoumarin to coumarin. 96 Unfortunately, when applied to the dihydro-2H- 1,4-
oxazin-2-one 206 it proved to be unsuccessful, affording only baseline material 
(scheme 63). 
OBn 	 OBn 
N ° 	X 	Nj:IO 
II 	I 	 I 	I 
MeO MeO 
206 	 207 
Conditions: 
(a) BrCCI 3, DBU, DCM, -78°C —*0°C, no products were identified. 
Scheme 63 
In each of the above dehydrogenation attempts, the initial results (tic, crude NMR) 
looked promising, but no products could be identified after work-up or purification: 
the products were too unstable to be isolated. 
Unfortunately the inability to synthesis a bidentate oxazinone meant that the 
hypothesis regarding the coordination to the catalyst could not be tested. Reappraisal 
of the project was carried out in light of these results and, owing to time constraints 
and the lack of progress, an alternative route to the target piperidine 115 was sought. 
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Chapter 4: Results and Discussion Part lii 
Oxidative cleavage/ring closure methodology 
Despite the failure of the aza-Diels-Alder reactions, the pyrone nucleus and 
methodology developed by Marko et al. 74-80  could allow facile construction of the 
framework of the target, and hence alternative possibilities for the introduction of the 
nitrogen were investigated. It was envisaged that the aza-sugar might be built up by 
an oxidative cleavage/ring closure methodology as illustrated in scheme 64. 
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The majority of the stereochemistry of the target 115 could be set up via a 
stereoselective IEDDA using the ytterbium catalyst developed by Marko. 7880 
Cleavage of the lactone 210 with ammonia followed by a Hofmann rearrangement 
would introduce the amine functionality to the correct site. Oxidative cleavage of the 
alkene 209 to the bis-aldehyde 208 and intramolecular condensation with the amine 
would set up the piperidine ring and all that would remain would be the introduction 
of the methyl group and manipulation of the different functionalities around the ring 
to synthesise the aza-fucitol target 115. 
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The viability of this pathway was supported by work carried out by Afarinkia and 
Mahmood who have made the amino sugar 216 via a thermal Diels-Alder reaction of 
ethyl coumalate 211 with vinylene carbonate and subsequent Hofmann 
rearrangement (scheme 65). 97 
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(a) Vinylene carbonate, 110-115°C, 12 days, sealed tube, 81%; (b) 1-1 2 , Pd-C, EtOAc, ii, 8h, 
100%; (c) NH 3, 1 ,4-dioxane, argon, 6h, 91%; (d) i) PhI(OCOCF 3)2 , 1:1 MeCN/1-1 20, dark, rt, 5 
days; ii) aq. HC1, 92%; (e) pyridine/THF, LiAIH 4 , rt, 48h; ii) pyridine, Ac 20, rt, 6h, 88%. 
Scheme 65 
This approach has many advantages over the previous methods. Firstly it is based on 
a unique combination of established reactions, each of which has broad literature 
precedent. Secondly, most of the stereochemistry is set up in one step by asymmetric 
catalysis, resulting in a short, and therefore relatively straightforward, synthetic 
pathway. Thirdly, each functional group around the piperidine nucleus is protected in 
a different manner and this orthogonality lends itself to the selective introduction or 
deletion of functionalities. Finally, the methodology is such that it could be applied 
to the synthesis of a wide range of similar molecules, including unnatural amino 
acids, carbasugars and azasugars. 
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In order to investigate the viability of this approach, it was decided to attempt the 
synthesis of the less complicated racemic analogue (±)-217 (scheme 66). It should be 
noted that all molecules described in this chapter are racemic: only the relative 
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Scheme 66 
The IEDDA reaction between the pyrone 190 and ethyl vinyl ether (EVE) was 
carried out according to the literature procedure 79' 80  using ytterbium triflate and 




1OEt 	a 	MeO2C, 
190 	 201 
Conditions: 
(a) Yb(OTf) 3 , RS-BINOL, DIEA, DCM, 20h, 81%. 
Scheme 67 
The reaction proceeded efficiently as expected although a large amount of an 
insoluble red solid was formed as a by-product which made purification difficult, 
especially when carried out on a large scale. A variety of different work-up protocols 
were tried in order to remove this solid, however the best results were achieved when 
the crude reaction mixture was simply concentrated in vacuo and immediately 
subjected to column chromatography. The choice of correct solvent system was 
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essential otherwise the product remained contaminated with the red by-product. The 
racemic bicyclic lactone 201 was made in gram quantities by this approach. 
A recent project carried out by a 5  1 Year MChem undergraduate student under my 
supervision investigated the use of tert-butyl vinyl ether (TBVE) and chloroethyl 
vinyl ether (CEVE) as dienophiles in this reaction. It was hoped that the use of the 
tert-butyl group might increase the selectivity of the IEDDA and allow the hydroxyl 
group to be revealed more easily in later stages of the synthesis. Interestingly, upon 
reaction with the pyrone 190 under enantioselective catalysis using R-BINOL, the 
bicyclic lactone derivative was formed in zero enantiomeric excess. It had been 
reported that the selectivity of the reaction increased with the size of the vinyl ether 
as the rate of the reaction is slowed down. However this rule of thumb does not 
appear to hold in this example. It might be the case that the ability of the tert-butyl 
substituent to stabilise a positive charge at the quaternary centre results in greater 
electron density on the alkene, i.e. the dienophile is more electron rich. This could 
increase the rate of addition thus destroying the selectivity. 
Chloroethyl ethers are also relatively easy to remove (relative to ethyl ethers) and 
therefore the use of CEVE in the IEDDA was investigated. Analysis by chiral HPLC 
indicated that the reaction proceeded with an e.e. of Ca. 30%. Further work is needed 
to optimise the conditions for this reaction, however this promising result shows that 
asymmetric catalysis can be used to control the absolute stereochemistry of the 
Diels-Alder addition product, and therefore the target piperidines 217 and ultimately 
115. 
The second step in the synthesis was the opening of the lactone 201 with ammonia. 
This apparently simple transformation did not turn out as expected and provided 
some interesting results, which are summarised scheme 68. Initially, the lactone was 
dissolved in a 50% methanol/2M aq. ammonia solution and monitored by tic. Whilst 
this method did afford some of the desired amide 219, the major product proved to 
be the bis-ester 220, indicating that attack of methoxide on to the lactone carbonyl 
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was preferred to the attack of ammonia. When the reaction was carried out under 
non-aqueous conditions using 2M methanolic ammonia, the amide 219 was formed 


















(a) See Table. 
Conditions Yield of amide 219 Yield of bis-ester 220 
MeOH, 2M aq. ammonia solution, rt, 1.5h 17% 32% 
2M methanolic ammonia, rt, 7h 93% Trace 
0.5M ammonia in dioxane, rt, 2 days 0% 0% 
'butanol:conc. aq. ammonia sol., rt, 6h Quantitative 0% 
Scheme 68 
It was believed that the formation of the ester could be eliminated by the use of a 
different, non-nucleophilic solvent for the reaction. Therefore, the lactone 201 was 
treated with a 0.5M solution of ammonia in dioxane, an aprotic, non-nucleophilic 
solvent. Surprisingly, no reaction occurred under these conditions even when the 
reaction was carried out in a sealed vessel for 2 weeks. It might be the case that a 
greater concentration of ammonia (such as that in concentrated aqueous ammonia 
solution) is necessary in order for the reaction to proceed at an appreciable rate, 
however the absence of any product whatsoever when this solvent is used does 
suggest that the reaction is highly dependant upon the properties of medium. It might 
be the case that dioxane is not able to stabilise a developing negative charge on the 
tetrahedral intermediate 221, whereas both methanol and water are able to hydrogen 
bond to developing anion (scheme 69) and this interaction could lower the energy of 
the transition state so that addition can occur. 
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Scheme 69 
It seemed that protic solvents were required in order to effect the transformation and 
hence it was proposed that a more sterically demanding alcohol be used to solubilise 
the substrate in an aqueous ammonia solution; a sterically hindered alcohol would be 
less likely to attack the lactone carbonyl. tert-Butanol was considered to be the best 
candidate and hence the bicyclic molecule was dissolved in a solution of tert-butanol 
and concentrated aqueous ammonia solution added carefully (scheme 68). Analysis 
by tic and ESMS showed an efficient conversion to the amide 219 which was 
recovered by concentration in vacuo when complete. Analytical samples were 
prepared either by recystallisation or column chromatography, although the crude 
product contained only traces of impurities and could be carried through to the next 
step without affecting the yield. The crystal structure of the amide 219 was obtained 
(figure 16) and clearly illustrates the relative stereochemistry around the ring, with 
the alcohol and amide groups on the opposite side of the ring to the ethyl ether and 
ester groups. 
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041 
Figure 16 
The Hofmann rearrangement of amides to amines via an isocyanate is a well 
established reaction. 98  The classical reagent for this transformation is basic bromine 
water, however a number of alternatives have recently been introduced. Bis-
(trifluoroacetoxy)iodobenzene97' 99-102  is a mild reagent which has been reported to 
initiate the rearrangement cleanly and hence it was decided to use this hypervalent 
iodine species to synthesise the amine 223 (scheme 70) 
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OE t 	aq. HCI OEt 
CIH3N 	CO2Me 
OH OH OH 
219 222 223 
Conditions: 
(a) PhI(OCOCF 3 ) 2 , MeCN, H20, rt, dark, 6 days, 66% 
Scheme 70 
The reaction was carried out simply by dissolving the substrate and reagent in a 1:1 
mixture of acetonitrile and water. The solution was stirred in the dark until complete, 
whereupon it was quenched with dilute hydrochloric acid thus converting any 
remaining isocyanate 222 to the amine salt 223. Any non-ionic by-products were 
removed by washing the aqueous solution with ethyl acetate and the amine salt 
recovered by concentration under reduced pressure. 
Unfortunately it was found that the product 223 was particularly unstable, rapidly 
decomposing to a brown oil as the solution became more concentrated, and 
subsequently when left in the fridge. This decomposition may be catalysed by traces 
of triflic acid produced in the reaction, however it was thought that it might be 
overcome by protection of the amine functionality prior to the concentration. 
Attempts were made to convert the isocyanate intermediate 222 directly to a 
carbamate via addition of a suitable alcohol (e.g. benzyl alcohol) to the reaction. 
However, it proved difficult to eliminate all traces of water from the reaction and 
hence hydrolysis of the isocyanate could not be prevented and this idea was dropped 
in favour of a two-step procedure. 
It was decided to return to the original reaction conditions, but attempt to protect the 
amine formed during the work-up in situ by addition of excess benzyl chioroformate 
to the dilute aqueous solution followed by basification with sodium bicarbonate 
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(scheme 71). Upon completion, the product 224 was recovered by extraction with 
ethyl acetate and purified by recrystallisation. 
Not Isolated 
	






OH 	 OH 
b 	 OHOEt 
219 223 224 
Conditions: 
(a) i) PhI(0 2CCF3) 2 , MeCN, H20, ii, dark, 2 days; ii) aq. HCI; (b) benzylchloroformate, 
dioxane, NaHCO 3 , 3 days, 93%. 
Scheme 71 
Whilst this method appears crude, it resulted in an excellent 93% yield of pure 
Z-protected amine 224 and was easily extended to multigram scale reactions. 
It should be noted at this point that the procedure that has been developed allows the 
facile synthesis of a family of conformationally restricted ct-amino acid analogues 
such as those illustrated in scheme 72. Unnatural amino acids can be used in the 
development of novel peptides which might have interesting biological properties. 
The steric hindrance of the ct,ct'-disubstituted centre could be expected to lend 
stability to the peptide by preventing or slowing enzymatic hydrolysis, and the 
conformational restriction imposed by the ring could influence the secondary 
structure of the peptide. In addition, the hydroxyl groups around the ring provide 
handles for further elaboration of the general motif, therefore increasing the number 
of possible analogues. Whether or not this approach proves to be successful for the 
synthesis of the target piperidine, it does provide a straightforward and efficient entry 
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Hydroxyl protection was required before attempting the oxidative cleavage, and this 
was achieved using acetic anhydride, pyridine and DMAP in DCM to afford the 
acetate 225 (scheme 73). 
ZHN CO Me 
OEt 	a 





(a) Ac20, py, DMAP (cat.), DCM, rt, 2 days, quant. 
Scheme 73 
The next, key step in this synthesis was the oxidative cleavage of the double bond to 
give a ring-opened precursor of the piperidine. Ozonolysis has been used to open 
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cyclohexenes in good yields to afford a bis-aldehyde: the ideal functionality for the 
subsequent cyclisation. 103 Unfortunately, all attempts to effect this transformation 
failed; the substrate 225 was consumed but gave a complex mixture of products 








(a) i) 03/02, DCM, -78°C; ii) PPh3 , ii, complex mixture of polar products. 
Scheme 74 
Ozone is not a particularly selective reagent and could oxidise other functional 
groups in the molecule or cause further oxidation of an intermediate. In addition, the 
NMR spectrum of the crude product mixture contained five different aldehyde peaks, 
which suggests that the product was unstable under these conditions and reacted 
further. 
An alternative procedure for the cleavage of alkenes is dihydroxylation followed by 
oxidative cleavage. It has been reported that catalytic osmium tetroxide in the 
presence of excess sodium periodate achieves the cleavage of the double bond in a 
one-pot, two step procedure. 104  The alkene 225 was submitted to these conditions 
and a sample analysed by 'H NMR after 18 hours (scheme 75). 
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225 227 226 
Conditions: 
(a) 0s04 , Na104 , THF, water, ii, 18h, Ca. 3% conversion to bis-aldehyde 226 (by NMR). 
Scheme 75 
Whilst two aldehyde peaks were clearly visible in the 'H NMR spectrum (figure 17), 
the major component was unreacted substrate 225. Integration of relevant peaks 
indicated only Ca. three percent of the substrate had reacted. Interestingly, no 
resonances corresponding to the diol 227 were seen, which suggests that the 
dihydroxylation is the rate determining step for this process. 
10 	 - 	8 	 7 	 6 	 5 	 4 	 3 	 7 
0.54 	 68.76 	 4365 	 31.66 	 51.03 	 16.65 	 50.70 
6,82 	 -1.26 	 15.04 	 0.00 	 56.00 	 623.05 	 121.60 
Figure 17 
Unfortunately, when the reaction was followed by tic and worked up after ten days 
(at which point the substrate had been consumed), the crude NMR spectrum 
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indicated many aldehyde peaks, and when subjected to column chromatography the 
polar product mixture remained on the silica. 
These results suggested that the osmium tetroxide was reacting extremely slowly 
with the alkene 225, and that the aldehyde 226 was unstable over the length of time 
needed for the first step to reach completion. This might not be surprising given the 
relatively electron deficient nature of the double bond and the sterically challenging 
approach to it. 
A literature search for a more reactive reagent identified ruthenium tetroxide as a 
possible candidate. 105  Ruthenium tetroxide is generated in situ from catalytic 
ruthenium chloride and sodium periodate and has the added advantage that it is not 
as toxic as osmium. Submission of the alkene 225 to these conditions for 5 minutes 
afforded a mixture of the two cis-diol products 227 and 228 in 50% yield (scheme 
76). 
ZHN Co Me 
OEt 	a 
ZHN 	CO2 Me ZHN CO2 Me 
::: 0Et+ :II 0Et 
ÔAC ÔAc ÔAC 
225 227 228 
Conditions: 
(a) RuC1 3 .xH 20, Na104 , EtOAc, MeCN, H 20, 0°C, 5 mm, 50% (combined yield). 
Scheme 76 
Care was needed as the oxidant can attack other functional groups in the molecule 
(for example Ru04 is known to cleave N-Z-protected (x-amino alcohols,' 06  oxidise 
heteroatoms (e.g. sulfides to sulfones)' °7 and also convert benzene rings to 
carboxylic acids);' 08  with such short reaction times there was not much room for 
error. The yield was slightly disappointing and attempts were made to optimise the 
conditions for this reaction, but unfortunately time constraints did not allow a 
comprehensive study to take place. 
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The previous examples using osmium had shown that the sodium periodate also 
reacts quickly with the diol to give the ring-opened product, so it was expected this 
might be occurring at the same time as hydroxylation. For this reason only a small 
sample was purified for analysis and the crude products taken through to the next 
step so as to maximise the yields. In addition a small sample of the diol mixture 
227/228 was converted to the acetonides 229 and 230 using standard conditions 
(scheme 77). The yields of this straightforward reaction appear low as a result of the 
extensive column chromatography that was required to separate the two 
diastereomers. 
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(a) 2,2-DMP, TsOH (cat.), DCM, rt, 20h, 229:27%, 230:10%. 
Scheme 77 
Despite confusing and complex coupling patterns, 'H NMR studies on these two 
products suggest that the major product of the dihydroxylation is the isomer 227. A 
comparison of this spectrum with that of the major diol 227 indicates that the NH 
resonance is shifted downfield by 1 ppm from 5.42 in the diol to 6.47 in the 
acetonide, whilst the methyl ester remains unaffected. In the case of the minor 
diastereomer the opposite is true: the NH resonance in the acetonide at 5.53 ppm is 
similar to that of the diol whereas the methyl ester is broadened. Whilst the geometry 
of these dials is not important for subsequent steps, it is nonetheless interesting that 
the major dihydroxylation product 227 appears to arise from attack from the most 
hindered side of the ring. Given the low yield (50%) of the ruthenium tetroxide 
reaction, one explanation of this might be that the least hindered diol 228 is more 
susceptible to periodate cleavage and hence reacts further, whereas the more 
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hindered diol 227 builds up in the reaction medium, giving the impression that it is 
the major product. In addition, the high reactivity of the catalyst would tend to result 
in poor selectivity, resulting a roughly equal product distribution. 
Kinoshita et al. report that the oxidative cleavage of the aminoglycoside 231 is 
achieved in excellent yields using sodium periodate, and, more interestingly, that the 
aldehyde produced is trapped by the protected amine via an intramolecular ring 
closure to give the hemiaminal 232.109  This compound was then acetylated and the 
product 233 isolated (scheme 78). 
ZHN 	 BnO.,.O 
a 	
N OH 
ZHN OH 	 OHCO" NHZ 
	









(a) Na104 , acetone, water, 33°C, 40h, 72%; (b) Ac 20, py, 86%. 
Scheme 78 
It was postulated that these reaction conditions when applied to the diols 227/228 
would result in the same intramolecular attack despite the more hindered nature of 
the amine group. Therefore the diols 227/228 were reacted with sodium periodate in 
acetone/water solution at 33°C and the reaction followed by tic (scheme 79). 
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Conditions: 
(a) Na104 , acetone, water, 33°C, 20h. 
Scheme 79 
Analysis of the products indicated the disappearance of the starting materials (RF 
(hex:EtOAc, 1:1)0.11) and the formation of a less polar compound (RF (hex:EtOAc, 
1:1) 0.28). The 'H NMR spectrum of this product was not at all clear and seemed to 
indicate that more than one species were present in the sample. In contrast to the 
NMR data, the electrospray mass spectrum showed a very clean product with a mass 
of 446 daltons. This mass could be attributed to the sodium adduct of the oxidised 
diols 227/228 (M = 423 Da) and hence it was proposed that the oxidative cleavage 
and subsequent cyclisation had indeed occurred to afford the piperidines 235 and 
In addition, the proximity of the hydroxyl group of the hemiaminal 236 to the 
second aldehyde could result in further cyclisation to give the bicyclic compound 
The equilibration of all of these species in solution via the bis-aldehyde 234 
could explain the complex NMR spectrum. It was hoped that this process could be 
stopped by acetylation of the free hydroxyl, therefore allowing a firm conclusion as 
to the nature of the products. Accordingly, the crude products from the oxidative 
cleavage were acetylated using standard conditions as shown in scheme 80. 







Two major products 
Conditions: 
(a) Ac 20, pyridine, DMAP (cat.), DCM, rt, 20h. 
Scheme 80 
The reaction proceeded smoothly as expected to give a less polar product at RF 0.51 
(hex:EtOAc, 1:1). The electrospray mass spectrum showed a clean, strong peak at 
488 Daltons, indicating that the product had a mass corresponding to a 
monoacetylation of the equilibrating mixture 234/235/236/237 (MS ubstrate = 423; Mprod 
I = 465 Da, MprodNa
+  = 488 Da). Despite being much clearer than before, the H NMR 
spectrum (figure 18) indicated only one aldehyde peak at 9.57 ppm, and seemed to 
consist of signals from two different but related compounds, both with the same RF. 
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Figure 18 
Results and Discussion Part III 
Close inspection of the clear resonances of this spectrum seemed to indicate two 
distinct sets of peaks corresponding to an aldehyde and a related acetal. Using the 
integration as a guide, the singlet at 9.56 ppm, the doublet at Ca. 7.00 ppm and the 
roofed ABX system of the benzyl CH 2 group between 5.00 and 5.50 ppm would 
appear to belong to the aldehyde compound, whereas the singlet at 6.54 ppm, the 
doublet at ca. 6.05 ppm, and the benzyl hydrogen singlet at 5.15 ppm all belong to 
the second group of resonances. As a result of these findings, it is proposed that the 
two products 238 and 239 are formed in this reaction (scheme 81). 
This result seems to support the proposal made previously that the hemiaminal 236 
which possesses the hydroxyl and aldehyde groups on the same side can cyclise to 
give the bicyclic compound 239, and that this must be preferentially acetylated as the 
hydroxyl group is more accessible. It should also be noted that two possible isomers 
of the bicyclic acetal 239 are possible, and closer inspection of the 'H NMR 
spectrum given in figure 18 does indeed indicate a minor isomer with resonances at 
ca. 6.50 ppm and 5.75 ppm - i.e. similar to those assigned to the compound 239. 










ÔAC 	 ÔAC 	 ÔAC 
234/235/236/237 	 238 239 
Conditions: 
(a) Ac 20, pyridine, DMAP (cat.), DCM, ii, 20h, 53% (combined yield from diols 227/228). 
Scheme 81 
Despite all this evidence, the spectrum could not be completely elucidated owing to 
the overlaying of similar peaks of all the possible compounds. In order to acquire 
conclusive data, it was necessary to separate the compounds. Careful column 
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chromatography proved unsuccessful, returning only mixtures, and initial attempts to 
reduce the compound mixture with sodium borohydride to give a single product (the 
piperidine 240) afforded only a complex mixture of products (scheme 82). 
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(a) NaBH 4, MeOH, THF, rt, 20h; complex product mixture. 
Scheme 82 
Further attempts to reduce this mixture either by use of an alternative borohydride 
such as sodium cyanoborohydride, or possibly triethyl silane/borontrifluoride 
etherate were planned, but unfortunately time constraints have prevented this from 
being achieved. 
The above sequence of reactions from the alcohol 224 was repeated using a tert-
butyl(dimethyl)silyl protecting group in the place of the acetate. This group was 
chosen as it was thought that it might be more easily and selectively removed than an 
acetate and could provide more evidence as to the nature of the products of the 
periodate cleavage reaction. Accordingly, the alcohol 224 was simply protected as 
the TBDMS ether in 85% yield using standard conditions and the alkene 241 
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(a) TBDMSC1, imidazole, DCM, 2 days, 86%; (b) RuCI 3 .xH 20, Na104, EtOAc, MeCN, H 20, 
rt, 5 mm., 18%. 
Scheme 83 
The dihydroxylation did not proceed as effectively as with the acetoxy alkene 225, 
affording the diol 242 in only 18% yield, as well as some unidentified less polar 
products and recovered starting material. This is probably a result of the increased 
steric hindrance around the double bond which causes even slower dihydroxylation. 
The unidentified products could be a result of the oxidative cleavage of the diol 242, 
however time constraints prevented further investigation into this result. 
Inspection of the 'H NMR spectrum of diol 242 indicated that only one isomer 
appeared to have been formed in the reaction; the acetylated compound 225 had 
formed both diols 227 and 228 upon dihydroxylation. Considering the large size of 
the TBDMS group compared with that of the acetate, it is most likely that the 
underneath of the alkene 241 (as drawn in scheme 83) is too hindered by the benzyl 
carbamate and the silyl ether such that the ruthenium tetroxide can only attack from 
the other face. 
The low yield of this reaction prompted an attempt to dihydroxylate the alkene 241 
using osmium tetroxide and NMO (scheme 84) in an adaption of the literature 
procedure.' ° As before, it appears that this less reactive reagent is unable to oxidise 
the double bond: both tic and 'H NMR indicated that no reaction had occurred at all; 
96% of the starting material was recovered after purification. 
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(a) 0s04, NMO, acetone, water, rt, 2 days. 
Scheme 84 
The next key step in the synthesis was the oxidative cleavage. With the 
dihydroxylation proving inefficient, the best yields for this transformation were 
achieved when excess sodium periodate was added to the dihydroxylation reaction, 
thus effecting the cleavage in situ. Immediate acetylation and purification of the 
products of this three step sequence afforded two compounds with almost identical 
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Conditions: 
(a) i) RuCI 3 .xH 20, Na104 (4 equiv.), MeCN, water; ii) Ac 20, pyridine, DMAP (cat.) DCM, 
38% (two steps). 
Scheme 85 
Inspection of the data suggests that these compounds might be the bicyclic acetals 
243 and 244. Whilst careful column chromatography could not separate them 
completely, it did afford fractions enriched in the major isomer, as shown by the 'H 
NMR spectrum in figure 19. 
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Figure 19 
The most obvious point that can be made about this spectrum is the total absence of 
any aldehyde peaks. This would suggest that the TBDMS protected equivalent of the 
piperidine 238 is not formed, possibly because the steric hindrance of the bulky 
protecting group forces the hydroxyl group to the same face as the aldehyde. The 
presence of two strong singlets at Ca. 6.20 and 6.80 ppm could represent the aminal 
and acetal protons of the major isomer although the aminal resonance ought to be 
split as a result of coupling to the adjacent proton. If only small, this coupling might 
be lost in the broadness of the signal. As illustrated above, all of the signals can be 
attributed to a particular proton of the product, supporting the structural assignment. 
Unfortunately, owing to time constraints, the identity of these products has not yet 
been confirmed. 
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Conclusions 
Significant progress has been made towards the synthesis of the complex piperidine 
target 1,1 -bis-hydroxymethyl- 1 ,5-dideoxy- 1 ,5-imino-L-fucitol 115. A simple, 
efficient and adaptable strategy for the synthesis of a range of highly substituted 
a,ct'-bis-hydroxylmethyl piperidines and novel aminoacid derivatives has been 
developed using the simplified racemic analogue 217 as the initial target. 
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115 217 
Figure 20 
The initial step of the synthesis employs an ytterbium catalysed inverse electron 
demand Diels-Alder reaction of the commercially available pyrone 190 with EVE to 
establish the core stereochemistry. The lactone 201 was opened with ammonia and 
Hofmann rearrangement of the amide intermediate 219 was achieved in excellent 
93% yield using a hypervalent iodine catalyst, affording the novel amine 224 which 
could form the basis of a family of novel highly functionalised, conformationally 
restricted aminoacid derivatives (scheme 86). 
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224 	 219 
Conditions: 
(a) Yb(OT03, BINOL, DIEA, EVE, DCM, rt, 20h, 81%; (b) 4:1 tert-butyl alcohol/conc. aq . 
ammonia solution, 6h, quant.; (c) i) PhI(OCOCF 3) 2 , MeCN, H20, rt, dark, 2 days; ii) 
benzylchloroformate, NaHCO 3 , water, dioxane, 3 days, 93%. 
Scheme 86 
Protection of the alcohol 224 as the acetate followed by oxidative cleavage using a 
Ru047NaIO4 protocol afforded an inseparable mixture of isomers believed to be the 








OH OAc OAc OAc 
224 225 238 239 
Conditions: 
(a) Ac 20, py, DMAP (cat.) DCM, 2 days, quant.; (b) RuC1 3 .xH20, Na104 , 0°C, 5 mm, 50%; 
ii) Na104, acetone, water, 33°C, 20h; iii) Ac 20, py, DMAP (cat.), DCM, II, 20h, 53% (two 
steps). 
Scheme 87 
Similarly, oxidative cleavage and acetylation of the TBDMS protected alcohol 241 
afforded a mixture of isomers, believed to be the bicyclic compounds 243 and 244 
(scheme 88). 
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OH OTBDMS OTBDMS OTBDMS 
224 241 243 244 
Conditions: 
(a) TBDMSCI, imidazole, DCM, 2 days, 86%; (b) RuCI 3 .xH20, Na104 (XS), 0°C, 3 mm, 
14%; ii) Ac 20, py, DMAP (cat.), DCM, rt, 20h, 38% (two steps). 
Scheme 88 
Unfortunately, the synthesis of the simplified target 217 could not be completed in 
the allotted time. The final steps described in this thesis remain unoptimised and 
work is still required in order to unambiguously prove the identities of the 
piperidines 238, 239, 243 and 244. 
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Future Work 
The first and most important task in the coming months is to confirm the identities of 
the products from the oxidative cleavage reactions. As mentioned above, the simplest 
way to do this would be to reduce the aminal and acetal functionalities thus giving 
only one compound 217 (scheme 89) which should simplify the data. The reduction 
step might be achieved using borohydride reduction or hydrosilylation. 
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Having achieved and optimised the synthesis of the racemic target 217, it will be 
necessary to investigate how the remaining functional groups of the fucitol 115 could 
be incorporated into the above synthetic pathway. It might be possible to introduce 
the methyl group to the 6-position of the acetoxypiperidine intermediate (i.e. 237/239 
or 242/244), however the final hydroxyl at the 4-position is likely to be less 
straightforward. Construction of a trans bis-alkoxy dienophile such as 245 to submit 
to the IEDDA reaction may be the simplest method for achieving the synthesis of the 
target 115 (scheme 90). 
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Once the target has been synthesised, future work will concentrate on extending this 
methodology to other targets, such as the family of unnatural, conformationally 
restricted aminoacid derivatives mentioned above (scheme 72). 
Experimental 
Chapter 5: Experimental 
Experimental techniques 
Melting points (m.p.) were measured using a Gallenkamp melting point apparatus 
and are given in (°C) uncorrected. The solvents used for recrystallisation are given in 
parentheses. 
Optical rotations were measured on an Optical Activity AA- 1000 polarimeter with a 
cell path length of 1 dm and concentrations (c) quoted in g/100 mL (sodium 589 nm 
detection). SYMVB1o1 values are given in 101  deg cm2 g* 
Elemental analyses were carried out within the department on a Perkin-Elmer 2400 
Cl-IN Elemental Analyser. 
Infrared spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR spectrometer, 
absorption maxima (Vmax .) being recorded in wavenumbers (cm -1 ) and classified as 
strong (s), medium (m), weak (w), broad (br), or a shoulder (sh). Samples were 
recorded as KBr discs, as thin films using either sodium chloride plates or disposable 
JR cards (3M, type 61, polyethylene 19 mm aperture), as nujol mulls or in solution. 
'H and ' 3 C NMR spectra were recorded on either a Varian Gemini 200, Bruker AC 
250, or a Bruker WH 360 spectrometer. Chemical shifts (cs-,) are quoted in parts per 
million (ppm) downfield of tetramethyl si lane and are referenced to residual CHC1 3 
(7.27 ppm). Assignments were made on the basis of chemical shift and coupling 
data. Abbreviations used in the descriptions of multiplicities are s (singlet), d 
(doublet), t (triplet), q (quartet), in (multiplet) and br (broad). Coupling constants (J) 
are quoted in Hertz (Hz) to the nearest 0.5 Hz. Chemical shifts () are quoted in 
parts per million (ppm) downfield of tetramethylsilane and are referenced to residual 
CHC13 (76.9 ppm). Assignments were made by comparison with the data obtained 
from similar structures. 
Experimental 
Electron Impact (El) mass spectrometry was carried out on a Finnegan 4500 or a 
Finnegan 4600 instrument. Fast Atom Bombardment (FAB) mass spectrometry was 
performed using a Kratos MS50TC instrument. Electrospray (ES) and Atmospheric 
Pressure Chemical lonisation (APCI) mass spectrometry were carried out on a 
Micromass VG Platform II instrument from a mixed solvent system (MeCN:H 20, 
1:1) in +ve or -ye scan mode as stated. m/z values are reported in Daltons and are 
followed by their percentage abundances in parentheses. 
Thin layer chromatography was performed on Merck DC-Alufolien Kieselgel 60F 254 
0.2mm precoated plates or Merck 60F 254 0.25mm glass backed silica gel plates. 
Product spots were visualised by the quenching of u.v. fluorescence (A max. = 254 nm) 
then stained and heated with one of three solutions as appropriate: (i) an acidic 
solution of ninhydrin, (ii) an alkaline solution of potassium permanganate (KMn0 4), 
(iii) a molybdate solution. Where retention factors (RF) are reported, the solvent 
system follows in parentheses. Flash column chromatography was performed by the 
method of Still et al." using silica gel (Merck 9385, particle size 0.04-0.063mm). 
The solvent system follows in parentheses. 
All non-aqueous experiments were carried out under Ar or N 2 atmosphere unless 
specified otherwise using oven-dried glassware (T 150°C). Solvents and 
commercially available reagents were dried or purified, where appropriate, using 
standard procedures. THF was obtained dry and oxygen-free by distillation from 
sodium benzophenyl ketyl under nitrogen. DCM was heated at reflux over and 
distilled from calcium hydride. In each experimental procedure the work-up was 
performed at room temperature unless reported otherwise. Brine refers to a saturated 
aqueous solution of sodium chloride. 
Experimental 




To a stirred solution of ethyl benzyloxyacetate (446 mg, 2.30 mmol) in DCM (10 
mL) at -78°C was added dropwise DIBAL-H (1.OM in toluene, 2.53 mL, 2.53 
mmol). After 2 h, the reaction was quenched by careful addition of sat. aq . NH4C1 
(10 mL) and 1M HC1 (10 mL). The aqueous phase was separated and washed with 
DCM (3 x 10 mL), the combined organic extracts dried (Na 2 SO4) and the solvent 
removed in vacuo to yield crude product (388 mg). Purification by flash column 
chromatography (hexane:EtOAc, 5:1) afforded benzyloxyacetaldehyde 130 as a 
clear oil (331 mg, 95%). RF (hexane:EtOAc, 2:1) 0.31; vmax ./cm' (film, 
polyethylene) 3065, 3032 (w, CH), 1722 (s, C=O), 1455(s), 1114 (s, br), 698 (s, 
ArH); 41 (200MHz, CDC13) 4.12 (2H, d,J0.5, CH2CHO), 4.65 (2H, s, CH2Ph), 
7.20-7.45 (5H, m, Ark!), 9.74 (1H, d,J0.5, CHO). 




To a stirred solution of BTMSA (194 mg, 1.14 mmol) in THF (5 mL) at -40°C was 
added MeLi (1.5M in diethyl ether as LiBr complex, 0.76 mL, 1.14 mmol) and the 
reaction stirred at room temperature for 1 h, cooled to 0°C and a solution of 
benzyloxyacetaldehyde 130 (95 mg, 0.63 mmol) in THF (2 mL) added dropwise. The 
reaction was stirred at room temperature for 1 h and quenched by careful addition of 
sat. aq . NH4C1 (10 mL) at 0°C. The aqueous phase was extracted with ether (3 x 10 
mL) and the combined organic extracts dried (MgSO 4) and concentrated in vacuo to 
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afford crude products. Purification by flash column chromatography (hexane:EtOAc, 
5:1) afforded the racemic alcohols 132 as an oil (61 mg, 39%). RF (hexane:EtOAc, 
5:1) 0.30; vmax ./cm ' (film, polyethylene) 3402 (m, OH), 3065, 3031 (w, CH), 2175 
(w, CC), 1473 (m), 1463 (s), 1251 (m), 1095 (m br), 844 (s), 760 (m), 698 (m); cj-j 
(200MHz, CDC1 3) 0.19 (9H, s, Si(CH3)3), 2.55 (1H, d, J4.5, 011), 3.57 (1H, dd,J 
10.0, 7.5, CHHOBn), 3.68 (111, dd, J 10.0, 3.5, CH[IOBn), 4.54-4.64 (1H, obscured 
m, CHOH), 4.64 (2H, s, CH2Ph), 7.31-7.39 (5H, m, ArII); 9C (50.3MHz, CDC1 3) -0.4 
(CH3 , Si(CH3 )3 ), 61.9 (CH, CHOH), 73.2 (CH 2 , CH2Ph), 73.3 (CH2, CH 20Bn), 90.4, 
102.9 (2 x C, C'_=C acetylene), 127.7, 127.8, 128.4 (CH, ArC), 137.5 (C, ArC); m/z 
(APCI +ve, NH 3) 231 (100%, MHtH20), 159 (8), 114 (24), 91(12). 




To a stirred solution of BTMSA (264 mg, 1.55 mmol) in THF (2.5 mL) at -40°C was 
added MeLi (1.5M in diethyl ether as LiBr complex; 1.03 mL, 1.55 mmol). The 
reaction mixture was stirred at room temperature for 1.5 h and added dropwise to a 
stirred solution of ethyl benzyloxyacetate (200 mg, 1.03 mmol) and borontrifluoride 
etherate (126 mL, 1.03 mmol) in THF (5 mL) at -78°C. After 2 h the reaction was 
quenched by addition of sat. aq . NH4C1 (10 mL) and the aqueous layer extracted with 
ether (3 x 10 mL). The combined organic extracts were dried (Na 2SO4) and 
concentrated in vacuo to afford crude products. Purification by flash column 
chromatography (hexane:EtOAc, 5:1) afforded recovered starting material and the 
acetylene 133 as an oil (100 mg, 42%). RF (hexane:EtOAc, 6:1) 0.50; vmax/cm' 
(film, polyethylene) 3065 (w), 3032 (w, CH), 2152 (m, CEC), 1694 (s, C0), 1455 
(m), 1253 (s), 1187 (m), 1083 (s), 847 (s), 762 (m), 738 (m), 698 (m); cj-j (200MHz, 
CDC1 3) 0.25 (911, s, Si(CH3)3), 4.24 (2H, s, CH2CO), 4.65 (2H, s, CH2Ph), 7.30-7.42 
(5H, m, ArH); Jc (50.3MHz, CDC13) -1.1 (CH3 , Si(C11 3)3), 73.2 (CH2, CH2Ph), 75.6 
Experimental 
(CH2 , CH20Bn), 99.6, 101.2 (2 x C, CaC acetylene), 127.9, 128.0, 128.4 (CH, ArC), 
136.9 (C, ArC), 184.7 (C, C0); m/z (APCI +ve, NH3) 216 (12%), 207 (23), 175 
([M-C3H8Si]H, 50), 173 (15), 132 (20), 106 (11), 91(100). 
Method II 
To a stirred solution of BTMSA (128 mg, 0.75 mmol) in THF (2.5 mL) at -40°C was 
added MeLi (1.5M in diethyl ether as LiBr complex, 0.50 mL, 0.75 mmol). The 
solution was stirred at room temperature for 1 h and added via syringe to a stirred 
solution of N-methoxy-N-methyl-benzyloxy-acetamide 139 (1.05 mg, 0.50 mmol) in 
THF (2.5 mL) at -78°C. After 1 h, sat. aq . NH4C1 (5 mL) and water (2 mL) were 
added and the reaction stirred at room temperature for 30 minutes. The aqueous layer 
was extracted with ether (10 mL) and the combined organic extracts washed with 
water (10 mL), dried (Na 2 SO4) and concentrated in vacuo to afford crude products 
(128 mg, 104%). Purification attempts by flash column chromatography 
(hexane:EtOAc, 1:5) caused partial desilylation to afford a mixture of acetylenes 140 
and 141 (91 mg, Ca. 4:1 by n.m.r., 78% (combined yield)) and recovered starting 
material (19 mg, 18%). 140: Data as above; 141: dataas below. 
I -Benzyloxy-but-3-yn-2-one 141 
0 	Ph 
To a stirred solution of BTMSA (211 mg, 1.24 mmol) in THF (2.5 mL) at -40°C was 
added MeLi (1.5M in diethyl ether as LiBr complex; 0.82 mL, 1.24 mmol). The 
reaction was stirred at room temperature for 1 h and added dropwise to a stirred 
solution of ethyl benzyloxyacetate (200 mg, 1.03 mmol) and borontrifluoride 
etherate (12.6 mL, 0.10 mmol) in THF (5 mL) at -78°C. After 1 h the reaction was 
quenched by addition of sat. aq . NH4C1 (7 mL) solution and stirred at room 
temperature for 30 minutes. The aqueous layer extracted with ether (3 x 10 mL), and 
the combined organic extracts dried (Na 2 SO4) and concentrated in vacuo to afford 
crude products. Purification by flash column chromatography (hexane:EtOAc, 5:1) 
Experimental 
afforded acetylene 141 (40 mg, 22%) and recovered starting material (78 mg, 39%). 
RF (hexane:EtOAc, 6:1) 0.33; vmax ./cm' (film, polyethylene) 3260 (m, CC-H), 3064 
(w), 3032 (w, CH), 2093 (s, CC), 1702 (s, C=O), 1455 (m), 1069 (s), 742 (m), 698 
(m); & (200MHz, CDC1 3) 3.33 (IH, s, Cu), 4.24 (2H, s, CH2CHO), 4.64 (2H, s, 
CH2Ph), 7.27-7.45 (5H, m, AruI); 5C (50.3MHz, CDC1 3) 73.5 (CH, CH 2Ph), 75.7 
(CH2 , C1120),79.3 (C, CCO), 81.3 (CH, CCH), 128.0, 128.2, 128.6 (CH, ArC), 
136.8 (C, ArC), 184.5 (C, CO); m/z (APCI +ve, NH 3) 207 (29%),175 (14, MH), 
132 (9), 127(12), 117 (20), 87 (16),74 (20), 56 (100). 
N-methoxy-N-methyl-benzyloxy-acetam ide 139 
0, NA
~-10'-'10 
To a stirred solution of NO-dimethyl-hydroxylamine hydrochloride (581 mg, 5.96 
mmol) and anhydrous pyridine (963 mL, 942 mg, 11.91 mmol) in DCM (30 mL) at 
0°C was added dropwise a solution of benzyloxyacetyl chloride 138 (855 PL, 1 g, 
5.42 mmol) in DCM (10 mL). After 10 minutes the solution was concentrated in 
vacuo and DCM (25 mL) added. The organic solution was washed with brine (25 
mL), dried (MgSO4) and concentrated in vacuo to afford crude amide (1.248 g). 
Purification by flash column chromatography (hexane:EtOAc, 1:5) afforded pure 
amide 139 as an oil (1.073 g, 95%). RF (hexane:EtOAc, 2:1); vmax./cm 1 (film, 
polyethylene) 3063 (w), 3031 (w, CH), 1682 (s, C=O), 1455 (m), 1329 (m), 1141 
(m), 1089 (m), 993 (m) 742 (m), 700 (m, ArH); & (200MHz, CDC1 3) 3.20 (3H, s, 
NCH3), 3.64 (3H, s, OCH3), 4.29 (2H, s, CH2OBn), 4.68 (2H, s, CH2Ph), 7,25-7.45 
(5H, m, ArH); ô (50.3MHz, CDC1 3) 30.9 (CH3 , NCH 3), 60.0 (CH3 , UGH3), 65.7 
(CH2, CH20Bn), 71.8 (CH 2 , GH2Ph), 126.5, 126.7, 127.1 (CH, ArC), 136.2 (C, ArC), 
169.7 (C, C=O); m/z (APCI +ve, NH3 ) 210 (40%, MH), 180 (6),132 (13),91 (100). 
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N-( tert-butoxycarbonyl)-L-alan i ne-N-methoxy-N-methylamide 14764 
To a stirred suspension of NO-dimethyl-hydroxylamine hydrochloride (8.33 g, 0.085 
mol) in DCM (55 mL) at 4°C was added N-methylpyrrolidine (10.4 mL, 8.47 g, 
0.085 mol) and this solution stirred at 4°C until used. 
To a stirred solution of N-butoxycarbonyl-L-alanine 146 (16.15 g, 0.085 mol) in THF 
(160 mL) and DCM (80m1) at -50°C was added N-methylpyrrolidine (10.4 mL, 8.47 
g, 0.085 mol). The reaction was brought to -14°C and methyichioroformate (6.6 mL, 
8.07 g, 0.085 mol) added. After 2 minutes the solution of free N,O-dimethyl-
hydroxylamine was cannulated onto the reaction and stirring maintained at room 
temperature for 21h. The reaction was quenched by addition of 0.2M HC1 (160 mL) 
at -4°C and the biphasic solution stirred for 10 minutes. The organic phase was 
separated and washed with 0.2M HC1 (160 mL), 0.5M NaOH (2x200 mL) and brine 
(250 mL), dried (Na 2 SO4) and concentrated in vacuo to afford the Weinreb amide 
147 as a white crystalline solid (14.95 g, 75%). Mp 147.0-147.5°C; RF 
(hexane:EtOAc, 2:1) 0.23; 8j i (200MHz, CDC1 3) 1.31 (3H, d,J7.0, CHCH3), 1.44 
(9H, s, C(CH3 ) 3 ), 3.21 (3H, s, NCH3), 3.77 (3H, s, OCH3), 4.55-4.80 (1H, m, 
CHCH3), 5.15-5.35 (1H, br.d, NI-I); c (50.3MHz, CDC13) 18.4 (CH3 , CHC113), 28.2 
(CH3 , C(CH3)3), 31.9 (CH3 , NCH3), 46.3 (CH, CHCH3), 61.4 (CH 3 , OCH3), 79.3 (C, 
CCH3), 155.1 (C, OCO), 173.5 (C, H3 CNCO); m/z (C.I., NH3) 256 (0.5%, MNa), 
233 (0.7, MH), 177 (10), 159 (14), 133 (100, (MH 2-Boc)), 101 (10), 74 (17), 57 





O fl, NH 
To a stirred solution of LiA1H4 (1.0M in diethyl ether, 28.0 mL, 0.028 mot) in THF 
(65 mL) at -20°C was added a solution of Weinreb amide 147 (11.8 g, 0.051 mot) in 
THF (270 mL) over 45 minutes. After 0.5 h the reaction was brought to -10°C and 
quenched by addition of sat. aq . KHSO4 (19 g, 0.14 mot) and the mixture stirred at 
room temperature for 1 h. The aqueous phase was extracted with ethyl acetate (5 x 
50 mL) and the combined organic extracts washed with brine (50 mL). The brine 
wash was extracted with ethyl acetate (3 x 25 mL) and the combined organic extracts 
dried (Na2 SO4) and concentrated in vacuo to afford the crude product. 
Recrystallisation from EtOAc/hexane afforded the aldehyde 148 as a white 
crystalline solid (7.80 g, 89%). Mp 89.0-90.0°C; RF (hexane:EtOAc, 2:1) 0.43;  41 
(200MHz, CDC1 3) 1.33 (3H, d, J7.5, CHCH3), 1.44 (91-1, s, C(CH3) 3), 4.10-4.30 (1H, 
br m, CHCH3), 5.05-5.30 (111, br s, NH), 9.55 (1H, s, CHO); & (50.3MHz, CDC13) 
14.6 (CH3 , CHCH3), 28.1 (CH 3 , C(CH3) 3), 55.3 (CH, CHCH 3), 79.9 (C, C(CH 3)3), 
155.2 (CO, NCO), 199.8 (CO, CHO); m/z (APCI +ve, NH3) 173 (13%, MH), 132 
(42), 118 (11), 100 (23), 88(43), 74(100), 56(27); HRMS (FAB +ve, THIOG) 
174.1130 (Fragment. C 8H 16NO3 requires 174.1130). 
(3RS, 4S)-N-(tert-butoxycarbonyl)-4-amino-1 -(trimethylsilyl)pent-1 -yn-
3-ol 155/156 
0 	 SIMe, 
~VH'5~' 
To a stirred solution of BTMSA (3.94 g, 23.1 mmol) in THF (75 mL) at -40°C was 
added MeLi (1.4M in diethyl ether as LiBr complex, 16.5 mL, 23.1 mmol) and the 
reaction stirred at room temperature for 1 h, brought to -78°C and BF 3 .OEt2 (2.93 
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mL, 23.1 mmol) added. After 0.5 h a solution of aldehyde 148 (1.00 g, 5.8 mmol) in 
THF (20 mL + 5 mL) was cannulated onto the reaction and stirring continued for a 
further 0.5 h. MeOH (50 mL) followed by sat. aq . NH4C1 solution (60 mL) were 
added and the reaction warmed to room temperature. The aqueous phase was 
separated and extracted with ether (3 x 50 mL), and the combined organic extracts 
washed with brine (20 mL) and water (20 mL), dried (Na 2 SO4) and concentrated in 
vacuo to afford a pale yellow oil. Purification by flash column chromatography 
(hexane:EtOAc, 6:1) afforded a mixture of diastereomeric amino-alcohols (SS:RS, 
Ca. 6:1, 1.16g, 74% combined yield). RF (hexane:EtOAc, 2:1) 0.61; vmax ./cm' (film, 
polyethylene) 3374 (br, OH), 2174 (m, CC), 1694 (s, C=O), 1504 (s,. NH), 1251 
(s), 1170 (s), 1046 (m), 102 (m), 845 (s), 761 (m); .5f- (200MHz, CDC1 3 ) major 155: 
0.17 (9H, s, Si(CH3)3), 2.23 (3H, d,J7.0, CHCH3), 1.45 (9H, s, C(CH3 ) 3), 2.90-3.20 
(1H, br s, OH), 3.70-4.00 (1H, br m, CHCH3), 4.32 (1H, app. t, J5.5, CHOH), 4.60-
4.85 (1H, br.d, NH); minor 156: 0.17 (9H, s, Si(CH3)3), Ca. 1.19 (3H, obsc. d, 
CHCH3 ), other resonances obscured by major; (50.3MHz, CDC1 3) major 155: -0.3 
(CH3 , Si(CH3) 3), 16.1 (CH3 , CHCH3), 28.2 (CH3 , C(CH3 ) 3), 50.6 (CH, CHCH3), 66.0 
(CH, CHOH), 79.6 (C, C(CH3 ) 3), 90.4, 104.0 (CH and C, CCH), 155.8 (CO, C=O); 
m/z (FAB +ve, THIOG) 272 (MH, 11%), 216 (86), 144 (26) 73 (100); HRMS (FAB 
+ve, THIOG) 272.1684 (Fragment. C 13H26NO3 Si requires 272.1682). 
(2S, 3S)-2-Am I no-N-(tert-butoxycarbonyl)pent-4-yn-3-oI 157 
A solution of diastereomeric amino-alcohols 155/156(1.11 g, 4.10 mmol) and 
K2CO3 (850 mg, 6.14 mmol) in MeOH (40 mL) was stirred at room temperature for 
3h. The reaction was quenched by addition of water (50 mL) at 0°C and the aqueous 
phase extracted with ether (3 x 50 mL). The combined organic extracts were washed 
with brine (40 mL), dried (Na 2 SO4) and concentrated in vacuo to afford the 
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diastereomeric amino-alcohols 157/158 (0.86 g). Purification by recrystallisation 
(slow evaporation of ether from hexane) afforded the (2S,35)-diastereomer 157 as a 
white crystalline solid (385 mg, 47%). Mp 77.0-77.5°C; RF (hexane:EtOAc, 2:1) 
0.40, (hexane:EtOAc, 4:1) 0.12; (Found: C, 60.26; H, 8.70; N, 6.99. C 10H 17NO3 
requires C, 60.26; H, 8.60; N, 7.03%); vmax ./cm ' (film, polyethylene) 3363 (br m, 
OH), 3310 (m, NH), 2980 (m, CH), 2118 (w, CC), 1694 (s, C=O), 1169 (s); 4-
(200MHz, CDC1 3) 1.25 (3H, d,.J6.5, CHCH3), 1.44 (9H, s, C(CH3)3), 2.46 (1H, d,J 
2.0, CCH), 3.30-3.50 (1H, br s, OH), 3.75-3.95 (1H, br m, CHCH 3 ), 4.37 (1H, td, J 
5.5, 2.0, CHOH), 4.76 (1H, br d, NH); Sc (50.3MHz, CDC1 3) 15.6 (CH3 , CHCFI3), 
28.1 (CH3 , C(CH3 )3), 50.4 (CH, CHCH3), 65.3 (CH, CHOH), 73.8, 79.8, 82.1 (CH 
and 2 x C, CCH and OC(CH3 ) 3), 155.9 (C, C=O); m/z (FAB +ve, 3-NOBA) 200 
(MH, 26),144 (100), 100 (MH 2-Boc)), 87 (10); FIRMS (FAB +ve, 3-NOBA) 
200.1282 (Fragment. C joH j8NO3  requires 200.1287). 
(2S,3S)-2-Am i no-N-( tert-butoxycarbonyl)-3-(tert-butyl - 
dimethylsilyloxy)pent-4-yne 159 
Si 
A stirred solution of alcohol 157 (141 mg, 0.71 mmol), TBDMSC1 (160 mg, 1.06 
mmol) and imidazole (145 mg, 2.13 mmol) in DCM (5 mL) was heated at 40°C for 
2.5h. Water (15 mL) was added and the aqueous phase extracted with DCM (3 x 15 
mL). The combined organic extracts were washed with brine (10 mL), dried 
(Na2 SO4) and concentrated in vacuo to afford crude products. Purification by flash 
column chromatography (hexane:EtOAc, 12:1) afforded pure acetylene 159 as an oil 
(230 mg, quant.). RF (hexane:EtOAc, 4:1) 0.62; vmax ./cm' (film, polyethylene) 3451 
(m), 3312 (m), 2958 (s), 2862 (m, CH), 2113 (CC), 1699 (s, C=O), 1505 (s), 1367 
(m), 1252 (m), 1171(m), 1095 (br, m), 1057 (m), 840 (m), 779 (m); & (200MHz, 
CDC1 3) 0.12 (3H, s, SiCH3), 0.16 (3H, s, SiCH3), 0.91 (9H, s, SiC(CH3)3), 1.19 (311, 
d, J6.5, CHCH3), 1.45 (9H, s, OC(CH3) 3), 2.36 (1H, d, J2.0, CCH), 3.70-3.95 (1H, 
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br m, CHCH 3),4.42 (1H, dd, J4.0, 2.0, CHOSi), 4.55-4.75 (1H, br m, NH); 
(50.3MHz, CDC13), -5.3, -4.8 (2 x CH3 , Si(CH3) 2), 15.5 (CH 3 , CHCH3), 18.0 (C, 
SiC(CH3)3), 25.6 (3 x CH3 , SiC(CH3)3), 28.2 (CH3 , C(CH 3)3), 50.4 (CH, CHCH3), 
65.3 (CH, CHOSi), 73.2, 79.2, 82.5 (CH and 2 x C, CCH and OC(CH3)3), 155.1 (C, 
C=O); m/z (FAB +ve, THIOG) 314 (MH, 24%),258 ([MH-'Bu]H, 76),242 (29), 
214 ([MH-Boc]H, 54%), 200 ([MH-Si(CH3 ) 2C(CH3)3]H, 100); HRMS (FAB +ve, 
THIOG) 314.2149 (Fragment. C 1 6H32NO3 Si requires 314.2152). 




To a stirred solution of acetylene 159 (90 mg, 0.29 mmol) in THF (2 mL) at -78°C 
was added "BuLi (2.09M in hexanes, 0.30 mL, 0.63 mmol). After 10 minutes a 
solution of Weinreb amide 139 (60 mg, 0.29 mmol) in THF (1 mL + 1 mL wash) was 
added and the reaction stirred for 0.5h and quenched by addition of sat. aq . NH4C1 (6 
mL). The aqueous phase was separated and extracted with ether (3 x 10 mL), dried 
(Na2 SO4) and concentrated in vacuo to afford an oil. Purification by flash column 
chromatography (hexane:EtOAc, 8:1) afforded recovered acetylene 159 (31 mg, 
34%), 1-benzyloxy-hexan-2-one (22 mg, 37%) and the ketone 160 (18 mg, 14%). RF 
(hexane:EtOAc, 4:1) 0.46; Vmax /cm (film, polyethylene) 2956 (w, CH), 2209 (w, 
CC), 1699 (s, C0), 1505 (m), 1366(m), 1253 (m, 1168 (m), 1113 (br, m), 1057 
(m), 838 (m), 780 (m); 5j (200MHz, CDC1 3) 0.13 (3, s, SiCH3), 0.15 (3H, 5, SiCH3), 
0.90 (911, s, SiC(CH3)3), 1.19 (31-1, d,J7.0, CHCH3), 1.44 (9H, s, OC(CH3)3), 3.75-
3.95 (1H, br dq, J4.0, 7.0, CHCH3), 4.21 (211, s, CH2CHO), 4.59 (1H, d, J4.0, 
CHOSi), Ca. 4.55-4.75 (1H, br m, NH), 4.65 (2H, s, CH2Ph), 7.27-7.40 (5H, m, Phil) 
m/z (C.I., NH3) 406 (MH, 4%), 364 (29), 363 (100), 212 (11); Decomposition 
prevented further characterisation. 
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1-(Benzyloxy)hexan-2-one X: RF (hexane:EtOAc, 4:1) 0.50; vmax ./cm' (film, 
polyethylene) 3065 (w), 3031 (w, CH), 1721 (s, C=O), 1455 (m), 1255 (w), 1208 
(w), 1119 (br, m) 738 (m), 698 (m); c- (200MHz, CDC1 3) 0.91 (3H, t, J7.0, CH3 ), 
1.23-1.43 (2H, m, CH2CH3), 1.52-1.67 (2H, m, CH2CH2CH3), 2.46 (2H, t,J7.5, 
CH2CH2CO), 4.07 (2H, s, OCH2CO), 4.60 (2H, s, CH2Ph), 7.25-7.45 (5H, m, An]). 
(4S, 5RS)-N-(tert-butoxycarbonyl)-2,2,4-tri methyl -5-
((trimethylsilyl)ethynyl)oxazolidine 161/162 
0 	 SMe3 
To a stirred solution of diastereomeric amino-alcohols 157/158 (182 mg, 0.67 mmol) 
in DCM (5 mL) at room temperature was added 2,2-DMP (5 mL) and TsOH (Ca. 1 
mg, cat.) and the reaction heated under reflux for 5 h. Water (10 mL) was added and 
organic phase separated and washed with brine (5 mL), dried (Na 2 SO 4) and 
concentrated in vacuo to give a yellow oil. Purification by flash column 	- 
chromatography (hexane:EtOAc, 16:1) afforded the pure diastereomeric oxazolidines 
161/162 (174 mg, 84%) as a pale yellow oil. RF (hexane:EtOAc, 5:1) 0.66; 
(200MHz, CDC1 3) major 161: 0.15 (9H, s, Si(CH3 ) 3), 1.30 (3H, d,J6.0, CHCH3), 
1.47 (911, s, C(CH3)3 ), 1.50 (3H, s, NCCH3), 1.68 (3H, s, NCCH3), 3.85-4.15 (1H, br 
m, CHCH3), 4.35 (1H, d,J3.5, CHOC); minor 162: 0.17 (9H, s, Si(CH3) 3), Ca. 1.25 
(3H, obsc.d, CHCH3), 1.37 (3H, s, NCCH3), 1.47 (9H, s, C(CH3)3), 1.57 (3H, s, 
NCCH3), 3.85-4.15 (1H, br m, CHCH3), 4.70 (1H, d,J5.5, CHOC). 
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A solution of oxazolidines 161/162 (90 mg, 0.29 mmol) and K2CO3 (58 mg, 0.42 
mmol) in MeOH (5 mL) was stirred at room temperature for 3 h. Water (5 mL) was 
added and the solution extracted with ether (3 x 10 mL). The combined extracts were 
dried (Na2 SO4) and concentrated in vacuo to give the diastereomeric oxazolidines 
163/164 as a clear oil (66 mg, 95%). RF (hexane:EtOAc, 2:1) 0.67; vmax ./cm' (film, 
polyethylene) 3255 (w), 2979 (m), 2874 (w, CH), 2117 (w, CC), 1699 (s, C=O), 
1386 (s), 1255 (m), 1177 (m), 1084 (m), 856 (w), 770 (w); cij- (200MHz, CDC13) 
major 163: 1.31 (311, d,J6.0, CHCH3), 1.47 (9H, s, C(CH3) 3), 1.52 (3H, s, NCCH3), 
1.69 (3H, s, NCCH3), 2.50 (1H, d, J2.0, CCII), 3.90-4.15 (1H, br m, CHCH 3), 4.37 
(1H, dd, J3.5, 2.0, CHOC); minor 164: CHCH3 , C(CH3 ) 3 , NCCH3 resonances 
obscured by major, 2.55 (1H, d, J2.0, CCH), Ca. 3.90-4.15 (1H, obsc.br m, CHCH3), 
4.37 (1H, dd,J5.5, 2. 0, CHOC). 
Method II 
To a stirred solution of the alcohols 157/158 (182 mg, 0.91 mmol) in DCM (5 mL) 
was added 2,2-DMP (1.5 mL, XS) and tosic acid (cat.) and the reaction heated at 
65°C for 1.5h. After addition of water, the organic layer was separated, washed with 
brine (25 mL), dried (Na 2SO3) and concentrated in vacuo to afford a yellow oil. 
Purification by flash column chromatography (hexane:EtOAc, 16:1) afforded the 
oxazolidines 163/164 as a clear oil (211 mg, 97%). Data as above. 
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To a stirred solution of acetylenes 163/164 (66 mg, 0.27 mmol) in THF (2 mL) at - 
78°C was added BuLi (1.59M, 0.18m1, 0.29 mmol). After lh a solution of Weinreb 
amide 139 (61 mg, 0.29 mmol) in THF (2 mL) was added dropwise. The reaction 
was stirred for 2h and quenched by addition of sat. aq . NH4CL (5 mL), warmed to 
room temperature and extracted with ether (3 x 10 mL). The combined organic 
extracts were dried (Na 2 SO4) and concentrated in vacuo to afford crude products. 
Purification by flash column chromatography (hexane:EtOAc, 8:1) afforded 
recovered starting materials 163/164 (11 mg, 17%) and the ketones 165/166 (49 mg, 
48%). RF (hexane:EtOAc, 2:1) 0.47; 	(200MHz, CDC1 3) major 165: 1.34 (3H, d, J 
6.5, CHCH3), 1.49 (9H, s, C(CH3)3), 1.56 (3H, s, NCCH3), 1.68 (3H, s, NCCH3), 
4.00-4.30 (1H, br m, CHCH3), 4.22 (2H, s, CH2013n), 4.55 (1H, d, J2.5, CHOC), 
4.64 (2H, s, CH2Ph), 7.25-7.45 (5H, m, An!); minor 166: CHCH3 , C(CH3)3 , NCCH3 , 
NCCH3 , CHCH3 resonances obscured by major, 4.26 (2H, s, CH 2CHO), 4.64 (211, s, 
CH2Ph), 4.86 (111, d,J5.5, CHOC), 4.64 (2H, s), 7.25-7.45 (5H, m, ArJI); 
Decomposition prevented further characterisation. 
Experimental 
Electrophilic cyclisation approach 
(3RS, 4S)-N-(tert-butoxycarbonyl)-4-amino-1 -(trimethylsilyl)pent-1 -en-
3-ol 1731174 
BOCHN ' M' 
To a stirred solution of alkyne 155/156 (138 mg, 0.51 mmol) in pyridine (7.5 mL) 
under Ar was added PdJBaSO 4 (Ca. 5mg, cat.). The vessel was evacuated, hydrogen 
gas (1 atm) introduced and the reaction followed by ESMS. Upon completion (24 h), 
the solution was passed through a celite plug and concentrated in vacuo. Purification 
by flash column chromatography (hexane:EtOAc, 5:1) afforded a complex mixture 
of the diasteromeric alkenes 173/174 (96 mg, 69%) as a clear oil. Rapid 
decomposition of this material occurred at room temperature. RF (hexane:EtOAc, 
2:1) 0.59; c (200MHz, CDC13 ) 3S,4S-Z-isomer: 0.07 (9H, s, Si(CH3)3), 1.14 (3H, d, 
J6.5, CHCH3 ), 1.44 (91-1, s, OC(CH3 )3), 3.60-3.80 (1H, br m, CHCH3), 3.98 (1H, dd, 
J4.5, 4.5, CHOH), 4.60-4.80 (1H, br, NH), 5.95-6.05 (2H, m, 2 x alkenyl CH); 
3S,4S-E-isomertrans: 0.15 (91-1, s, Si(CH3 )3), 1.16 (31-1, d,J7.0, CHCH3 ), 1.45 (91-1, 
s, OC(CH3)3 ), 3.70-3.95 (1H, br m, CHCH3), 4.31 (1H, dd, J5.0, 5.0, CHOH), 4.60-
4.75 (1H, br, NH), 5.79 (1 H, d, J 14.5, HC=CHSi), 6.27 (1H, dd, J 9.0, 14.5, 
CH=CHSi); 3R,4S diastereomers resonances obscured; m/z (APCI +ve, NH 3) 337 
([M+MeCN]Na, 100%), 274 (MH, 36), 238 (27). 
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(3RS, 4S)-4-Ami no-N-( tert-butoxycarbonyl)-3-( tert-butyl-
dimethylsilyloxy)-1 -(trimethylsilyl)pent-1 -yne 175 
1-O  ANL 
H 	DMS 
To a stirred solution of the alcohols 155/156 (110 mg, 0.41mmol) in DCM (5 mL) 
under Ar was added TBSC1 (73 mg, 0.48 mmol) and imidazole (83 mg, 1.22 mmol). 
After 22h, a further portion of TBSC1 (20 mg, 0.13 mmol) was added and the 
reaction stirred for 2 h. Water (15 mL) was added and the aqueous solution extracted 
with DCM (3 x 15 mL). The combined organic extracts were washed with brine (10 
mL) dried (Na2 SO4) and concentrated in vacuo. Purification by flash column 
chromatography (hexane:EtOAc, 6:1) afforded the alkyne 175 as an oil (147 mg, 
94%). RF (hexane:EtOAc, 4:1) 0.71; c5 (200MHz, CDC1 3) 0.10,0.14(2 x 311, 2 x s, 
Si(CH3)2C(CH3)3), 0.16 (9H, s, Si(CH3 ) 3), 0.90 (9H, s, Si(CH3 ) 2C(CH3 ) 3), 1.16 (3H, 
d, J6.5, CHCH3), 3.65-3.90 (1H, br m, CHCH 3), 4.36 (1H, d, J4.0, CHOSi), 4.55-
4.75 (1H, br, Nil); c- (50.3MHz, CDC1 3) -5.2, -4.7 (2 x CH 3 , Si(CH3 )2), -0.3 (CH 3 , 
Si(CH3) 3), 16.0 (CH3 , CHCH3), 18.0 (C, SiC(CH 3 ) 3), 25.6 (3 x CH3 , SiC(CH3 )3), 
28.3 (CH 3 , C(C171 3) 3), 50.4 (CH, CHCH3), 66.0 (CH, CHOSi), 79.1, 90.1, 104.5 (CH 
and 2 x C, CCH and OC(CH3)3), 155.1 (C, C0); m/z (FAB +ve, THIOG) 386 
(MH, 32%),330 ([MH-'Bu]H, 56),314 ([MH-SiMe 3]H, 34),286 ([MH-Boc]H, 
32), 272 ([MH-Si(CH3 )2C(CH3 ) 3 ]H, 100), 241 (18), 198 (34), 147 (45); HRMS 
(FAB +ve, THIOG) 386.2533 (Fragment. C 19H40NO3 Si2 requires 386.2547). 
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Attempted synthesis of (3RS, 4S)-4-amino-N-( tert-butoxycarbonyl)-3-
(tert-butyl-dimethylsilyloxy)-1 -(trimethylsilyl)pent-1 -ene 176/177 
'~'~JI=DMS 
To a stirred solution of the alkyne 175 (61 mg, 0.16 mmol) in pyridine (4 mL) was 
added PdIBaSO4 (ca. 5 mg, cat.) and hydrogen (1 atm) introduced. After 6 days, the 
solution was passed through a celite plug and concentrated in vacuo. Purification by 
flash column chromatography (hexane:ethyl acetate, 12:1) afforded an inseparable 
mixture of alkenes 176/177 contaminated with alkyne 175 and the over-reduced 
alkane 178 (42 mg, 68%).RF (hexane:EtOAc, 4:1) 0.71; cjj (200MHz, CDC1 3) major 
product 177: 0.03, 0.07 (2 x 3H, 2 x s, OSi(CH3) 2), 0.13 (9H, s, Si(CH3 ) 3), 0.89 (9H, 
s, SiC(CH3 ) 3 ), 1.12 (3H, d,J6.5, CHCH3), 1.44 (9H, s, OC(CH3)3), 3.50-3.90 (1H, br 
m, CHCH 3 ), 4.17 (1H, d, J9.0, CHOSi), 4.50-4.70 (1H, br, NH), 5.59 (1H, d, J 14.5, 
CH=CHSi), 6.24 (1H, dd, J 9.0, 14.5, CH=CHSi); other isomers obscured by major; 
m/z (ES +ve) 412 ([Alkane 178]Na, 15%) 410 ([Alkenes 176/177]Na, 100), 408 
([Alkyne 175]Na, 38), 388 ([Alkenes 176/177]H, 22), 386 ([Alkyne 175]H, 11), 
332 ([Alkenes 176/177-'Bu]H, 57), 330 ([Alkyne 175-tBu]H, 27), 301 (78). 
(2S, 3RS)-2-Am i no-N-(tert-butoxycarbonyl)pent-4-an-3-oI 179 
BocHN  '_ rH 
To a stirred solution of alkyne 157 (100 mg, 0.50 mmol) in EtOAc (1 mL) at room 
temperature was added Pd/C (5% Pd; Ca. 2 mg), the vessel evacuated and hydrogen 
(ca. 1 atm) introduced. After 1 .5h the suspension was filtered through a celite plug 
and the solvents removed in vacuo to afford an oil. Purification by flash column 
chromatography (hexand:ethyl acetate; 2:1) afforded the alkane 179 (94mg, 93%). RF 
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(hexane:EtOAc, 2:1) 0.40; c (200MHz, CDC1 3) 0.94 (3H, t,J7.0, CH2CH3), 1.14 
(311, d, J6.5, CHCH3), 1.41 (9H, s, OC(CH3 ) 3), 1.30-1.50 (2H, obsc. dt, CH2CH3), 
2.65-2.85 (1H, br s, 011), 3.30-3.45 (1H, m, CHNH), 3.50-3.75 (1H, m, CHOH), 
4.86 (1H, br d, J8.5, Nil); m/z (ES +ve) 267 ([M+MeCN]Na, 100%), 226 (MNa, 
51), 204 (MH, 81), 148 (32). 
(2S,3RS)-2-amino-N-(tert-butoxycarbonyl)pent-4-en-3-oI 180 
BocHN 
To a stirred solution of alkyne 157 (250 mg, 1.26 mmol) in EtOAc (7 mL) at room 
temperature was added Lindlar catalyst (5% Pd on CaCO 3 ; Ca. 10 mg), the vessel 
evacuated and hydrogen (ca. 1 atm) introduced. The reaction was followed by ESMS 
and after 35 min the suspension was filtered through a celite plug and concentrated in 
vacuo. Purification by flash column chromatography (hexane:EtOAc; 2:1) afforded 
the alkene 180 as an oil (237 mg, 95%). RF (hexane:EtOAc, 2:1) 0.40; & (200MHz, 
CDC1 3) 1.15 (3H, d,J7.0, CHCH3), 1.41 (911, s, OC(CH3 )3), 2.90-3.05 (111, br, OH), 
3.55-3.75 (1H, m, CHCH 3), 3.95-4.05 (1H, m, CHOH), 4.79 (1H, br d, J7.5, Nil), 
5.17 (1 H, ddd, J 1. 0, 2.0, 10.5, CH=CHH), 5.28(1H,ddd,J1.5, 1.5, 17.0, 
CHCHII), 5.86 (1H, ddd, J6.0, 10.5, 17.0, CHCHH); ni/z (APCI +ve, NH3) 265 








To a stirred solution of alkene 180 (246 mg, 1.22 mmol) in pyridine (1 mL) and 
DCM (2 mL) at 0°C was added Fmoc succinate (620 mg, 1.84 mmol) and the 
reaction stirred at room temperature. After 20h, 1M aq. ammonium bicarbonate 
solution (10 mL) was added and the reaction stirred for ca 1 0mm. The organic layer 
was separated, washed with 1M aq. citric acid solution (10 mL) and concentrated in 
vacuo. The white solid was triturated with ethyl acetate and the solid removed by 
filtration. The filtrate was concentrated in vacuo and purified by flash column 
chromatography to afford recovered starting material 180 (228 mg, 93%). Data as 
above. 
Method II 
To a stirred solution of alkene 180 (228 mg, 1.13 mmol) in DCM (4 mL) and 
pyridine (1 mL) at 0°C was added Fmoc chloride (440 mg, 1 .7Ommol). After 3h, 
DCM (20 mL) was added and the solution washed with 1M aq. ammonium 
bicarbonate solution (30 mL), 1M aq. citric acid solution (2 x 20 mL) and 
concentrated in vacuo. Purification by flash column chromatography (hexane:EtOAc 
4:1) afforded the product 182 as a clear viscous oil (477 mg, 99%). RF 
(hexane:EtOAc, 2:1) 0.58; c- (200MHz, CDC1 3) 1.19 (3H, d,J7.0, CHCH3), 1.46 
(9H, s, OC(CH3) 3), 3.85-4.10 (1H, br m, CHCH 3), 4.28 (1H, br dd, J7.0, 7.0, 
CHCH20), 4.46 (2H, app.d, J7.0, CHCH20), 4.50-4.80 (1H, br m, NH), 5.11 (1H, 
dd,J4.0, 6.0, CHCH00O 2), 5.25-5.45 (2H, m, CH=CH2), 5.86 (1H, ddd, J 6.0,10.5, 
17.0, CH=CH2), 7.25-7.50 (4H, m, aryl CH), 7.63 (2H, d,J7.5, aryl CH), 7.79 (2H 
d, J 7.5, aryl CH); m/z (APCI +ve, NH3) 462 (MK, 34%), 446 (MNa, 100), 441 
(44), 173 (25). 
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(3RS, 4S)-4-amino-3-(flu ore nylmethoxycarbonyloxy)pent-1 -ene, 
triflate salt 185 
TO 
To a stirred solution of alkene 182 (477 mg, 1.13 mmol) in DCM (7 mL) at -78°C 
under Ar was added TMSOTf (260 jtL, 300 mg, 1.35 mmol) and the reaction 
followed by tic. After lh, the reaction was opened to the atmosphere and allowed to 
warm to room temperature. After 2h, hexane (ca. 15 mL) was added and the ppt 
removed by filtration. Recrystallisation from ethyl acetate/hexane afforded the 
product 185 as a white solid (324 mg, 6 1%). RF (EtOAc) 0.00; vm ax.Icm' (film, 
polyethylene), 3067 (w br, NH, CH), 1749 (s, C=O), 1270 (vs); 9 f- (250MHz, d6-
DMSO) 1.10 (311, d,J6.5, CHCH3), 3.30-3.55 (11-1, obsc. m, CHCH 3), 4.30 (1H, dd, 
J5.5, 6.0, CHCH20002), 4.60 (1H, dd, J 5.5,10.5, CHCIIH00O2), 4.71 (1H, J6.0, 
10.5, CHCHH00O2), 4.97 (1H, dd, J6.5, 7.0, CH00O2), 5.20 (1H, d, J 17.0, 
CH=CHJI(cis proton)), 5.32 (1H, d, J 10. 5, CH=CIJH (trans proton)), 5.76 (1H, 
ddd, J6.5, 10.5, 17. 0, CH=CHH), 7.25-7.50, 7.60-7.55, 7.85-7.95 (8H, m, aryl Cl!), 
7.80-8.10 (3H, br, NH3 ); c (62.9MHz, d6-DMSO) 15.1 (CH 3 , CHCH3), 46.7, 48.5 
(2 x CH, CHCH 3 , and CHCH20002), 69.0 (CH2, CHCH20002), 79.0 (CH, 
CH00O2), 120.5 (CH, CH=CH2), 121.3 (CH2, CH=CH 2), 125.2, 127.5, 128.1, 131.8 
(CH, aryl CH), 141.1, 143.3, 143.6 (C, aryl Cand GF 3), 153.6 (C, C=O); m/z (ES 
+ve) 324 (MH, 100%); HRMS (FAB +ve, THIOG) 324.1598 (Fragment. 









To a stirred solution of amine salt 185 (108 mg, 0.23 mmol), 4A molecular sieves 
(ca. 100 mg) and DEKM (52 giL, 60 mg, 0.34 mmol) in 'BuOMe (10 mL) at -78°C 
was added TMSOTf(48 jL, 56 mg, 0.25 mmol) and the reaction stirred at this 
temperature for 6h then brought to room temperature. After 4 days, sat. aq . sodium 
bicarbonate (30 mL) was added and the aqueous layer separated and washed with 
ether (2 x 30 mL). The combined organics were dried (MgSO 4) and concentrated in 
vacuo. Purification by flash column chromatography (EtOAc) afforded the product 
189 as a pale yellow oil (41 mg, 40%). RF (hexane:EtOAc, 2:1) 0.48; vmax ./cm ' 
(film, polyethylene) 3384 (w, NH), 3067, 2982 (w, CH), 1757 (s, CO), 1736 (s, 
C=O), 1259(s); c (200MHz, CDC1 3) 1.28 (6H, t,J7.0, 2 x CH2CH3), 2.90 (2H, d,J 
7.5, NCCH), 4.24 (4H, q, J7.0, 2 x CH2CH3), 4.25-4.40 (1H, obsc., CHCH20002), 
4.48 (2H, d, J 7.5, CHCH20CO2), 4.93 (1H, dt, 6.5, 7.5, CH=CHOC), 7.03 (1H, d, J 
6.5, CH=CHOC), 7.25-7.50 (4H, m, aryl CH), 7.63 (2H, d,J7.5, aryl CH), 7.79 (2H 
d,J7.5, aryl CH); 9C(50.3MHz, CDC1 3) 13.4(2 x CH3 , 2 x CH2 CH3), 30.2 (CH2, 
NCCH2), 45.9 (CH, CHCH20002), 61.4 (2 x CH2 , 2 x CH2CH3), 64.6 (C, CNH2), 
69.8 (CH2 , CHCH20002), 106.4 (CH, CHCHOC), 119.5, 124.5, 126.7, 127.4 (aryl 
C), 138.2 (CH, CH=CHOC), 140.7, 142.5 (aryl C), 152.2 (C, 00O2), 170.5 (2 x C, 2 
X CCO2); m/z (ES +ve) 492 (MK, 11%), 476 (MNa, 100), 454 (MH, 39), 322 (22); 
HRMS (FAB +ve, THIOG) 454.1861 (Fragment. C 251128N07 requires 454.1866). 
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Diels-Alder approach: oxazinone as diene I 
O-Acetonyl -N-benzyloxycarbonyl val me 196 93 
0 	 0 
To a stirred solution of Z-protected valine 195 (10.4 g, 50 mmol) in EtOAc (75 mL) 
was added triethylamine (5.05 g, 50 mmol) and chloroacetone (9.2 g, 100 mmol) and 
the reaction refluxed for 5h. The solid was removed by filtration and the filtrate 
washed with 2M HC1 (3 x 25 mL), sat. aq . sodium bicarbonate solution (3 x 25 mL) 
and water (2 x 25 mL). The organic phase was dried (Na 2 SO4), concentrated in vacuo 
and purified by recrystallisation (hexane:EtOAc, 1:2) to afford the product 196 as a 
white solid (11.79 g, 77%). RF (hexane:EtOAc, 1:1) 0.52; vmax ./cm' (nujol® mull) 
3321 (s, NH), 1747 (s, C=O), 1726 (s, C=O), 1687 (s, C=O), 1531 (s); & (250MHz, 
CDC1 3) 0.96 (311, d, J7.0, CH3CHCH3), 1.02 (3H, d, J7.0, CH3 CHCH3), 2.12 (3H, 
s, CH3 CO), 2.28 (1H, sepd, J4.5, 7.0, CH3 CHCH3), 4.40 (11-1, dd, J4.5, 9.0, CJINH), 
4.69 (2H, ABX q, OCH2CO), 5.10 (2H, s, PhCH2), 5.27 (1H, br d, J9.0, NH), 7.25-
7.45 (5H, m, Phil); c (62.9MHz, CDC13) 17.1, 18.9 (2 x CH3 , H3 CCHCH3), 25.9 
(CH3 , C(0)CH3), 31.0 (CH, CHCHNH), 58.8 (CH, CHNH), 67.0 (CH 2 , PhCH2), 68.5 
(CH2 , OCH2CO), 128.0, 128.1, 128.4 (CH, Ar CH), 136.0 (C, Ar C), 156.1 (C, 
NHCO2), 171.3 (C, CHCO2), 200.6 (C, C(0)CH3); m/z (ES +ve) 346 (MK, 16%), 
330 (MNa, 100), 102 (80); HRMS (FAB +ve, THIO) 308.1499 (Fragment. 
C 16H22N05 requires 308.1499). 
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O-Acetonyl valine hydrobromide 197 93 
BrH. H 2NYJ 0 "'k 
A solution of carbamate 196 (3.0 g, 9.8mmol) in 30% HBr/AcOH (18 mL) was 
stirred under an inert atmosphere at room temperature for 1.5h then heated to 50°C 
for 10 minutes. After cooling, sodium-dried ether (50 mL) was added and the 
solution placed in an ice bath for 15 minutes. The solid was removed by filtration, 
washed several times with pre-cooled sodium-dried ether (100 mL in total) and 
placed in a dessicator for 48h to afford the product 197 as a off-white solid (2.31 g, 
93%) which was carried through directly to the cyclistation. RF (EtOAc) 0.00; m/z 
(ES +ve) 174 (MH, 34%),104 (19), 102 (100); FIRMS (FAB +ve) 174.1125 
(Fragment. C 8H 16NO3 requires 174.1130). 
3-Isopropyl-5-methyl-3,6-dihydro-2H-1 ,4-oxazin-2-one 198 93 
': &1 0 
To a stirred solution of amine 197 (4.2 g, 17 mmol) in anhydrous CHC1 3 (50 mL) 
over 4A molecular sieves (5.0 g) at 0°C was added dropwise a solution of 
triethylamine (2.3 mL, 1.67 g, 0.17 mmol) in anhydrous CHCI 3 (5 mL). After 15 
minutes, the solution was concentrated in vacuo at 0°C and sodium-dried ether (100 
mL) added. The ppt was removed by filtration and the filtrate concentrated in vacuo 
to afford the product 198 as a pale yellow oil (2.18 g, 8 5%). c (200MHz, CDC1 3) 
0.95 (3H, d,J6.5, CH3 CHCH3), 1.09 (3H, d. J7.0, CH3 CHCH3), 2.09 (3H, d,J 1.5, 
CH3 CN), 2.43 (lH, septd,J4.0, 7.0, C11 3 CHCH3), 4.00-4.10 (1H, m, CHNH), 4.80 
(2H, ABX, CH2000); (50.3MHz, CDC1 3) 16.4 (CH 3 , CH3CHCH3), 17.6 (CH3 , 
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CH3 CHCH3), 20.8 (CH3 , CH3 CN), 30.9 (CH, CH 3 CHCH3), 62.3 (CH, NCH), 68.1 
CH2000), 162.3 (C, OC=O), 166.9 (C, C=N). 
3-Isopropyl-5-methyl-2H-1 ,4-oxazin-2-one 199 93 
0 
To a stirred solution of imine 198 (1.08 g, 6.95 mmol) in Cd 4 (15 mL) under Ar was 
added NBS (1.18 mg, 6.6 mmol) and AIBN (cat. amount) and the reaction warmed to 
65°C for 20 minutes. The reaction was cooled in an ice bath and filtered to remove 
the black solids produced in the reaction. Pyridine (0.69 mL, 591 mg, 6.95 mmol) 
was added to the filtrate and the reaction stirred for 10 minutes at room temperature, 
then warmed to 50°C for 5 minutes. The solution was cooled in an ice-bath, filtered 
and concentrated in vacuo. Purification by flash column chromatography afforded 
the product 199 as a pale oil (492 mg, 46%). RF (hexane:EtOAc, 1:1) 0.64; c 
(200MHz, CDC1 3) 1.16 (6H, d, J7.0, CH(CH3 ) 2), 2.07 (3H, d, J 1.5, CH3CN), 3.23 
(1H, sept, J7.0, CH(CH3 )2), 6.97 (1H, br s, CHOCO); c (50.3MHz, CDC13) 15.8 
CH3CN), 18.2 (2 x CH 3 , CH(CH3 ) 2), 30.3 (CH, CH(CH3) 2), 128.2 (C, 
CH3 CN), 134.1 (CH, CHOCO), 152.0 (C, NCC=O), 160.5 (C, C=O). 
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Attempted ytterbium catalysed Diels-Alder reaction of the oxazinone 
199 
To a stirred solution of ytterbium triflate (20 mg, 0.03 mmol) in anhydrous DCM (1 
mL) was added 'BuOH (8 p.L, 6 mg, 0.08 mmol), the solution brought to 0°C and 
DIEA (14 pL, 10 mg, 0.08 mmol) added. After 0.5h a solution of oxazinone 199 (49 
mg, 0.32 mmol) in DCM (2 x 1 mL) was added, followed after 5 minutes by EVE 
(82 1tL, 69 mg, 0.96 mmol) and the reaction allowed to reach room temperature. 
After 3 days the solution was concentrated in vacuo and purified by flash column 
chromatography to afford recovered starting material (25 mg, 51%). Data as above. 
Stability test of Oxazinone 199 
A solution of oxazinone 199 (10 mg, 0.065 mmol) in toluene (0.5 mL) was heated at 
110°C for lh. tic indicated a complex mixture of products had been formed and 
concentration of the solution in vacuo caused total decomposition of the material. 
Literature Diels-Alder reaction in presence of oxazinone 199 
To a stirred solution of ytterbium triflate (60 mg, 0.10 mmol) in anhydrous DCM (1 
mL) was added 'BuOH (8 L, 6 mg, 0.08 mmol), the solution brought to 0°C and a 
solution of DIEA (14 L, 10 mg, 0.08 mmol) in DCM (1 mL) added. After 0.5h a 
solution of pyrone 190 (120 mg, 0.78 mmol) and oxazinone 199 (10 mg, 0.07 mmol) 
in DCM (2 x 2 mL) was added, followed after 5 minutes by EVE (223 p1, 168 mg, 
2.34 mmol) and the reaction allowed to reach room temperature. After 19h the 
solution was concentrated in vacuo and purified by flash column chromatography 




Diels-Alder approach: oxazinone as diene II 
N-(2-acetoxyacetyl)-O-benzyl serine 203 
oo 
OJX1OH 
To a stirred suspension of O-benzyl serine 202 (3.43 g, 17.6 mmol) in anhydrous 
DCM (60 mL) and anhydrous MeCN (6 mL) was added TMSC1 (2.23 mL, 1.91 g, 
17.6 mmol) and the reaction heated at 60°C for 2h. After cooling to -30°C, 
acetoxyacetyl chloride (1.98 mL, 2.52 g, 18.4 mmol) was added followed by careful 
addition of triethylamine (pre-dried over 4A molecular sieves, 5.14 mL, 3.73 g, 36.9 
mmol) such that the temperature remained below -20°C. The suspension was stirred 
at -15°C for 2h, then at 0°C for a further 2h, after which time 0.5M HC1 (40 mL) was 
added and the aqueous layer washed with DCM (2 x 30 mL). The combined organic 
fractions were washed with 0.5M HC1 (30 mL), dried (MgSO 4) and concentrated in 
vacuo to afford the product 203 as a white solid (5.14 g, 99%). A small sample was 
purified by recrystallisation (EtOAc/hexane) for analysis. RF (EtOAc) 0.00-0.10; 
vmax./cm' (film, polyethylene) 3405 (s, NH), 1747 (s, C=O), 1627 (s), 1541 (m), 
1231 (s); Yfl (200MHz, CDC1 3) 2.15 (3H, s, CO2CH3), 3.73 (1H, dd,J3.5, 9.5, 
CHHOCH2Ph), 3.99 (1H, dd,J3.5, 9.5, CHJIOCH 2Ph), 4.55 (211, ABX, CH2OAc), 
4.60 (2H, s, PhCH2), 4.81 (114, dt, J 3.5, 8.0, CHNH), 7.02 (1H, br d, J 8.0, NH), 
7.25-7.39 (5H, m, PhI]'), 8.25 (1H, br s, 011); c (50.3MHz, d 6-DMSO) 20.2 (CH 3 , 
CH3 CO2), 51.9 (CH, CHCO 2H), 61.6 (CH 2 , C}T20Bn), 69.1 (CH2 , OCH2Ph), 71.9 
(CH2, CH20Ac), 127.2, 127.2, 127.9 (CH, aryl CH), 137.6 (C, aryl C), 166.5, 169.4, 
170.9 (3 xC, CO2H, CONH, CH 3 CO2); m/z (ES -ye) 294 (EM-H], 100%); HRMS 
(FAB +ve, THIOG) 296.1147 (Fragment. C 14H 18N06 requires 296.1134). 
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N-(2-hydroxyacetyl)-O-benzyl sen ne 204 
0 033 
RO OK 
To a stirred solution of NaOH (4 10 mg, 10.2 mmol) in water (60 mL) at room 
temperature was added N-acetoxyacetyl-O-benzyl serine 203 (1.5 g, 5.1 mmol). 
After 3h, the pH was brought to Ca. 2.5 by addition of conc. HC1, the solution cooled 
to 5°C and extracted with EtOAc (6 x 20 mL). The solution was concentrated in 
vacuo and dried under vacuum for 18h to afford the product 204 as a pale yellow 
solid (1.26 g, 97%). No further purification was attempted. RF (EtOAc) 0.00-0.05; 
vmax /cm' (nujol® mull) 3510 (br, OH), 3377 (s, NH), Ca. 2700 (br, acid OH), 1709 
(m, C=O), 1618 (s, C=O), 1377 (s); c-j (200MHz, d6-DMSO) 3.76 (1H, dd,J3.5, 
10.0, CHHOCH2Ph), 3.93 (1H, dd, J4.0, 10.0, CHHOCH2Ph), 3.97 (214, s, CH2011), 
4.57 (211, s, PhCH2), 4.81 (11-1, obsc. m, CHNH), 7.25-7.50 (511, m, Phil), 7.84 (1H, 
d, J 8.0, NR); 9c (50.3MHz, d6-DMSO) 51.4 (CH, CHCO 2H), 60.9 (CH 2 , CH20Bn), 
69.1 (CH2 , OCH2Ph), 71.9 (CH2 , CH20Ac), 127.1, 127.2, 127.9 (CH, aryl CH), 
137.6 (C, aryl C), 171.0, 171.4 (2 x C, CO 2H, CONH); m/z (ES -ye) 252 (EM-H], 
100%); HRMS (FAB +ve, THIOG) 254.1032 (Fragment. C 121-1 16N05 requires 
254.1029). 




To a suspension of N-hydroxyacetyl O-benzyl serine 204 (1.04 g, 4.11 mmol) in 
toluene (50 mL) was added TsOH (cat.) and the reaction heated to 110°C until 
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completion (indicated by NMR of a small sample). The solvent was removed in 
vacuo and the residue taken up in EtOAc (100 mL) and MeCN (10 mL), washed with 
pH 7 phosphate buffer (25 mL) and concentrated in vacuo to afford an off-white 
solid (0.709 g, 73%). A sample was purified by flash column chromatography 
(EtOAc) to give the pure product 205 as a white solid. RF (hexane:EtOAc, 1:1) 0.09; 
vmax./cm' (nujol® mull) 3265 (m, NH), 1749 (s, C=O), 1687 (m, C=O), 1377 (s); AH 
(200MHz, CDC1 3) 3.73 (1H, dd,J3.5, 9.5, NCHCHH), 3.83 (1H, dd, J 5.5,9.5, 
NCHCHH), 4.23-4.31 (1H, m, NCR), 4.51 (21-1, ABX, PhCH2), 4.61 (1H, d, J 16.5, 
CIIHOCO), 4.80 (1H, d, J 16.0, CFIHOCO), 6.20 (1H, br s, NII),7.20-7.35 (5H, m, 
Phil); 6c (50.3MHz, d 6-DMSO) 53.5 (CH, CHNH), 67.2 (CH2 , CH20Bn), 71.0 
(CH2 , C1-I2Ph), 72.3 (CR 2, OCH2CO), 127.2, 127.5, 128.1 (CH, aryl CH), 137.5 (C, 
aryl C), 165.0 (C, CONH), 166.6 (C, CO2); m/z (FAB +ve, THIOG) 344 (17%),236 
(MH, 26),91 (100); HRMS (FAB +ve, THIOG) 236.0916 (Fragment. C 12H 14N04 
requires 236.0923). 
3-(Benzyloxymethyl)-3,6-dihydro-5-methoxy-2H-1 ,4-oxazin-2-one 206 
(OJ) 
MeO 
To a stirred solution of morpholinedione 205 (575 mg, 2.45 mmol) in DCM (10 mL) 
at room temperature was added BF 4 .OMe3 (517 mg, 3.50mmol). After 20h, a 
solution of Na2HPO4 (1.55 g, mmol) and NaH2PO4.2H20 (0.63 g, mmol) in water (7 
mL) was added at 0°C and the aqueous phase separated and washed with ether (3 x 
15 mL). The combined organics were dried (MgSO 4) and concentrated in vacuo to 
give a yellow oil. Purification by flash column chromatography (EtOAc) afforded the 
pure product 206 as a clear oil (412 mg, 68%). RF (hexane:EtOAc, 1:1) 0.58; 
vmax /cm 1 (film, polyethylene) 1750s (C=O), 1697, 1466s, 1291, 1104, 1083; c5j-i 
(200MHz, CDC1 3) 3.76 (3H, s, OCH3), 3.77 (1H, dd, J2.5, 9.0, NCHCHH), 4.04 
(1H, dd, .J3.0, 9.0, NCHCHH), 4.34-4.37 (1H, m, NCR), 4.51 (211, ABX q, PhCH 2), 
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4.62 (1H, dd,J 1.0, 15.5, CHHOCO), 4.92 (1H, dd,J0.5, 15.5, CHHOCO), 7.20-
7.40 (5H, m, Phil); Jc (50.3MHz, CDC1 3) 52.1 (CH, NCH), 57.0 (CH3 , OCH3), 64.0 
(CH2, NCHCH2), 71.0 (CH2 , PhCH2), 72.1 (CH2 , CH2000), 126.2, 126.5, 127.1 
(CH, aryl CH), 136.4 (C, aryl C), 159.3 (C, OCN), 167.5 (C, OCO). 
Attempted preparation of 3-(Benzyloxymethyl)-3,6-dihydro-5-
methoxy-2H-1 ,4-oxazin-2-one 207 
Method I 
A solution of imidate 206 (160 mg, 0.64 mmol), NBS (109 mg, 0.61 mmol) and 
AIBN (cat.) in CC1 4 (2 mL) was degassed by passing Ar through it for Ca. 5 minutes. 
The solution was heated at reflux for 10 minutes, cooled to 0°C and pyridine (52 p1, 
51 mg, 0.64 mmol) added. The reaction was stirred at room temperature for 20 
minutes then heated briefly to 50°C and concentrated in vacuo. The residue was 
resuspended in DCM (10 mL) and washed with phosphate buffer (pH;-7, 2 x 5 mL), 
dried (MgSO4) and concentrated in vacuo to afford a yellow oil. Purification by flash 
column chromatography (hexane:EtOAc, 4:1) afforded recovered starting material 
206 (51 mg, 32%) and an unstable unknown which rapidly decomposed to 
unidentified products. 
Method II 
To a stirred solution of imidate 206 (73 mg, 0.29 mmol) in THF (2 mL) at -78°C was 
added 'BuOK (30 mg, 0.29 mmol). After 20 minutes NBS (52 mg, 0.29 mmol) was 
added and the reaction brought to room temperature. After 18h, the solvents were 
removed in vacuo to afford a complex mixture of polar compounds. Purification 




To a stirred solution of imidate 206 (176 mg, 0.75 mmol) in DCM (5 mL) at -78°C 
was added DBU (112 jtL, 114 mg, 0.75 mmol) then BrCC13 (74 tL, 149 mg, 0.75 
mmol) dropwise. The reaction was monitored by tic and brought to 0°C after lh. The 
pale yellow solution was concentrated in vacuo to form a brown residue. Attempted 
purification by flash column chromatography failed to yield any products. 
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To a stirred solution of ytterbium triflate (1.342 g, 2.16 mmol) in anhydrous DCM 
(50 mL) at 0°C was added a solution of BThOL (774 mg, 2.7 mmol) in DCM (30 mL 
+ 10 mL) and, after 5 minutes, a solution of DIEA (942 tL, 699 mg, 5.4 mmol) in 
DCM (6 mL + 4 mL). The reaction was stirred for 30 minutes, after which time a 
solution of pyrone 190 (4.475 g, 29.1 mmol) in DCM (50 mL + 10 mL) was added 
followed by EVE (10 mL, 7.54 g, 105 mmol) and the reaction stirred for 20h. The 
solution was concentrated in vacuo and purified by flash column chromatography 
(hexane:ether, 1:1) to afford the bicyclic lactone 201 (5.34 g, 81%). RF 
(hexane:EtOAc, 2:1) 0.22, (EtOAc) 0.70; Vmax /cm (nujol® mull) 1758 (s, C=O), 
1732 (s, C=O), 1280 (s), 1090 (s); cSIT  (200MHz, CDC1 3) 1.09 (3H, t,J7.0, CH2CH3), 
1.67 (1H, app. ddd,J1.5, 2.0, 14.0, CHCHHCH), 2.60 (1H, ddd, J4.0, 7.5, 14.0, 
CHCHHCH), 3.38-3.60 (2H, m, CH2CH3), 3.90 (3H, s, CO2CH3), 4.37 (1H, dm, J 
7.5, CHOEt), 5.24 (11-1, dddd,J 1.5, 1.5, 3.0, 5.0, CHOC(0)C), 6.60 (1H, dd,J5.0, 
8.0, CH=CHCHOAc), 6.78 (CH, app. dt, J 1.5, 8.0, CH=CHCHOAc); (50.3MHz, 
CDC1 3) 14.4 (CH3 , CH2 CH3), 34.8 (CH2, C171 2CHOEt), 52.2 (CH3 , CO2 CH3), 60.7 
(C, CCO2Me), 64.9 (CH 2, CH2CH3), 71.7 (CH, CHOEt), 73.4 (CH, CHOCO), 129.0 
(CH, CCHCH), 129.8 (CH, CCHCH), 166.8, 168.0 (2 x C, 2 x C=O); m/z (FAB 
+ve, THIOG) 335 (45%), 317 (23), 227 (MH, 53), 155 (100), 123 (77); HRMS 
(FAB +ve, THIOG) 227.0912 (Fragment. C, 1H1505  requires 227.0920). 
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(±)-(1 S, 3S, 6R)-6-Amido-1 -ethoxy-6-(methoxycarbonyl)cyclohex-4-en-





Opening with aqueous/rn ethanolic ammonia 
To a stirred solution of bicyclic lactone 201 (110 mg, 0.49 mmol) in MeOH (2 mL) 
was added 2M aqueous ammonia solution (2 mL) and the reaction stirred at room 
temperature for 1.5h. The solution was concentrated to half volume in vacuo and 
extracted with DCM (3 x 5 mL). The combined organic extracts were dried (MgSO 4) 
and concentrated in vacuo. Purification by flash column chromatography 
(hexane:EtOAc, 2:1 —> 0:1) afforded the bisester 220 (40 mg, 32%) as a clear oil and 
the amide 219 (20 mg, 17%) as a white solid. 
Bisester 220: RF (hexane:EtOAc, 2:1) 0.13; vmaxlcm' (film) 3397 (br, OH), 2954 (m, 
CH), 1735 (s, C=O), 1435 (m), 1251 (m), 1071 (s); 	(250MHz, CDC1 3) 1.09 (3H, 
d,J7.0, CH2CH3), 1.75 (1H, ddd,J 1.5, 10.0, 13.5, CHCHHCH), 2.49 (1H, dddd,J 
1.5, 4.5, 6.0, 13.5, CHCHHCH), 3.37 (1H, dq, J7.0, 9.5, OCHHCH 3), 3.65 (1H, dq, 
J7.0, 9.5, OCHJICH3), 3.69 (3H, s, CH302CCCO2CH3), 3.73 (3H, s, 
CH302CCCO2CH3), 4.33 (1H, m, CHOEt), 4.37 (1H, m, CHOH), 5.90 (111, ddd, J 
1.5, 2.0, 10.0, CHCHCHOH), 6.00 (1H, ddd, J 1.5, 1.5, 10.0, CHCHCHOH); c 
(62.9Hz, CDC1 3) 15.2 (CH3 , CH2 CH3), 32.9 (CH2, CHCH2CH), 52.5, 52.7 (2 x CH3 , 
2 x OCH3), 58.8 (C, CCO 2Me), 63.5 (CH, CHOEt), 65.1 (CH 2 , 0CH2CH3), 76.0 
(CH, CHOH), 122.9 (CH, CH=CHCHOH), 134.6 (CH, CH=CHCHOH), 168.6, 
169.1 (2 xC, 2 x CO2Me); m/z (FAB +ve, THIOG) 367(18%), 259 (MH, 49), 197 
(87), 137 (100); HRMS (FAB +ve, THIOG) 259.1181 (Fragment. C 12H 1 906 requires 
259.1182). 
Amide 219: (Found: C, 54.5; H, 6.9; N, 5.75. C 11 H 17NO5 requires C, 54.3; H, 7.05; 
N, 5.76%); RF (EtOAc) 0.18; vmax /cm ' (nujol® mull) 3413 (s, NH), 3301 (br OH, 
NH), 1739(s, C=O), 1678 (s), 1628 (s); & (200MHz, CDC1 3) 1.16 (3H, t,J7.0, 
CH2CH3), 1.81 (111, ddd,J2.0, 8.5, 13.5, CHHCHOEt), 2.45 (1H, ddd,J6.0, 6.5, 
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13.5, C1-IHCHOEt), 3.46 (1H, dq,J7.0, 9.5, OCHHCH 3) 3.70 (1H, dq,J7.0, 9.5, 
OCHJICH3), 3.79 (31-1, s, CO2CH3), 4.32 (11-1, app.d,J6.0, CHOEt), 4.35-4.50 (1H, 
m, CHOH), 5.45-5.60 (>1H, br s, NHH), 6.03 (1H, d, J 10. 5, CCH=CH), 6.12 (1H, 
dd,J2.5, 10.5, CCH=CH); c (62.9Hz, CD3 0D) 15.6 (CH 3 , CH2 CH3), 32.9 (CH2 , 
CHCH2CH), 52.0 (CH3, OCI-1 3), 58.9 (C, CCO 2Me), 62.1 (CH, CHOEt), 64.3 (CH 2 , 
OC1712CH3), 76.6 (CH, C}IOH), 123.5 (CH, CCH=CH), 134.1 (CH, CCH=CH), 
168.8 (C, CO2NH2), 170.0 (C, CO 2Me); m/z (ES) 307 (MNa + MeCN, 14%),266 
(MNa, 100), 244 (MH, 7); HRMS (FAB +ve, THIO) 244.1185 (Fragment. 
C 11 H 18N05 requires 244.1185). 
Opening with methanolic ammonia 
A solution of bicyclic lactone 201 (48 mg, 0.21 mmol) in methanolic ammonia (2M, 
4 mL) was stirred under Ar at room temperature for 7h. The solution was 
concentrated in vacuo to afford a white solid and a pale green oil. Purification by 
flash column chromatography (ethyl acetate) afforded the amide 219 (48 mg, 93%) 
as a white solid and the bisester 220 (trace). Data as above. 
Attempted opening with ammonia in dioxane 
Bicyclic lactone 201 (44 mg, 0.19 mmol) was dissolved in a solution of ammonia in 
dioxane (0.5M, 5 mL) and the reaction stirred under Ar at room temperature for 2 
days. The solution was concentrated in vacuo to afford recovered starting material. 
Data as above. 
Opening with conc. aq . ammonia in tB uOH 
To a stirred solution of bicyclic lactone 201 (5.05 g, 22.3 mmol) in 'BuOH (56 mL) 
was added dropwise conc. aq . ammonia solution (14 mL). After 6h the solution was 
concentrated in vacuo to afford the amide as a white solid (5.42g, quant.). No further 
purification was attempted. Data as above. 
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(±)-(1 S, 3S, 6S)-6-Amino-1 -ethoxy-6-(methoxycarbonyl)cyclohex-4-en-
3-01 hydrochloride salt ± 223 
HCI.H N CO Me 
OD 
OH 
To a stirred solution of amide 219 (55 mg, 0.22 mmol) in MeCN (3 mL) and water (3 
mL) at room temperature was added PhI(0 2CCF 3)2 (97 mg, 0.23 mmol) and the 
reaction stirred in the dark for 6 days. Water (10 mL) and 1M aq. HC1 (5 mL) were 
added, the aqueous phase separated and washed with hexane/ethyl acetate (1:9, 3 x 
15 mL). Concentration of the aqueous solution in vacuo caused partial 
decomposition, affording the amine salt 223 as a white/brown solid (32 mg, 66%). 
Attempts to purify the compound further caused decomposition. RF (EtOAc) 0.00; 44 
(200MHz, D 20) 1.10 (3H, t,J7.0, OCH2CH3), 2.00-2.15 (1H, m, CHHCHOEt), 
2.20-2.40 (1H, m, CHHCHOEt), 4.49 (1H, dq,J7.0, 10. 0, OCHHCH 3), 3.70 (1H, 
dq,.J7.0, 10.0, OCI-IHCH 3), 3.77 (3H, s, CO2CH3), 3.97 (1H, dd,J4.5, 10.5, 
CHOEt), 4.45-4.55 (1H, m, CHOH), 5.69 (1H, d, J 10.0, CCH=CH), 6.22 (1H, dd, J 
4.0, 10.0, CCH=CII); m/z (ES +ve) 279 (17%),238 (MNa, 63),216 (MH, 100), 
198 (22), 152 (24). 
(±)-(1 S, 3S, 6S)-6-(Benzyloxycarbonylamino)-1 -ethoxy-6-






To a stirred solution of amide 219 (1.25 g, 5.14 mmol) in MeCN (60 mL) and water 
(50 mL) at room temperature was added PhI(0 2CCF3 ) 2 (2.65 g, 6.17 mmol) and the 
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reaction stirred in the dark for 2 days. The solution was diluted with water (100 mL) 
and conc. aq . HC1 (10 mL) was added dropwise with vigorous stirring. The aqueous 
phase was washed with ether (3 x 50 mL) and the aqueous phase concentrated in 
vacuo to Ca. 50 mL. Dioxane (100 mL) and benzyl chloroformate (2.5 mL, excess) 
were added and the solution brought to pH 10 by careful addition of NaHCO 3 and 
stirred for 3 days. The aqueous solution was extracted with DCM (5 x 25 mL) and 
the combined organics dried (MgSO 4) and concentrated in vacuo to afford the crude 
product. Purification by recrystallisation (hexane:EtOAc, -30°C) afforded the 
carbamate 224 as a white solid (1.676 g, 93%). (Found: C, 61.3; H, 6.5; N, 3.8. 
C 1 8H23N06 requires C, 61.9; H, 6.6; N, 4.0%); RF (hexane:EtOAc, 1:1) 0.16; 
vmax ./cm' (nujol® mull) 3441 (br, OH), 3267 (m, NH), 1710 (s, C=O), 1524 (s), 1251 
(s); c5j (250MHz, CDC1 3) 1.08 (3H, t, J7.0, CH 2CH3), 2.12 (1H, obsc. m, 
CHCIIHCH), 2.16 (1H, obsc. m, CHCHHCH), 3.05-3.25 (1H, hr d, OH), 3.56 (2H, 
m, OCH2CH3 ), 3.76 (3H, s, OCH3), 4.32 and 4.38 (2 x 1H, obsc. m, CHOEt and 
CHOH), 5.08 (2H, ABX q, PhCH2), 5.50 (1H, d, J9.5, CCH=CH), 6.22 (1H, dd, J 
5.5, 9.5, CCH=CH), 6.37 (1H, br s, NI!), 7.27-7.40 (5H, m, Phil); SC (62.9MHz, 
CDC13) 15.3 (CH 3 , CH2 CH3), 34.8 (CH2 , CHCH2CH), 53.0 (CH 3 , CO2 CH3), 64.1 
(CH, CHOEt), 64.1 (C, CCO2Me), 66.3 (CH2, OCH2CH3), 66.7 (CH2, PhCH20), 
74.4 (CH, CHOH), 128.0, 128.1, 128.2, 128.5, 131.7 (CH, aryl and vinyl CH), 135.9 
(C, aryl C), 154.4 (C, OCONH), 170.0 (C, CO2Me); m/z (ES +ve) 413 (MINa + 
MeCN, 17%), 372 (MNa, 100); HRMS (FAB +ve, NOBA Matrix) 350.1605 
(C 18H24N06 requires 350.1604). 
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(±)-(1 S, 3S, 6S)-3-Acetoxy-6-(benzyloxycarbonylam ino)-1 -ethoxy-6-
(methoxycarbonyl)cyclohex-4-ene ± 225 
0 
)LH cr.0 N 0Et 
ÔAC 
To a stirred solution of the carbamate 224 (525 mg, 1.50 mmol) in DCM (15 mL) 
was added acetic anhydride (213 jiL, 230 mg, 2.26 mmol), pyridine (182 tL, 178 
mg, 2.26 mmol) and DMAP (cat.). After 2 days, 2M HC1 (15 mL) was added and the 
aqueous phase washed with DCM (3 x 20 mL). The organic fractions were washed 
with brine (10 mL), dried (MgSO 4) and concentrated in vacuo. Purification by flash 
column chromatography (hexane:EtOAc, 2:1) afforded the product 225 as a viscous 
oil (587 mg, quant.). RF (hexane:EtOAc, 1:1) 0.47; vmax.Icm' (film, polyethylene) 
3341 (br, OH, NH), 2975 (m, CH), 1733 (s, C=O), 1521 (m), 1241 (s); cij (250MHz, 
CDC13) 1.10 (3H, t,J7.0, CH2CH3), 1.97-2.06 (1H, in (partially obscured), 
CHCHHCHOH), 2.06 (3H, s, COCH3), 2.36 (1H, ddd, J 5.5, 11.0, 14.5, 
CHCHJICHOH), 3.45-3.63 (2H, m, CH2CH3), 3.75 (3H, s, CO2CH3 ), 4.12-4.19 (1H, 
m, CHOEt), 5.09 (2H, ABX app. dd, J 12.0, 15.5, PhCH2), 5.43-5.48 (1H, m, 
CHOAc), 5.97 (3H, app. br s, HC=CH and NH), 7.30-7.37 (5H, m, Phil); c 
(62.9MHz, CDC1 3 ) 15.3 (CH 3 , CH2 CH3), 21.2 (CH3 , COCH3), 30.3 (CH 2 , 
CHCH2CH), 53.1 (CH 3 , CO2 CH3), 63.4 (C, CCO2Me), 65.8 (CH2 , OCH2CH3), 66.6 
(CH2, PhCH2), 66.8 (CH, CHOEt), 74.6 (CH, CHOAc), 127.6 (CH, vinyl CH), 
128.0, 128.1, 128.4 (CH, aryl CH), 130.5 (CH, vinyl CH), 136.1 (C, aryl C), 154.4 
(C, OCONH), 169.9 (C, CO 2CH3), 170.5 (C, 02CCH3); m/z (FAB +ve, THIOG) 332 
([MH-AcOH], 54%), 91(100); HRMS (FAB +ve, THIOG) 392.1711 (Fragment. 
C20H26N0 7 requires 392.1709). 
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Attempted synthesis of ±-methyl (2S, 3S, 5R)-5-acetoxy-2-
(benzyloxycarbonylami no)-3-ethoxy-6-oxo-2-(oxymethyl)hexanoate 
± 226 




The alkene 225 (54 mg, 0.15 mmol) was dissolved in DCM (3 mL) at -78°C and 
ozone (in 02,  200V, 35 1h) passed through for 10 minutes. 02 was passed through 
the solution for a further 10 minutes, after which time Ar gas was introduced and the 
vessel warmed to room temperature. Triphenyiphosphine (57 mg, 0.22 mmol) was 
added to the vessel and the reaction stirred at room temperature for 16h. 
Concentration under reduced pressure afforded a complex mixture of compounds, 
and attempts to isolate the products afforded only recovered triphenyiphosphine and 
triphenyiphoshine oxide. 
Method II 
To a stirred solution of the alkene 225 (50 mg, 0.13 mmol) in THF:water (25:1) was 
added 0s04 (4% wt sol. in water, 0.04 mL, 0.006 mmol) and the reaction stirred at 
room temperature for 10 minutes, after which time a solution of Na10 4 (60 mg, 0.28 
mmol) in water (1 mL) was added dropwise over 3 minutes. The reaction was stirred 
at room temperature for 18h, filtered and concentrated in vacuo to remove any 
organic solvents. The aqueous residue was extracted with EtOAc (4 x 5 mL), the 
combined extracts washed with brine, dried (Na 2 SO4) and concentrated in vacuo to 
afford a yellow oil. 'H NMR analysis of this product indicate that it consisted 
predominantly of the starting material, although two small aldehyde peaks could be 
identified. 
Method I/I 
To a stirred solution of the alkene 225 (50 mg, 0.13 mmol) in THF:water (25:1) was 
added 0s04 (4% wt sol. in water, 0.04 mL, 0.006 mmol) and the reaction stirred at 
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room temperature for 10 minutes, after which time a solution of Na10 4 (60 mg, 0.28 
mmol) in water (1 mL) was added dropwise over 3 minutes. The reaction was stirred 
at room temperature for 10 days, filtered and concentrated in vacuo to remove any 
organic solvents. The aqueous residue was extracted with EtOAc (4 x 5 mL), the 
combined extracts washed with brine, dried (Na 2SO4) and concentrated in vacuo to 
afford a yellow oil. Analysis by tic indicated that a complex polar mixture of 
compounds had been formed and the 'H NMR spectrum contained many peaks in the 
aldehyde region. None of the products could be identified. 








To a vigorously stirred solution of alkene 225 (350 mg, 0.90 mmol) in EtOAc (7.5 
mL) and MeCN (7.5 mL) at 0°C was added a solution of RuC1 3 .xH20 (139 mg, 0.67 
mmol) and Na104 (286 mg, 1.34 mmol) in water (4.5 mL). After 5 minutes, sat. aq . 
Na2S203 solution (ca.200 mL) was added, the aqueous layer washed with EtOAc (3 x 
25 mL) and the combined organic fractions dried (MgSO 4) and concentrated in 
vacuo. Purification by flash column chromatography (hexane:EtOAc, 2:1) afforded 
an inseparable mixture of diols 227/228 (190 mg, 50%) and recovered starting 
material (60 mg, 17%). RF (hexane:EtOAc, 1:1) 0. 11, (hexane:EtOAc, 1:2) 0.38, 
(EtOAc) 0.62; vmax ./cm' (film, polyethylene) 3500-3200 (br, OH), 2916 (m, CH), 
1734 (s, C=O), 1525 (m), 1246 (s); 9H (250MHz, CDC1 3) major 227: 1.14 (311, t, J 
7.0, CH2CH3), 1.88, (1H, ddd, J3.5, 7.5, 14.5, CHHCHOAc), 2.08, (3H, s, CH3CO2), 
2.26 (1H, ddd, J3.5, 8.0, 14.5, CHJICHOAc), 3.44 (1H, dq, J7.0, 9.5, CHHCH 3), 
3.65 (1H dq, J 7.0, 9.5, CHHCH 3), 3.76 (3H, s, CO2CH3 ), 3.82 (1H, dd, J4.0, 6.0, 
CHOH), 4.10 (1H, dd, J3.5, 7.5, CHOEt), 4.42 (111, m, CHOH), 4.73 (1H, br d, J 
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5.0, 011), 5.10 (2H, ABX q, PhCH2), 5.23 (1H, m, CHOAc), 5.42 (1H, br s, Nil), 
7.30-7.41 (51-1, m, Phil); Minor 228: resonances obscured by major; 6C (62.9MHz, 
CDC13) major 227: 15.2 (CH3 , CH2 GH3), 21.1 (CH3 , GOGH3), 29.6 (CH2 , 
CHC112CH), 53.0 (CH 3 , CO2 CH3), 66.0 (CH2 , OGH2CH3), 66.8 (C, CCO2Me), 67.3 
(CH2 , PhCH2), 69.8 (CH, CHOEt), 70.5 (CH, CH(OH)CHOAc), 71.1 (CH, CCHOH) 
76.5 (CH, CHOAc), 128.2, 128.4, 128.5 (CH, aryl CH), 135.5 (C, aryl C), 155.4 (C, 
OCONH), 170.2 (C, CO 2CH3), 171.0 (C, 02CCH 3 ); m/z (ES +ve) 448 (MNa, 
100%), 416 (24); HRMS (FAB +ve, THIOG) 426.1760 (Fragment. C 20H28N09 
requires 426.1764). 
(±)-(l S, 2R, 3R, 4S, 5S)-1-Acetoxy-4-(benzyloxycarbonylamino)-5-
ethoxy-4-(methoxycarbonyl)cyclohexan-2,3-diol dimethyl ketal 229 
and (±)-(l S, 2S, 3S, 4S, 5S)-1-Acetoxy-4-(benzyloxycarbonylamino)-5-
ethoxy-4-(methoxycarbonyl)cyclohexan-2,3-diol dimethyl ketal 230 






To a stirred solution of the diols 227/228 (44 mg, 0.10 mmol) in DCM (5 mL) was 
added 2,2-dimethoxypropane (5 mL, excess) and TsOH (cat.). After 20h, the solution 
was concentrated in vacuo and purified by careful flash column chromatography 
(hexane:EtOAc, 7:1 —* 4:1) to afford the major acetonide 229 (13 mg, 27%) and the 
minor acetonide 230 (5 mg, 10%). 
Major 229: RF (hexane:EtOAc, 1:2) 0.78; 5H (250MHz, CDG1 3) 1.04 (3H, t, J 7.0, 
CH2CH3), 1.30 (3H, s, CH3CCH3), 1.39 (3H, s, CH3CCH3), 1.90, (1H, ddd,J6.0, 
7.0, 14.5, CHHCHOAc), 2.11, (3H, s, CH3 CO2), 2.48 (1H, ddd,J5.0, 8.0, 14.5, 
CHJICHOAc), 3.36 (1H, dq, J 7.0, 9.5, CHHCH 3), 3.51 (1H dq, J 7.0, 9.5, 
CHJJCH3), 3.80 (3H, s, CO2CH3), 4.33 (1H, dd, J5.5, 8.0, CHOEt), 4.32-4.40 (1H, 
obs. m, CHCHOAc), 4.90 (1H, d, J5.0, CCHOCMe2), 5.10 (2H, ABX q, PhCH2), 
5.47 (1H, app. dt, J5.0, 7.0, GHOAc), 6.47 (1H, br s, Nil), 7.30-7.40 (5H, m, Phil); 
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(62.9MHz, CDC1 3) 15.2 (CH 3 , CH2 CH3), 21.2 (CH3 , COCH3), 24.3, 26.0 (2 x 
CH3 , C(CH3) 2), 30.0 (CH2 , CHCH2CH), 52.7 (CH3 , CO2 CH3), 66.2 (CH2 , 
OCH2CH3), 66.5 (CH2, PhGH2), 68.0 (C, CCO2Me), 70.3, 73.8, 76.2, 76.4 (4 x CH, 
CHOEtCH2CH(OAc)CH(OC)CH), 109.4 (C, C(CH 3 )2), 127.8, 128.1, 128.4 (CH, 
aryl CH), 136.1 (C, aryl C), 154.4 (C, OCONH), 168.7 (C, CO2CH 3), 170.1 (C, 
02 CCH3); in/z (FAB +ve, THIOG) 466 (MH, 10%), 91(100); HRMS (FAB +ve, 
THIOG) 466.2088 (Fragment. C 23H32N09 requires 466.2077). 
Minor 230: RF (hexane:EtOAc, 1:2) 0.74; 	(200MHz, CDC1 3) 1.16 (3H, t, J 7.0, 
CH2CH3), 1.51 (3H, s, CH3CCH3), 1.56 (3H, s, CH3 CCH3), 1.95-2.15, (2H, m, 
CHHCHOAc), 2.09, (3H, s, CH3 CO2), 3.37 (111, dq,J7.0, 9.5, CHHCH3), 3.62 (1H 
dq,J7.0, 9.5, CHHCH3), 3.75 (3H, br s, CO2CH3), 4.15-4.25 (1H, dd,J5.5, 8.0, 
CHOEt), 4.57-4.63 (1H, obs. m, CHCHOAc), 5.02-5.08 (1H, d, J5.0, CCHOCMe2), 
5.09 (2H, s, PhCH2), 5.40 (1H, app. dt, J4.5, 6.5, CHOAc), 5.53 (1H, br s, Nil), 
7.30-7.40 (5H, m, Phi]); m/z (FAB +ve, THIOG) 466 (MH, 43%),332 (34),91 
(100); FIRMS (FAB +ve, THIOG) 466.2081 (Fragment. C23H 32N09 requires 
466.2077). 





To a stirred solution of the diols 227/228 (93 mg, 0.22 mmol) in acetone (4 mL) was 
added a solution of Na10 4 (140 mg, 0.66 mmol) in water (1.5 mL) and the reaction 
heated at 33°C for 20h. The white solid was removed by filtration, the solution 
concentrated in vacuo to Ca. 2 mL and the aqueous solution extracted with DCM (3 x 
20mL), the combined organics dried (Na2SO 4) and concentrated in vacuo to afford 
the crude products 235/236/237 which were carried through directly to the next step. 
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RF (hex:EtOAc, 1:1) 0.28; & (200MHz, CDC1 3 ) 0.90-1.40, 1.90-2.10, 3.20-3.90, 
4.00-4.10, 4.40-4.55, 4.80-5.30, 5.80-5.90, 7.20-7.40, 9.54, 9.78; m/z (ES +ve) 487 
([M+MeCN]Na, 21%), 446 (MNa, 100). 
(±)-(2S, 3S, 5S, 6R)-2,3-Bis-(acetoxy)-1 -(benzyloxycarbonyl)-5-ethoxy-
6-(methoxycarbonyl)-6-(oxymethyl)-piperidine 238 and bicyclic acetal 
239 
0 










To a stirred solution of the crude piperidines 235/236/237 (carried over from 
previous experiment, 0.22 mmol) in DCM (15 mL) was added acetic anhydride (0.5 
mL), pyridine (0.4 mL) and DMAP (cat.). After 20h, the organic solution was 
washed with 0.5M HC1 (20 mL) and concentrated in vacuo. Purification by flash 
column chromatography (hexane:EtOAc, 2:1) afforded the acetates 238 and 239 as 
an oil (54 mg, 53% over two steps). RF(hexane:EtOAc, 1:1) 0.51; c5j (200MHz, 
CDC13) 1.09 (3H, t,J7.0, CH2CH3), 1.15 (3H, t,J7.0, CH2CH3), 1.86, 1.96, 1.98, 
1.99 (4 x 3H, 4 x s, 4 x 02CCH3), 1.80-2.30 and 2.40-2.60 (4 x H, obsc. m, 2 x 
CHHCHOEt), 3.25-3.45 and 3.50-3.70 (2 x 2H, m, 2 x CH2CH3), 3.65 (611, s, 2 x 
CO2CH3), 4.12 (1H, dd, J6.5, 11.5, CHOEt), 4.51 (1H, dd, J3.0, 4.0, CHOAc), 
4.90-4.95 (IH, m, CHOAc), 5.05 and 5.38(2 xH, 2 x d,J 12.0, PhCHHO), 5.15 (2H, 
s, PhCH20), 6.07 (1H, d,J3.5, NCHOCH), 6.54 (1H, s, OCHOAc), 7.00 (1H, d,J 
3.5, NCHOAc), 7.20-7.40 (10H, m, 2 x Phil), 9.55 (1H, s, CHO); m/z (ES +ve) 529 
(MNa+MeCN, 12%),488 (MNa, 100), 483 (14), 466 (MH, 14),406 (MH-HOAc, 
13), 316 (33). 
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To a stirred solution of alcohol 224 (170 mg, 0.49 mmol) in DCM (5 mL) was added 
TBSC1 (108 mg, 0.72 mmol) and imidazole (99 mg, 1.46 mmol). After 2 days water 
(15 mL) was added and the aqueous solution extracted with DCM (3 x 15 mL), the 
combined extracts dried (MgSO 4) and concentrated in vacuo. Purification by flash 
column chromatography (hexane:EtOAc, 5:1) afforded the product 241 as an oil (194 
mg, 86%). RF (hexane:EtOAc, 1:1) 0.75; 	(360MHz, CDC1 3) 0.12 (6H, s,2 x 
SiCH3), 0.93 (91-1, s, C(CH3 ) 3), 1.17 (3H, t,J7.0, CH2CH3), 1.83 (1H, ddd,J3.0, 5.5, 
13.5, CHHCHOSi), 2.26 (111, ddd, J5.0, 8.5, 13.5, CHHCHOSi), 3.47 (1H, dq, J 
7.0, 9.5, OCHHCH3), 3.65 (1H, dq,J7.0, 9.5, OCHHCH 3), 3.77 (31-1, s, CO2CH3 ), 
3.98 (11-1, dd, J3.0, 8.5, CHOEt), 4.50 (1H, tdd, 1.0, 3.5, 5.0, CHOSi), 5.09 (11-1, 
distorted d,J 12.0, PhCHH), 5.16 (1H, distorted d, J 12.0, PhCHR), 5.53 (1H, s, 
NH), 5.91 (1H, dd, J3.5, 10.0, CHCHOSi), 6.15 (1H, br d, 10.0, CH=CHCHOSi), 
7.30-7.40 (5H, m, Phil); i (62.9MHz, CDC13) -5.0, -4.7 (2 x CH3 , Si(CH3)2), 15.2 
(CH3 , CH2CH3 ), 18.0 (C, SiC(CH3 )3), 25.7 (CH3 , C(CH3 ) 3), 32.8 (CH2 , CH2CHOSi), 
52.6 (CH3 , CO2 CH3), 62.0 (C, CCO 2Me), 64.5 (CH, CHOEt), 65.3 (CH 2, OCFI2CH3), 
66.7 (CH2, PhCH2), 76.6 (CH, CHOSi), 125.9 (CH, CHCHOSi), 128.0, 128.1, 128.3 
(CH, aryl CH), 132.4 (CH, CH=CHCHOSi), 136.0 (C, aryl C), 154.9 (C, NHCO 2), 
170.8 (CH3, CO2CH3); m/z (FAB +ve, NOBA) 486 (MNa, 49%),464 (MH, 25), 
406 ([MH-'Bu]H, 50), 391 (42) 332 ([MH-TBDMS]H, 66), 267 (48), 208 (58), 91 















To a stirred solution of alkene 224 (120 mg, 0.26 mmol) in EtOAc (6 mL) and 
MeCN (6 mL) was added a solution of ruthenium chloride hydrate (6 mg, 0.03 
mmol) and sodium periodate (389 mg, 1.8 mmol) in water (3 mL). After 3 minutes 
the reaction was poured into sat. aq . Na2S 203 solution (50 mL) and stirred for 15 
minutes. The solution was concentrated in vacuo so as to remove the organic 
solvents and the aqueous solution extracted with EtOAc (3 x 50 mL). The combined 
extracts were dried (MgSO 4) and concentrated in vacuo. Purification by flash column 
chromatography (hexane:EtOAc, 5: 1-2: 1) afforded recovered starting material, 
some unidentified products and the diol 242 as an oil (18 mg, 14%). RF 
(hexane:EtOAc, 3:2) 0.27; vmax /cm' (film) 3415 (br, OH), 2955 (m, CH), 2856 (m, 
CH), 1725 (s, C=O), 1504 (m), 1259 (s), 1092 (s), 1027 (s); cj-j (250MHz, CDC1 3) 
0.07 (6H, s, 2 x SiCH3), 0.87 (91-1, s, C(CH3 ) 3), 1.13 (3H, t, J7.0, CH2CH3), 1.86 
(1H, ddd, .J4.0, 4.5, 14.0, CIIHCHOSi), 2.10 (11-1, ddd, J2.5, 11.0, 14.0, 
CH[ICHOSi), 3.34 (1H, dq,J7.0, 9.5, OCHHCH3), 3.61 (1H, dq,J7.0, 9.5, 
OCHJICH3), 3.74 (3H, s, CO2CH3), 3.82 (11-1, ddd, .J4.5, 4.5, 9.5, CCHOH), 3.96 
(1H, dd, J4.0, 11.0, CHOEt), 4.13 (1H, ddd, 2.5, 4.5, 4.5, CHOSi), 4.34 (1H, dd, J 
4.0, 4.5, CH(OH)CHOSi), 4.55-4.70 (1H, br, NH), 5.13 (211, ABX, PhCH2), 5.65-
5.80 (2H, br, 2 x 011), 7.30-7.45 (5H, m, Phil); tFc (62.9MHz, CDC1 3) -5.2, -5.0 (2 x 
CH3 , Si(CH3)2), 15.1 (CH3 , CH2 CI-13), 17.8 (C, SiC(CH 3 )3), 25.6 (CH3 , C(GH3)3), 
28.0 (CH2 , CH2CHOSi), 53.2 (CH 3 , CO2CH3), not seen (C, CCO2Me), 64.9 (CH 2 , 
137 
Experimental 
OCH2CH3), 67.4 (Cl2 , Phd 2), 70.0 (CH, CCHOH), 70.4 (CI, CHOEt), 72.1 (CH, 
CHOSi), 76.6 (CH, CH(OH)CHOSi), 128.2, 128.3, 128.5 (CH, aryl CH), 135.7 (C, 
aryl C), 156.9 (C, NHCO2), 171.9 (CH3 , CO2CH3). 
Method II 
To a stirred solution of alkene 224 (200 mg, 0.43 mmol) in acetone (15 mL) and 
water (3 mL) was added NMO (48 mg, 0.41 mmol) and 0s0 4 (4% wt. sol. in water, 
0.1 mL, 0.02 mmol). The reaction was stirred at room temperature for 20h, diluted 
with EtOAc (15 mL) and washed with sat. aq . Na2 S 203 solution. The aqueous layer 
was extracted with EtOAc (3 x 10 mL), the combined organic layers washed with 
brine (15 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (hex:EtOAc, 4:1) afforded only recovered alkene 224 (192 
mg, 96%). Data as above. 





1 1 OEt 
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To a stirred solution of alkene 241 (130 mg, 0.28 mmol) in EtOAc (4 mL) and 
MeCN (4 mL) at 0°C was added a solution of RuC13.xH20 (ca. 10 mg, cat.) and 
Na104 (240 mg, 1.12 mmol) in water (2 mL). The reaction was stirred for 15 
minutes, poured into sat. aq . Na2 S203 solution (50 mL) and stirred vigorously for 5 
minutes. The aqueous layer was washed with EtOAc (3 x 10 mL) and the combined 
organic layers washed with water (10 mL) and brine (10 mL), dried (MgSO 4) and 
concentrated in vacuo. The residue was taken up in DCM (15 mL), Ac20 (0.5 mL), 
pyridine (0.5 mL) and DMAP (cat.) added and the reaction stirred for 20h after 
which time 1 M HC1 (15 mL) was added, the organic layer washed with water 
(10 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (hex:DCM:EtOAc, 6:2:1) afforded the product 243/244 as an oil (54 
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mg, 38% over two steps). 41 (250MHz, CDC13) major product 243: 0.12 and 0.13 
(6H, s, Si(CH3 )2), 0.98 (9H, s, SiC(CH3)3), 1.06 (3H, t,J7.0, CH 2CH3), 2.00-2.30 
(2H, m, CHHCHOEt), 2.09, (3H, s, 02CCH3), 3.45-3.65 (2H, m, OCH2CH3), 3.77 
(3H, s, CO 2CH3), 4.21 (1H, dd,J3.0, 3.0, CHOEt), 4.95-5.20 (1H + 2H, m, CHOSi 
and PhCH2), 6.20 (1H, s, NCHOCH), 6.86 (1H, s, OCHOAc), 7.30-7.50 (5H, m, 
Phil); minor 244: 2.23 (3H, s, 02CCH3), 3.82 (3H, s, CO2CH3), 4.63 (1H, dd,J7.0, 
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The following section contains the X-ray diffraction data to support the crystal 
structures presented in the text. 
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Table 1. Crystal data and structure refinement for dbno49. 







Unit cell dimensions 
Volume 




F(000) 	 - 
B DATA COLLECTION 
Crystal description 
Crystal size 











a = 5.1707(10) A alpha = 90 deg. 
b = 8.7482(17) A beta = 90 deg. 
c = 25.214(5) A gamma = 90 deg. 
1140.5(4) A3 






0.43 x 0.12 x 0.04 mm 
3.51 to 70.03 deg. 
-5C=h<=5, -8c=k<=10, -24<=lc=30 
2486 
1548 [R(int) = 0.0286] 
Omega-theta with learnt-profile (Clegg) 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program. used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters  
direct (5M-YS-97) 
Full-matrix least-squares on F2 
$TTL-97 
Difmap,. then geometrically 
Riding or rotating group 
1548/0/133 
Goodness-of-fit on F2 
Conventional R [F>4sigma(F)] 
Weighted R (F*2 and all data) 
Absolute itructure paraaeter 
Extinction coefficient 
Final maximum delta/sigma 
1.065 
RI = 0.0451 [1239 data] 





caic w=1/(\a2(Fo2')+(0.0333P)^2+0.2621P) where P(Fo2'+2FC2')/3 
Largest diff. peak and hole 	0.164 and -0.169 e.A'-3 
Table 2. Atomic coordinates ( x 10'4) and equivalent isotropic 
displacement parameters (A*2 x 103) for dbno49. 	U(eq) is defined 
as one third of the trace of the orthogonalised Uij tensor. 
I 	 y 	•. 	 S 	 U(eq) 
.C(1) -3039(8) 9006(4) 10073(1) 62(1) 
 -1395(7) 9666(4) 9852(1) .41(1) 
 669(6) 10490(3) 9572(1) 36(1) 
0(31) 1346(4) 11877(3) 9837(1) 48(1) 
 -50(6) 10793(3) 8992(1) 31(1) 
C(41) -2382(6) 11807(3) 8929(1) 39(1) 
N(S) -465(5) 9346(3) 8718(1) .35(1) 
C(6) 1511(6) 8498(3) 8539(1) 32(1) 
0(61) 3769(4) 8847(3) 8584(1) 47(1) 
0(7) 624(4) 7229(2) 8297(1) 41(1) 
C(8) 2427(6) 6086(3) 8081(1) 37(1) 
 607(8) .4931(4) 7832(2) 81(2) 
 3967(8) 5373(4) 8524(1) 60(1) 
 4128(7) 6796(4) 7661(1) 48(1) 
































Symmetry transformations used to generate equivalent atoms: 
Table 4. Anisotropic displaceaent parameters (A*2 x 103) for dbno49. 
The anisotropic displaceaeflt factor exponent takes the form: 
-2 pi2 ( b2 a**,2 Ull + ... + 2 h k a* b* U12 ] 
• Ull U22 U33 U23 U13 U12 
 69(3) 59(2) 57(2) 16(2) -2(2) -6(2) 
 47(2) 38(2) 39(2) -1(1) -9(2) 5(2) 
 28(2) 35(2) 45(2) -12(1) -8(2) 2(2) 
0(31) 36(1) 50(1) 57(1) -32(1) -4(1) 0(1) 
 24(2) 31(1) 39(2) -11(1) 2(1) -2(2) 
C(41) 42(2) 37(2) 37(1) -6(1) -5(2) 9(2) 
11(5) 21(1) 36(1) 	• 48(1) -20(1) 1(1) 1(1) 
C(6) 28(2) 30(2). 38(1) -8(1) -2(2) -3(2) 
0(61) 22(1) 46(1) 74(2) -24(1) -2(1) -2(1) 
0(7) 22(1) 39(1) 61(1) -24(1) 2(1) 1(1) 
C(8) 29(2) 32(2) 49(2) -11(1) 3(2) 6(2) 
 45(2) 61(2) 137(4) -64(3) • 9(3) -4(3) 
 69(3) 54(2) 55(2) 11(2) 16(2) 23(2) 
 51(2) 49(2) 43(2) • 	 • 	 1(2) 	• 4(2) 15(2) 
Table 5. Hydrogen coordinates ( z 104) and isotropic 
displacement parameters (A2 x 103) for dbno49. 
x y z U(eq) 
R(1) -4360 8475 10251 74 
 2219 9826 9573 43 
E(31) 17 12294 9951 72 
 1435 11311 8822 37 
E(41A) -3868 11327 9094 58 
H(41B) -2727 11963 8555 58 
H(41C) -2053 12785 9097 58 
11(5) -2039 9025 8669 42 
H(81A) -360 5415 7549 122 
11(818) -583 4553 8099 122 
H(81C) 1601 4085 7690 122 
H(82A) 2797 4987 8793 89 
H(82B) 5099 6135 8679 89 
H(82C) 4996 4537 8385 89 
11(83k) 5485 7388 7830 71 
11(838) 3096 7460 7438 71 
H(83C) 4897 5996 7447 71 
m 
Table 1. Crystal data and stricture refinement for mordio. 
Contact 	 Simon Parsons, S.Parsons@ed.ac.uk 







Unit cell dimensions 
Volume 












a = 6.5377(9) A 	alpha = 90 deg. 
b = 10.1782(14) A. beta = 90 deg. 
o = 16.835(2) A gmm = 90 deg. 
1120.2(3) A3 
















0.44 x 0.08 x 0.08 mm 
CCD area detector 
2.34 to 26.40 deg. 
0<=h<=8, 0<=k<=12, 0<=l<=21 
1350 
1350 (R(int) = 0.00001 
phi and omega scans 
Sadabs 
(Tmin= 0.821, Tmax=l) 
C. SOLUTION' AND REFINEMENT. 
Solution 
	
direct (SHELXS-97 (Sheldrick, 1990)) 
Refinement type 	 Full-matrix least-squares on F2 
Program used. for refinement SHELXL-97 
Hydrogen atom. placement geom 
Hydrogen atom treatment. riding 
Data / restraints / parameters 1350/0/155 
Goodness-of-fit on F'2 1.102 
Conventional R (F>4sigma(F)] Ri = 0.0444 	[1288 data] 
Weighted R (FA2  and all, data) wR2 = 0.1151 
Absolute structure parameter 3 (2) 
Extinction coefficient 0.003(3) 
Final maximum delta/sigma 0.001 
Weighting scheme 
caic where P=(Fo2+2Fc'2)/3 
Largest diff. peak and hole 0.189 and -0.171 e.A-3 
Table 2. Atomic coordinates ( x 10"4) and equivalent isotropic 
displacement parameters (A'2 x 10'3) for mordio. 	U(eq) is defined 
as one third of the trace of. the- orthogonalized Uij tensor. 
x y z U(eq) 
0(1) 8570(3) 8492(2) 9457(1) 32(1) 
0(2) 11781(3) 8353(2) 9131(1) 41(1) 
 10358(4) 9039(3) 9285(2) 27(1) 
 10543(4) 10516(3) 9273(2) 27(1) 
N(4) 8904(3) 11153(2) 9713(1) 28(1) 
0(5) 5570 (3) 11277(2) 10047(1) 40(1) 
 7034 (4) .10663(3) 9785 (2) 28(1) 
 6738 (4) 9263 (3) 9536 (2) 32(1) 
 10602(4) 10974(3) 8421(2) 38(1) 
0(8) 8747(3) 10540(2) 8073(1) 39(1) 
 8546(5) 10888(5) 7257(2) 70(2) 
 6628(5) 10270(3) 6949(2) 37(1) 
 6236 (7) 8959 (3) 7079 (2) 53(1) 
 4500(9) 8393(3.) 6779(2) 74(2) 
 3126(7) 9127(3) 6351(2) 57(1) 
 3490(5) 10443(3) 6227(2) 34(1) 
 5238(4) 11004(3) 6515(2) 31(1) 




































C(15) -C(10)-C(9) 120.5(3) 





Symmetry transformations used to generate equivalent atoms: 
Table 4. 	.Anisotropic displacement parameters (A2 x 10'3) for mordio. 
The anisotropic displacement factor, exponent takes the form: 
-2 pi -2 ( h2 a*2. Ull + ... + 2+ h k a* b* U12 ] 
U].]. 	U22 	U33 	U23 	U13 	U12 
0(1) 29(1) 19(1) 47(1) -4(1) 1(1) 2(1) 
0(2) 34(1) 35(1) 56(1) -11(1) -2(1) 13(1) 
C (2) 25(1) 27'(l) 30(1) -4(1) -5(1) 6(1) 
C(3) 16(1) 26(1) 40(1) -4(1) -5(1) 1(1) 
N(4) 23(1) 19(1) 43(1) -8(1) -1(1) 0(1) 
0(5) 31(1) 29(1) 59(1) -4(1) 11 (1) 8(1) 
 25(1) 23(1) 36(1) -2(1) -1(1) 5(1) 
 21 (1) 23(1) 47(2) -1(1) 4(1) 0(1) 
 21(1) 47(2) 47(2) 9(2) 2(1) -5(1) 
0(8) 24(1) 60(1) 34(1) 15(1) -2(1) -6(1) 
C(9) 30(2) 141(4) 40(2) 38(2) -1(2) -20(2) 
C (10) 29(2) 59(2)' 24(1) 2(1) 8(1) 5(2) 
 84(3) 43(2) 32(1) -4(1) -4(2) 34(2) 
 151(5) 25(2) 45(2) -3(1) -38(3) -5(3) 
 88(3) 46(2) 36(2) 2(2) -22(2) -26(2) 
 35(2) 41(2) 26(1) 3(1) 3(1) 1(1) 
C (15) 33(2) 34(2) 26(1) 6(1) 6(1) -3(1) 
Table S. Hydrogen coordinates ( x 10"4) and isotropic 
displacement parameters (A^2 .x 103) for mordio. 
x y z U(eq) 
H(3) 11871 10759 9529 33 
H(4) 9169 11908 9946 34 
H(6A) 5837 8830 9929 38 
H(6B) 6013 9257 9020 38 
H(7A) 10706 11943 8395 46 
H(7B) 11790 10588 8140 46 
H(9A) 9742 10566 6953 84 
H(9B) 8474 11855 7200 84 
 7173 8445 7378 64 
 4244 7486 6868 88 
 1928 8729 6142 68 
 2529 10960 5941 41 
 .5502 11907 6417 37 
041 
Table 1. Crystal data and structure refinement for big092. 
Contact 	 Simon Parsons, S.Parsons@ed.ac.uk  
A.. CRYSTAL DATA 






Unit. cell dimensions 
Volume 





















a = 8.3363(8) A alpha = 105.2220(15) deg. 
b = 8.7772(9) A beta = 111.9063(15) deg. 
c = 10.1840(10) A ga-ma = 104.0512(16)deg 
616.89(11) A3 






0.43 x 0.35 x 0.32 mm 
SMART APEX CCD 
2.34 to 26.41 deg.' 
-10<=h<=10, -10<=k<=10, -12<=l<=12 
5043 
2490 (R(int) = 0.02111 
Omega 
Sadabs 
(Tinin 0.700, Tmax=0.928) 
C. SOLUTION AND REFINEMENT. 
Solution 
	 direct (SPITS-97 (Sheidrick, 1990)) 
Refinement type 
	 Full-matrix least-squares on F2 
Program used. for refinement 
Hydrogen atom placement 
Hydrogen. atom treatment 
Data 1 restraints / parameters 
Goodness-of-fit an F2 
Conventional R [F>4sigma(F)] 







Ri = 0.0407 [2033 data] 
wR2 = 0.1064 
0.247(15) 
Final maximum delta/sigma 	 0.002 
Weighting scheme 
caic 	1/(\s2'(Fo'2)+(0.0710P)^2'+O.0000P] where P(Fo'2+2Fc"2.)/3 
Largest diff. peak and hole 	0.260 and -0.284, e.A"-3 
"I' 
Table. 2.. Atomic coordinates ( x 10"4) and equivalent isotropic 
displacement parameters. (A2. x 103) for big092. 	U(eq) is defined 
as one third of the trace of the orthogonalized Ui3 tensor. 
y z U(eq) 
 3648(2) 1552(2) 2560(1) 22(1) 
 5715(2) 2763(2) 3496(1) 23(1) 
 .6953(2) 1822(2) 4077(1) 26(1) 
 6814(2.) 413(2) 1753(2) 26(1) 
C(S) 4815(2) -617(2) 1555(2) 27(1) 
C(6) 3409(2) -128(2) .1457(I) 25(1) 
0(11) 3768(1) 1884(1) 5038(1) 29(1) 
C(11) 2804(2) 1233(2) 3633(1) 23(1) 
N(12) 1006(2) 245(2) 2924(1) 31(1) 
0(13) 1587(1) 1889(1.) 322(1) 34(1) 
C(13) 2593(2) 2457(2) 1683(1) 24(1) 
0(14) 2915(1.) 3984(1) 2653(1) 30(1) 
C(15) 2184(2) 	. 5072(2) 1976(2) 43(1) 
0(21) 6106(1) 3374(1) 2432(1.) 25(1) 
 7674(2) 4933(2) 3137(2) 34(1) 
 7765(2) 5503(2) 1897(2) 38(1) 
0(41) 7742(1) -638(1) 3292(1) 31(1) 
Table I. Bond. lengths [A] and angles. [deg] for big092.. 
C(1)-C(6) 	. 1.5153(17) 
C(1)-C(13) . 1.5261(18) 
C(l)-C(2) 1.5366(17). 




C(4)-0(41) 	 . 1.4305(16) 


























N(12)-C(11)-C(1) - 115.26(11) 
0(13)-C(13)-0(14) 123.91(12) 
0(13)-C(13)-C(1) 125.85(12) 




Symmetry transformations. used to generate equivalent atoms: 
Table 4. Anisotropic displacement parameters (A2 x 10'3) for big092. 
The anisotropic displacement factor exponent takes the form: 
-2. pif2. ( h2 a**2. Ull +... + 2 h k a* b* U12 ] 
Ull 	U22 	1133 	U23 	1113 	1112 
 19(1) 26(1) 19(1) 8(1) 9(1) 5(1) 
 21(1) 26(1) 19(1) 7(1) 10(1) 5(1) 
 19(1) 30(1) 23(1) 10(1) 8(1) 5(1) 
 24(1) 33(1) 29(1.) 16(1) 16(1) 12(1) 
 30(1) 27(1.) 24(1) 7(1) 16(1) 8(1) 
 22(1) 27(1) 19(1) 5(1). 9(1) 3(1) 
0(11) 28(1) 36(1) 20(1) 10(1) 12(1) 7(1) 
C(11) 23(1) 24(1) 24(I) 10(1) 13(1) 9(1) 
N(12) 22(1) 42(1) 24(1) 11(1) 13(1) 5(1) 
0(13) 31(1) 36(1) 22(1) 10(1) 4(1) 7(I) 
C(13) 18(1) 30(1) 23(1) 11(1) 11(1) 5(1) 
0(14) 35(1) 33(1) 24(1) 12(1) 12(1) 17(1) 
C(15) 52(1) 43(1.) 36(1) 19(1) 15(1) 27(1) 
0(21) 22(1) 26(1) 22(1) 9(1) 11(1) 2(1) 
 32(1) 28(1) 31(1) 8(1) 13(1) -1(1) 
 40(1) 32(1) 44(1) 18(1) 23(1) 7(1) 
0(41) 30(1) 41(1) 40(1.) 24(1) 25(1) 19(1) 
Table 5.. Hydrogen coordinates (. x 104) and isotropic 
displacement parameters (A'2. x103) for big092. 
x y' z tl(eq) 
U(2) 5891. 3737 4381 27 
H(3A) 8267 2639 4717 31 
H(35) 6571. 1323 4731 31 
H(4) 7474 969 2258 32 
H(5) 4542. -1693 818 33 
H(6) 2189 -866 656 30 
H(12A) 370(20) -240(20) 1920(20) 40(4) 
H(123) 360(20) -20(20) 3404(19) 38(4) 
H(15A) 2.749 5315 1328 64 
H(15B) 2483 6145 2793 64 
H(15C) 825 4498 1347 64 
H(22A) 8834. 4766 3691. 41 
H(22B) 7539 5806 3886 41 
H(23A) 7857 4614 1145 58 
H(23B) 8864 6560 2350 58 
H(23C) 6632 5708 1383 58 
H(41) 7253 -1077 3759 47 
